_pmid,_doi,_publicationTitle,_year,_context,_confidence,_verdict,_usageType,softwareName
PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,Fiber Photometry Trace Processing Gradinaru Lab FP_Session_Processing_2.m https://github.com/GradinaruLab/dLight1/blob/master/FP_Session_Processing2.m,0.85,Accept,Experimental Usage,Fiber Photometry Trace Processing
PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,ABET II Software for Operant Control Lafayette Instrument Company Model 89501,0.85,Accept,Experimental Usage,ABET II Software for Operant Control
PMID:41468561,10.1212/WNL.0000000000214480,NF1-Specific Growth Charts for Head Circumference Over the First 3 Years of Life.,,...we implemented a recently described method called 'LMSz' to construct NF1-specific head circumference growth charts...,0.85,Accept,Experimental Usage,LMSz
PMID:41468561,10.1212/WNL.0000000000214480,NF1-Specific Growth Charts for Head Circumference Over the First 3 Years of Life.,,"...we fit generalized additive models for location, scale, and space (GAMLSS) with the normal distribution family...",0.8,Accept,Experimental Usage,GAMLSS
PMID:41468561,10.1212/WNL.0000000000214480,NF1-Specific Growth Charts for Head Circumference Over the First 3 Years of Life.,,...GAMLSS model visualization was performed using customized R functions (https://github.com/BGDlab/gamlssTools)...,0.85,Accept,Experimental Usage,gamlssTools
PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,,sequenced using the Thermo Sequenase fluorescent labelled primer cycle sequencing kit (Amersham Biosciences) and analysed on an ALF-express automated DNA sequencer,0.85,Accept,Experimental Usage,ALF-express automated DNA sequencer (Amersham Biosciences)
PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,,"The sequence environment of all donor- and acceptor sites was analysed using Splice Site Prediction by Neural Network (SSPNN, URL address:",0.9,Accept,Experimental Usage,Splice Site Prediction by Neural Network (SSPNN)
PMID:12057013,10.1186/1471-2164-3-13,Complex splicing pattern generates great diversity in human NF1 transcripts.,,The mfold computer program version 3.0 was used to predict the RNA secondary structure and to calculate the folding free energy,0.9,Accept,Experimental Usage,mfold computer program version 3.0
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,IncuCyte proliferation analysis was used to measure the effect of NF1 deficiency on cell proliferation and drug response,0.85,Accept,Experimental Usage,IncuCyte
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,We measured cellular energetics using Agilent Seahorse XF-96 Glyco Stress Test and Mito Stress Test assays,0.9,Accept,Experimental Usage,Agilent Seahorse XF-96
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,GENCODE was used to map FASTQ files to GRCh38 (release 33 with STAR v2.7.8a basic two-pass mode),0.9,Accept,Experimental Usage,STAR v2.7.8a
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,Trim Galore v0.6.0 was used to trim sequencing adapters from demultiplexed FASTQ files,0.9,Accept,Experimental Usage,Trim Galore v0.6.0
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,principal component analysis was computed using iDEP 9.1,0.9,Accept,Experimental Usage,iDEP 9.1
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,"Lipid identifications were assigned using LipidSearch (v5.0, Thermo Fisher Scientific)",0.9,Accept,Experimental Usage,LipidSearch v5.0
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,"Data was analyzed using Compound Discoverer (v 3.2, Thermo Fisher Scientific)",0.9,Accept,Experimental Usage,Compound Discoverer v3.2
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,Synergy was calculated using the SynergyFinder R package,0.9,Accept,Experimental Usage,SynergyFinder R package
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,"ATP metrics were calculated following Mookerjee et al., 2017 and using the CEAS R Package",0.9,Accept,Experimental Usage,CEAS R Package
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,PCA analysis was performed using the FactoMineR R package,0.9,Accept,Experimental Usage,FactoMineR R package
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,Msigdbr and clusterProfiler packages were used to perform Gene Set Enrichment Analysis (GSEA),0.9,Accept,Experimental Usage,msigdbr R package
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,Msigdbr and clusterProfiler packages were used to perform Gene Set Enrichment Analysis (GSEA),0.9,Accept,Experimental Usage,clusterProfiler R package
PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,"The ZetaView (Particle Metrix, version 8.04.02) was utilized to perform a detailed absolute size distribution analysis of the sEVs",0.85,Accept,Experimental Usage,"ZetaView (Particle Metrix, version 8.04.02)"
PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,"Flow cytometry analysis was conducted using a (BD Biosciences, San Jose, CA, USA), and the data were processed with FlowJo software (version X10.0.7)",0.85,Accept,Experimental Usage,FlowJo software (version X10.0.7)
PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,"The resulting color intensity was then measured at 450 nm using the SpectraMax M5 microplate reader (Molecular Devices, San Jose, CA, USA)",0.8,Accept,Experimental Usage,"SpectraMax M5 microplate reader (Molecular Devices, San Jose, CA, USA)"
PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,"An Orbitrap Fusion Lumos mass spectrometer (Thermo Fisher Scientific Inc., Waltham, MA, USA), paired with the EASY-nLC 1000 liquid chromatography system",0.85,Accept,Experimental Usage,"Orbitrap Fusion Lumos mass spectrometer (Thermo Fisher Scientific Inc., Waltham, MA, USA)"
PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,paired with the EASY-nLC 1000 liquid chromatography system (Thermo Fisher Scientific Inc.) was employed for a comprehensive analysis of proteins,0.85,Accept,Experimental Usage,EASY-nLC 1000 liquid chromatography system (Thermo Fisher Scientific Inc.)
PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,We used the STRING database (version 11.0) ( https://cn.string-db.org/ ) to construct a PPI network to show the relationships of the DeMiRNAs,0.85,Accept,Experimental Usage,STRING database (version 11.0)
PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,"Cytoscape (version 3.7.2) was used to construct the network, and the hub genes in the PPI network were analyzed using cytohubba in Cytoscape (version 3.7.2)",0.85,Accept,Experimental Usage,Cytoscape (version 3.7.2)
PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,The Image J software (version 1.51) was used to analyze the relative density of immunoreactive bands,0.85,Accept,Experimental Usage,Image J software (version 1.51)
PMID:41149489,10.3390/curroncol32100569,Small Extracellular Vesicles Derived from NF2-Associated Schwannoma Cells Modulate Tumor Progression and Immunity via HSP90.,,"Data are expressed as the Mean ± SD, and analyses were performed using GraphPad Prism (version 9.5.0)",0.85,Accept,Experimental Usage,GraphPad Prism (version 9.5.0)
PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,"...Histomorphometric measurements were performed using the Bioquant Analysis System (Nashville, TN, USA)...",0.8,Accept,Experimental Usage,Bioquant Analysis System
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,...Time-corrected data were analyzed in SEDFIT 16.1 in terms of a continuous c(s) distribution...,0.9,Accept,Experimental Usage,SEDFIT 16.1
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,...Data were analyzed globally in terms of a single noninteracting species in SEDPHAT 14.0...,0.9,Accept,Experimental Usage,SEDPHAT 14.0
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,...Negatively-stained neurofibromin particles were autopicked using EMAN2 e2boxer using a box size of 326 pixels...,0.9,Accept,Experimental Usage,EMAN2 e2boxer
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,...Reference-free 2D classification was carried out using the Iterative Stable Alignment and Clustering (ISAC) procedure implemented in a Sphire package...,0.9,Accept,Experimental Usage,Sphire
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,...All further analyses and visualizations were performed using Chimera...,0.9,Accept,Experimental Usage,Chimera
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,...Full-length NF1 dimer data were low-pass filtered to 60 Å and used as a reference in Relion for refinement...,0.9,Accept,Experimental Usage,Relion
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,...Data reduction followed standard procedures using MantidPlot...,0.9,Accept,Experimental Usage,MantidPlot
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,...The reduced SAXS and SANS data were analyzed using the ATSAS tools PRIMUS and GNOM...,0.9,Accept,Experimental Usage,ATSAS
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,...The DAMMIF program within ATSAS was used to generate ab initio shape reconstruction models...,0.9,Accept,Experimental Usage,DAMMIF
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,"...Astra software (Wyatt Technology, version 7.1.3) was used to collect and analyze the SEC-MALS data...",0.9,Accept,Experimental Usage,"Astra software (Wyatt Technology, version 7.1.3)"
PMID:31836666,10.1074/jbc.RA119.010934,Biochemical and structural analyses reveal that the tumor suppressor neurofibromin (NF1) forms a high-affinity dimer.,,...data were analyzed by Bio-Rad CFX Manager software (version 3.1)...,0.9,Accept,Experimental Usage,Bio-Rad CFX Manager software (version 3.1)
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Imaging was performed on a LSM700 confocal microscope (Zeiss) with ZEN imaging software (Zeiss),0.85,Accept,Experimental Usage,LSM700 confocal microscope (Zeiss)
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Imaging was performed on a LSM700 confocal microscope (Zeiss) with ZEN imaging software (Zeiss),0.85,Accept,Experimental Usage,ZEN imaging software (Zeiss)
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,quantitative RT-PCR analysis performed on an ABI Prism HT 7900 real-time PCR detection system (Applied Biosystems),0.85,Accept,Experimental Usage,ABI Prism HT 7900 real-time PCR detection system (Applied Biosystems)
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,equipped with SDS software version 2.4 (ThermoFisher Scientific),0.85,Accept,Experimental Usage,SDS software version 2.4 (ThermoFisher Scientific)
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Mapping was performed using STAR 2.4.2a software with mouse genome (mm9),0.9,Accept,Experimental Usage,STAR 2.4.2a
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Differential expression analysis was performed with DESeq2 using default settings,0.9,Accept,Experimental Usage,DESeq2
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Gene set enrichment analysis (GSEA) was performed with the entire gene list using GSEA software 4.0.1 desktop (Broad Institute),0.9,Accept,Experimental Usage,GSEA software 4.0.1 desktop (Broad Institute)
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,KEGG and gene ontology (GO) enrichment analysis was performed using the Signature Database (MSigDB) and DAVID 6.8,0.9,Accept,Experimental Usage,DAVID 6.8
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,analysed by MaxQuant (v1.5.3.30),0.9,Accept,Experimental Usage,MaxQuant (v1.5.3.30)
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,coupled online to a Q-Exactive HF Orbitrap mass spectrometer (Thermo Scientific),0.85,Accept,Experimental Usage,Q-Exactive HF Orbitrap mass spectrometer (Thermo Scientific)
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Images were acquired using a Fusion FX spectra gel documentation system (Vilber) with FUSION FX software,0.85,Accept,Experimental Usage,Fusion FX spectra gel documentation system (Vilber)
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Images were acquired using a Fusion FX spectra gel documentation system (Vilber) with FUSION FX software,0.85,Accept,Experimental Usage,FUSION FX software
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Blots images were analysed with ImageJ grey value analysis tool,0.85,Accept,Experimental Usage,ImageJ
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,that were used with high-resolution Oxygraph-2k (OROBOROS Instruments),0.85,Accept,Experimental Usage,Oxygraph-2k (OROBOROS Instruments)
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,DatLab software (OROBOROS INSTRUMENTS) was used for data acquisition and analysis,0.85,Accept,Experimental Usage,DatLab software (OROBOROS INSTRUMENTS)
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Imaging was performed using a Zeiss Stereo Discovery V12 and the AxioVision 4.6 software (Zeiss),0.85,Accept,Experimental Usage,Zeiss Stereo Discovery V12
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Imaging was performed using a Zeiss Stereo Discovery V12 and the AxioVision 4.6 software (Zeiss),0.85,Accept,Experimental Usage,AxioVision 4.6 software (Zeiss)
PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,"Drug–drug interactions were analyzed with CompuSyn software Version 1.0 (Informer Technologies, Los Angeles, CA, USA)",0.9,Accept,Experimental Usage,CompuSyn software Version 1.0
PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,Internally developed MR software SPIN (Signal Processing in MR (Version SVN Revision 1895); http://mrc.wayne.edu) was used for tumor volume measurement,0.85,Accept,Experimental Usage,SPIN (Signal Processing in MR Version SVN Revision 1895)
PMID:32781282,10.1016/j.trsl.2020.08.001,Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1.,,"Total body fat and lean tissue were assessed using a Bruker minispec LF90 TD‐NMR analyzer, which was calibrated prior to each use",0.85,Accept,Experimental Usage,Bruker minispec LF90 TD‐NMR analyzer
PMID:32781282,10.1016/j.trsl.2020.08.001,Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1.,,Indirect calorimetry was assessed using the Comprehensive Lab Animal Monitoring System (CLAMS),0.85,Accept,Experimental Usage,Comprehensive Lab Animal Monitoring System (CLAMS)
PMID:32781282,10.1016/j.trsl.2020.08.001,Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1.,,"Littermate male WT and Nf1 +/− mice (16 – 20 weeks old) were housed individually in oxymax cages (Columbus Instruments, Columbus OH)",0.8,Accept,Experimental Usage,"oxymax cages (Columbus Instruments, Columbus OH)"
PMID:32781282,10.1016/j.trsl.2020.08.001,Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1.,,"Serial blood glucose measurements were made every 10 minutes for 120 minutes using a glucometer (AlphaTrak 2, Zoetis, Parsippany, NJ)",0.8,Accept,Experimental Usage,"AlphaTrak 2 (Zoetis, Parsippany, NJ)"
PMID:32781282,10.1016/j.trsl.2020.08.001,Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1.,,Image Pro Plus was used to quantify the area of lipid accumulation (Oil Red-O stained) in each section from the liver and skeletal muscle,0.75,Accept,Experimental Usage,Image Pro Plus
PMID:25851896,10.3988/jcn.2015.11.2.172,Preclinical assessment of the anticancer drug response of plexiform neurofibroma tissue using primary cultures.,,"More than 200 cells were counted for each drug concentration using ImageJ software (version 1.48; National Institutes of Health, Behesda, MD, USA)",0.9,Accept,Experimental Usage,"ImageJ software (version 1.48; National Institutes of Health, Behesda, MD, USA)"
PMID:39110684,10.1371/journal.pone.0308207,Electrical stimulation of Schwann cells on electrospun hyaluronic acid carbon nanotube fibers.,,Fiber diameter and angle were measured using ImageJ (v1.53a) with at least 200 fibers per fiber type,0.8,Accept,Experimental Usage,ImageJ (v1.53a)
PMID:39110684,10.1371/journal.pone.0308207,Electrical stimulation of Schwann cells on electrospun hyaluronic acid carbon nanotube fibers.,,The images were analyzed using NIH ImageJ (version 1.53a) software,0.8,Accept,Experimental Usage,NIH ImageJ (version 1.53a)
PMID:18670322,10.1097/MLG.0b013e318177e20b,Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.,,"reverse transcribed using the Gene AMP kit (Perkin-Elmer; Waltham, MA) in a DNA Engine Peltier Thermal cycler (PTC-200; MJ Research, Watertown, MA)",0.8,Accept,Experimental Usage,"DNA Engine Peltier Thermal cycler (PTC-200; MJ Research, Watertown, MA)"
PMID:18670322,10.1097/MLG.0b013e318177e20b,Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.,,"An ABI Prism 7,000 Sequence Detection System was used for all reactions with the following cycling parameters",0.85,Accept,Experimental Usage,"ABI Prism 7,000 Sequence Detection System"
PMID:18670322,10.1097/MLG.0b013e318177e20b,Vestibular schwannoma quantitative polymerase chain reaction expression of estrogen and progesterone receptors.,,Results were analyzed using a Microsoft Excel program designed for Q-PCR quantitation based on internal control mRNA levels,0.75,Accept,Experimental Usage,Microsoft Excel program designed for Q-PCR quantitation
PMID:39966622,10.1038/s41598-025-88589-x,The development of an artificial intelligence auto-segmentation tool for 3D volumetric analysis of vestibular schwannomas.,,"To create the tumor models for the ground truth dataset, an image processing software (Simpleware ScanIP, Synopsys) was used.",0.95,Accept,Experimental Usage,Simpleware ScanIP
PMID:39966622,10.1038/s41598-025-88589-x,The development of an artificial intelligence auto-segmentation tool for 3D volumetric analysis of vestibular schwannomas.,,The helper (DPP V1.0) was trained using proprietary AI- and ML-based algorithms and information.,0.9,Accept,Development,DPP V1.0
PMID:33507822,10.1200/JCO.20.02220,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,,"A noncompartmental analysis was performed to estimate area under the concentration-time curve from time 0 to 12 hours using Phoenix WinNonlin (Version 8.1; Certara, Princeton, NJ).",0.8,Accept,Experimental Usage,Phoenix WinNonlin (Version 8.1)
PMID:33507822,10.1200/JCO.20.02220,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,,"A population pharmacokinetics (PK) analysis was also performed using nonlinear mixed effect modeling with NONMEM (version 7.2; ICON, Ellicott City, MD)",0.8,Accept,Experimental Usage,NONMEM (version 7.2)
PMID:33507822,10.1200/JCO.20.02220,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,,"NONMEM (version 7.2; ICON, Ellicott City, MD) with Perl speaks NONMEM version 3.6.2 and Pirana version 2.7.1 (Certara).",0.75,Accept,Experimental Usage,Perl speaks NONMEM version 3.6.2
PMID:33507822,10.1200/JCO.20.02220,NF106: A Neurofibromatosis Clinical Trials Consortium Phase II Trial of the MEK Inhibitor Mirdametinib (PD-0325901) in Adolescents and Adults With NF1-Related Plexiform Neurofibromas.,,"NONMEM (version 7.2; ICON, Ellicott City, MD) with Perl speaks NONMEM version 3.6.2 and Pirana version 2.7.1 (Certara).",0.75,Accept,Experimental Usage,Pirana version 2.7.1
PMID:38811427,10.1186/s41687-024-00732-w,Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.,,A digital version of the cNF-Skindex was administered to the participants using the data capture system Castor EDC,0.8,Accept,Experimental Usage,Castor EDC
PMID:38811427,10.1186/s41687-024-00732-w,Quality of life in individuals with neurofibromatosis type 1 associated cutaneous neurofibromas: validation of the Dutch cNF-Skindex.,,Statistical analyses were performed using SPSS version 28.0,0.8,Accept,Experimental Usage,SPSS version 28.0
PMID:37378983,10.1001/jamanetworkopen.2023.20599,Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial.,,"Assessments were completed at baseline, after treatment, and at 6- and 12-month follow-up via REDCap",0.85,Accept,Experimental Usage,REDCap
PMID:37378983,10.1001/jamanetworkopen.2023.20599,Effect of Mind-Body Skills Training on Quality of Life for Geographically Diverse Adults With Neurofibromatosis: A Fully Remote Randomized Clinical Trial.,,"We used SAS, version 9.4 (SAS Institute Inc), for analyses",0.8,Accept,Experimental Usage,"SAS, version 9.4"
PMID:29897904,10.1371/journal.pone.0197350,Traditional and systems biology based drug discovery for the rare tumor syndrome neurofibromatosis type 2.,,This work has created an openly accessible resource (www.synapse.org/SynodosNF2) of fully characterized isogenic schwannoma and meningioma cell systems,0.9,Accept,Development,www.synapse.org/SynodosNF2
PMID:41598414,10.3390/jcm15020475,Dermoscopy-Guided High-Frequency Ultrasound Imaging of Subcentimeter Cutaneous and Subcutaneous Neurofibromas in Patients with Neurofibromatosis Type 1.,,"...Recorded images were analyzed in SkinAid cloud software, stored under patient ID with demographic and lesion details...",0.8,Accept,Experimental Usage,SkinAid cloud software
PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,Confocal images were taken on either a Zeiss LSM 410 or LSM 510 microscope,0.85,Accept,Experimental Usage,Zeiss LSM 410
PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,Confocal images were taken on either a Zeiss LSM 410 or LSM 510 microscope,0.85,Accept,Experimental Usage,Zeiss LSM 510
PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,Wings were imaged under brightfield optics on a Zeiss Axioplan 2ie compound microscope,0.85,Accept,Experimental Usage,Zeiss Axioplan 2ie
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...Pressure-based cell lysis was performed for 60 cycles of 50 s at 30 °C and 310 MPa using the Barocycler NEP 2320 instrument (Pressure BioSciences, Easton, MA, USA)...",0.9,Accept,Experimental Usage,Barocycler NEP 2320 instrument (Pressure BioSciences)
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...A nanoflow high-performance liquid chromatography system Easy-nLC 1200 coupled to the Q Exactive HF mass spectrometer (Thermo Fisher Scientific, Bremen, Germany)...",0.85,Accept,Experimental Usage,Easy-nLC 1200
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...Easy-nLC 1200 coupled to the Q Exactive HF mass spectrometer (Thermo Fisher Scientific, Bremen, Germany) equipped with a nano-electrospray ionization source...",0.9,Accept,Experimental Usage,Q Exactive HF mass spectrometer (Thermo Fisher Scientific)
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,...The data were acquired automatically using Thermo Xcalibur 4.1 software (Thermo Fisher Scientific) and processed with the Spectronaut Pulsar software...,0.9,Accept,Experimental Usage,Thermo Xcalibur 4.1 software
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...acquired automatically using Thermo Xcalibur 4.1 software (Thermo Fisher Scientific) and processed with the Spectronaut Pulsar software (Biognosys, Schlieren, Switzerland)...",0.9,Accept,Experimental Usage,Spectronaut Pulsar software (Biognosys)
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,...The Ki67 immunohistochemistry was performed using the BenchMark Ultra system (Roche). A 36-min pretreatment with the Cell Conditioning Solution CC1...,0.85,Accept,Experimental Usage,BenchMark Ultra system (Roche)
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...All sections were counterstained with hematoxylin and imaged using the NanoZoomer S60 digital slide scanner (Hamamatsu, Hamamatsu City, Japan)...",0.85,Accept,Experimental Usage,NanoZoomer S60 digital slide scanner (Hamamatsu)
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...imaged using the NanoZoomer S60 digital slide scanner (Hamamatsu, Hamamatsu City, Japan) and Pannoramic Midi FL slide scanner (3DHistech Ltd, Budapest, Hungary)...",0.85,Accept,Experimental Usage,Pannoramic Midi FL slide scanner (3DHistech Ltd)
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...All analyses were performed using the R software for statistical computing, version 4.0.0, and package lmerTest, version 3.1-2...",0.85,Accept,Experimental Usage,"R software for statistical computing, version 4.0.0"
PMID:40394150,10.1038/s41416-025-03055-9,Mass spectrometric insights into the protein composition of human cutaneous neurofibromas: comparison of neurofibromas with the overlying skin.,,"...All analyses were performed using the R software for statistical computing, version 4.0.0, and package lmerTest, version 3.1-2...",0.85,Accept,Experimental Usage,"lmerTest package, version 3.1-2"
PMID:19191334,10.1002/glia.20845,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,,Target preparation and microarray hybridization were performed by the Siteman Cancer Center Multiplex Gene Analysis Core Facility using Affymetrix Mouse Genome 430 2.0 GeneChip microarrays,0.8,Accept,Experimental Usage,Affymetrix Mouse Genome 430 2.0 GeneChip
PMID:29402968,10.1038/s41598-018-20894-0,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,,"Target sequencing was performed using the Haloplex custom target enrichment system (Agilent Technologies, CA, USA) on the MiSeq sequencing platform",0.85,Accept,Experimental Usage,Haloplex custom target enrichment system
PMID:29402968,10.1038/s41598-018-20894-0,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,,"Target sequencing was performed using the Haloplex custom target enrichment system (Agilent Technologies, CA, USA) on the MiSeq sequencing platform",0.85,Accept,Experimental Usage,MiSeq sequencing platform
PMID:29402968,10.1038/s41598-018-20894-0,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,,"The data were analysed using NextGENe software v.2.3.4.1 (Softgenetics, PA, USA) with the default settings",0.9,Accept,Experimental Usage,NextGENe software v.2.3.4.1
PMID:29402968,10.1038/s41598-018-20894-0,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,,The width and length of the cranio-cartilage were measured using ImageJ software,0.85,Accept,Experimental Usage,ImageJ software
PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,Proximity maps were generated using PathVisio software,0.8,Accept,Experimental Usage,PathVisio software
PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,GO analysis was performed using g:Profiler,0.8,Accept,Experimental Usage,g:Profiler
PMID:31015291,10.1126/scisignal.aau8749,Proximity biotinylation identifies a set of conformation-specific interactions between Merlin and cell junction proteins.,,Venn diagrams were generated using BioVenn,0.8,Accept,Experimental Usage,BioVenn
PMID:40225167,10.1155/2023/9628049,Functional Assays Combined with Pre-mRNA-Splicing Analysis Improve Variant Classification and Diagnostics for Individuals with Neurofibromatosis Type 1 and Legius Syndrome.,,"Splice site prediction software (Alamut Visual Plus, version 1.5.1; Sophia Genetics) was used to identify variants likely to affect pre-mRNA splicing",0.85,Accept,Experimental Usage,"Alamut Visual Plus, version 1.5.1"
PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,,"Images were captured and merged using Openlab (Improvision, Waltham, MA).",0.8,Accept,Experimental Usage,"Openlab (Improvision, Waltham, MA)"
PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,,PCR fragment analyses were performed by the UCSF Genome Core using Peak Scanner software from Applied Biosystems.,0.85,Accept,Experimental Usage,Peak Scanner software from Applied Biosystems
PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,,All analyses were performed on R 2.7.0.,0.8,Accept,Experimental Usage,R 2.7.0
PMID:27081657,10.1002/acn3.288,A randomized placebo-controlled lovastatin trial for neurobehavioral function in neurofibromatosis I.,,"fMRI data analyses were performed using tools from the FMRIB software library ( www.fmrib.ox.ac.uk/fsl ), version 5.0",0.9,Accept,Experimental Usage,FMRIB software library (FSL)
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,Burrows–Wheeler Aligner (version 0.7.8) was utilized to map the paired-end clean reads,0.85,Accept,Experimental Usage,Burrows–Wheeler Aligner (version 0.7.8)
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,SAMtools (version 1.0) is used for sorting the BAM file,0.85,Accept,Experimental Usage,SAMtools (version 1.0)
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,Single-nucleotide variant is then identified using GATK (version 3.8),0.85,Accept,Experimental Usage,GATK (version 3.8)
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,subsequently annotated using ANNOVAR (version 2015Dec),0.85,Accept,Experimental Usage,ANNOVAR (version 2015Dec)
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,CNV is detected by control-FREEC (version 9.9),0.85,Accept,Experimental Usage,control-FREEC (version 9.9)
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,acquired using BD FACS Canto II and further analyzed by FlowJo software,0.8,Accept,Experimental Usage,FlowJo software
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,"using in-house software running in MATLAB (MathWorks, Natick, MA, version 2016b)",0.8,Accept,Experimental Usage,MATLAB (version 2016b)
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,We developed R codes and used RStudio (version 1.2.5033),0.8,Accept,Experimental Usage,RStudio (version 1.2.5033)
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,"R package ""Analyses of Phylogenetics and Evolution"" (APE, version 5.2)",0.85,Accept,Experimental Usage,R package APE (version 5.2)
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,"MEGAX (version 0.1, for MAC) to generate SKY-based phylogenetic trees",0.85,Accept,Experimental Usage,MEGAX (version 0.1)
PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,Microarray data was analyzed using Affymetrix expression console MAS 5.0 method. Significance was calculated with Welch's t-test,0.85,Accept,Experimental Usage,Affymetrix expression console MAS 5.0
PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,Heat maps were generated using XenoBase® version 3.5 from Affymetrix array data using MAS 5.0 normalization,0.9,Accept,Experimental Usage,XenoBase® version 3.5
PMID:24040940,10.1186/1479-5876-11-213,Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors.,,ensure detection of a single product based upon single and consistent melting temperatures for each primer set using StepOne Software v2.3 (Applied Biosystems),0.85,Accept,Experimental Usage,StepOne Software v2.3
PMID:39824854,10.1038/s41598-025-85386-4,Comparison of 1D and 3D volume measurement techniques in NF2-associated vestibular schwannoma monitoring.,,"postcontrast thin-sliced (≤ 3 mm) T1-weighted magnetic resonance (MR) sequences were uploaded into the iPlan Net software (Brainlab, Feldkirchen, Germany), and volumes were measured",0.9,Accept,Experimental Usage,"iPlan Net software (Brainlab, Feldkirchen, Germany)"
PMID:39824854,10.1038/s41598-025-85386-4,Comparison of 1D and 3D volume measurement techniques in NF2-associated vestibular schwannoma monitoring.,,"Statistical evaluation was performed using the Statistical Package for Social Studies (SPSS 10.0 for Windows, SPSS Inc.)",0.8,Accept,Experimental Usage,SPSS 10.0 for Windows
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,...Human Splicing Finder (HSF) Version 2.4.1 ( http://www.umd.be/HSF/ Assessing on 21 December 2020)...,0.9,Accept,Experimental Usage,Human Splicing Finder (HSF) Version 2.4.1
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,...Mutation taster ( http://www.mutationtaster.org/ Assessing on 21 December 2020)...,0.85,Accept,Experimental Usage,Mutation taster
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,...Combined Annotation Dependent Depletion (CADD) v1.6 ( https://cadd.gs.washington.edu/ Assessing on 21 December 2020)...,0.9,Accept,Experimental Usage,Combined Annotation Dependent Depletion (CADD) v1.6
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,...Protein sequence alignments were performed using Multalin ( http://multalin.toulouse.inra.fr/multalin/ Assessing on 28 December 2020)...,0.85,Accept,Experimental Usage,Multalin
PMID:33673681,10.3390/cancers13050999,Hybrid Minigene Assay: An Efficient Tool to Characterize mRNA Splicing Profiles of ,,...Densitometric analyses were performed using the ImageJ (Image Processing and analysis in Java) software...,0.85,Accept,Experimental Usage,ImageJ
PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,"Sequencing data were demultiplexed and analyzed using CRISPResso or CRISPResso2 ( Pinello et al., 2016 ; Clement et al., 2019 )",0.9,Accept,Experimental Usage,CRISPResso
PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,"Sequencing data were demultiplexed and analyzed using CRISPResso or CRISPResso2 ( Pinello et al., 2016 ; Clement et al., 2019 )",0.9,Accept,Experimental Usage,CRISPResso2
PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,"Logistic regressions were performed in JMP (JMP Pro 15.0.0, SAS Institute Inc., Cary, NC) using the presence or absence of germline transmission",0.85,Accept,Experimental Usage,JMP Pro 15.0.0
PMID:34630515,10.3389/fgene.2021.721045,Assessment of Mosaicism and Detection of Cryptic Alleles in CRISPR/Cas9-Engineered Neurofibromatosis Type 1 and ,,"Target sites within the genes of interest were selected using Massachusetts Institute of Technology's CRISPR design tool (now unavailable, previously: crispr.mit.edu, ), or later, CRISPOR",0.85,Accept,Experimental Usage,CRISPOR
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,"Sequence reads were aligned to human reference genome Ensembl GRCh37 (v.75), using STAR (v. 2.5.2a)",0.85,Accept,Experimental Usage,STAR
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,Differentially expressed genes in pair-wise comparisons were identified by edgeR's quasi-likelihood F test (v. 3.18.1),0.85,Accept,Experimental Usage,edgeR
PMID:33273014,10.1074/jbc.RA120.014960,mTOR kinase inhibition disrupts neuregulin 1-ERBB3 autocrine signaling and sensitizes NF2-deficient meningioma cellular models to IGF1R inhibition.,,Synergy scores were generated using the web-based SynergyFinder application (https://synergyfinder.fimm.fi/),0.85,Accept,Experimental Usage,SynergyFinder
PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,Sections were viewed and imaged using an Olympus BX61 upright light microscope and Q imaging Retiga Exi camera with InVivo 3.2.0 software,0.8,Accept,Experimental Usage,Olympus BX61 upright light microscope
PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,Sections were viewed and imaged using an Olympus BX61 upright light microscope and Q imaging Retiga Exi camera with InVivo 3.2.0 software,0.8,Accept,Experimental Usage,Q imaging Retiga Exi camera
PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,Sections were viewed and imaged using an Olympus BX61 upright light microscope and Q imaging Retiga Exi camera with InVivo 3.2.0 software (Media Cybernetics).,0.85,Accept,Experimental Usage,InVivo 3.2.0 software
PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,Computerized quantitative morphometric analysis was performed using Image-Pro Plus software (Media Cybernetics).,0.85,Accept,Experimental Usage,Image-Pro Plus software
PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,"The width and equatorial length of the testes were measured on testicular histological images using Image J1.45s, version 1.44p (NIH, Bethesda, MD).",0.9,Accept,Experimental Usage,"Image J1.45s, version 1.44p"
PMID:29408605,10.1016/j.neuroscience.2018.01.054,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,,Digital recordings at 50 kHz (using Windaq DI-720 hardware with Pro+ software) were made.,0.85,Accept,Experimental Usage,Windaq DI-720 hardware with Pro+ software
PMID:29408605,10.1016/j.neuroscience.2018.01.054,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,,"images captured with a Leica DMR III microscope and CCD camera running Metamorph software (Molecular Devices, Inc., Sunnyvale, CA).",0.85,Accept,Experimental Usage,Metamorph software
PMID:29408605,10.1016/j.neuroscience.2018.01.054,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,,"Using ImageJ software (NIH, Bethesda, MD), g-ratios were calculated on the EM micrographs",0.85,Accept,Experimental Usage,ImageJ software
PMID:29408605,10.1016/j.neuroscience.2018.01.054,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,,"Differences among means for each group were analyzed by using t-tests and one way ANOVA using SigmaPlot software (Systat, San Jose, CA).",0.8,Accept,Experimental Usage,SigmaPlot software
PMID:24958239,10.1186/gb-2014-15-6-r80,SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints.,,we used the non-B DNA database and the non-B DNA Motif Search Tool under preset search criteria,0.8,Accept,Experimental Usage,non-B DNA Motif Search Tool
PMID:24958239,10.1186/gb-2014-15-6-r80,SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints.,,we screened both datasets for the presence of direct and inverted repeats using the MEME suite software,0.8,Accept,Experimental Usage,MEME suite software
PMID:24958239,10.1186/gb-2014-15-6-r80,SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints.,,Both datasets were also investigated for the presence of retrotransposons by means of the UCSC Repeat Masker track,0.8,Accept,Experimental Usage,UCSC Repeat Masker
PMID:24958239,10.1186/gb-2014-15-6-r80,SVA retrotransposon insertion-associated deletion represents a novel mutational mechanism underlying large genomic copy number changes with non-recurrent breakpoints.,,we performed BLASTN self-alignments of the respective regions,0.8,Accept,Experimental Usage,BLASTN
PMID:32642737,10.1093/noajnl/vdz050,Assessing interobserver variability and accuracy in the histological diagnosis and classification of cutaneous neurofibromass.,,"The hematoxylin and eosin (H&E)-stained slides were scanned using an Aperio XT scanner. Digital slides were downloaded using the native image format, Aperio SVS files",0.85,Accept,Experimental Usage,Aperio XT scanner
PMID:32642737,10.1093/noajnl/vdz050,Assessing interobserver variability and accuracy in the histological diagnosis and classification of cutaneous neurofibromass.,,"analyzed using the CaloPix viewer (TRIBVN-HEALTHCARE, Chatillon, France), and digital images were shared with the reviewers through the internet",0.8,Accept,Experimental Usage,CaloPix viewer
PMID:32642737,10.1093/noajnl/vdz050,Assessing interobserver variability and accuracy in the histological diagnosis and classification of cutaneous neurofibromass.,,who entered free text of up to a 200 word description for each case into a REDcap database. Responses were analyzed for the most commonly used terms,0.85,Accept,Experimental Usage,REDcap database
PMID:38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,,An Agilent ChemStation software (version C.01.07) was used for data analysis,0.8,Accept,Experimental Usage,Agilent ChemStation software (version C.01.07)
PMID:38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,,"ROIs were manually drawn with VivoQuant software version 4.0 (Invicro, Needham, MA, USA)",0.8,Accept,Experimental Usage,VivoQuant software version 4.0
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,"MS was carried out using an Ultimate 3000 UPLC system (Thermo Fisher, Germany) connected to an Orbitrap Velos Pro mass spectrometer",0.8,Accept,Experimental Usage,"Ultimate 3000 UPLC system (Thermo Fisher, Germany)"
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,"Ultimate 3000 UPLC system (Thermo Fisher, Germany) connected to an Orbitrap Velos Pro mass spectrometer (Thermo Fisher, Bremen, Germany)",0.8,Accept,Experimental Usage,"Orbitrap Velos Pro mass spectrometer (Thermo Fisher, Bremen, Germany)"
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,Andromeda search engine integrated in MaxQuant version 1.3.05 programme was used to identify the proteins in the Uniprot database,0.9,Accept,Experimental Usage,MaxQuant version 1.3.05
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,"LFQ data generated by Maxquant were processed using Microsoft Excel and specially developed proteomics software, Perseus",0.85,Accept,Experimental Usage,Perseus
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,"Functional enrichment analysis was performed using Benjamini-Hochberg multiple correction testing integrated in to the database for annotation, visualization and integrated discovery (DAVID) software",0.85,Accept,Experimental Usage,DAVID software
PMID:28126595,10.1016/j.ebiom.2017.01.020,Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target.,,Confocal microscopy was performed using a Leica DMI6000B microscope,0.8,Accept,Experimental Usage,Leica DMI6000B microscope
PMID:41168866,10.1186/s13023-025-04093-5,Artificial intelligence-based tools for precision diagnosis and treatment of neurofibromatosis type 1 associated peripheral and central glial tumors.,,"...manual additions from SYNAPSE, the CTF data portal, and BioArchives, to collect technical reports and preprints...",0.8,Accept,Experimental Usage,SYNAPSE
PMID:41168866,10.1186/s13023-025-04093-5,Artificial intelligence-based tools for precision diagnosis and treatment of neurofibromatosis type 1 associated peripheral and central glial tumors.,,"...manual additions from SYNAPSE, the CTF data portal, and BioArchives, to collect technical reports and preprints...",0.8,Accept,Experimental Usage,CTF data portal
PMID:41168866,10.1186/s13023-025-04093-5,Artificial intelligence-based tools for precision diagnosis and treatment of neurofibromatosis type 1 associated peripheral and central glial tumors.,,"...manual additions from SYNAPSE, the CTF data portal, and BioArchives, to collect technical reports and preprints...",0.8,Accept,Experimental Usage,BioArchives
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,...Amplified biotinylated cRNA (1.5 µg) was hybridized to HumanRef-8_v2 Sentrix BeadChips...,0.9,Accept,Experimental Usage,HumanRef-8_v2 Sentrix BeadChips
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,"...dried, and scanned in an Illumina BeadStation 500 scanner...",0.88,Accept,Experimental Usage,Illumina BeadStation 500 scanner
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,"...The RNA quality was estimated on a 2100 Bioanalyzer, RNA 6000 Nano Chips (Agilent, Santa Clara, CA, USA)...",0.87,Accept,Experimental Usage,"2100 Bioanalyzer, RNA 6000 Nano Chips"
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,"...were interrogated by qPCR in all 79 samples that were analyzed on microarrays on 384-well microfluidic cards (Applied Biosystems, Carlsbad, CA, USA)...",0.86,Accept,Experimental Usage,384-well microfluidic cards
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,...The reactions were then analyzed on 3730 DNA Sequencers (Applied Biosystems)...,0.89,Accept,Experimental Usage,3730 DNA Sequencers
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,...we used genotyping calls obtained from Illumina Human OmniQuad-1M SNP-arrays...,0.91,Accept,Experimental Usage,Illumina Human OmniQuad-1M SNP-arrays
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,"...A targeted, multiplex PCR primer panel was designed using the custom Ion Ampliseq Designer v3.0 (Thermo Fisher Scientific, Life Technologies, Carlsbad, CA, USA)...",0.9,Accept,Experimental Usage,Ion Ampliseq Designer v3.0
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,"...templated, and sequenced on the Ion Torrent PGM Sequencer using the Ion PGM Template OT2 200 and Ion PGM Sequencing 200v2 kits...",0.89,Accept,Experimental Usage,Ion Torrent PGM Sequencer
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,...Tiled Regression as implemented in TRAP (Tiled Regression Analysis Package) was used to identify the set of independent significant variants...,0.88,Accept,Experimental Usage,TRAP (Tiled Regression Analysis Package)
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,...SNVs were checked for Mendelian segregation with PedCheck...,0.87,Accept,Experimental Usage,PedCheck
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,...Hardy-Weinberg equilibrium (HWE) proportions were tested with PEDSTATS on 70 unrelated individuals...,0.87,Accept,Experimental Usage,PEDSTATS
PMID:25329635,10.1371/journal.pgen.1004575,Genetic modifiers of neurofibromatosis type 1-associated café-au-lait macule count identified using multi-platform analysis.,,...SNP-array analysis was done according to the manufacturer's protocol using GenomeStudio (v. 2010.2) software (Illumina)...,0.89,Accept,Experimental Usage,GenomeStudio (v. 2010.2)
PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,Raw files were processed for label-free quantification by MaxQuant (version 1.6.10.43) LFQ using the Uniprot/Swiss-Prot mouse database,0.9,Accept,Experimental Usage,MaxQuant (version 1.6.10.43)
PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,LFQ intensities for kinases with at least two peptides were imported into Perseus (version 1.6.10.50),0.9,Accept,Experimental Usage,Perseus (version 1.6.10.50)
PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,"Data were acquired uncompensated and exported as FCS 3.0 files for analysis using FlowJo Software (version 9.9.6,Tree Star Inc)",0.9,Accept,Experimental Usage,FlowJo Software (version 9.9.6)
PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,"representative image were generated using HALO Image Analysis Software (version 2.3, Indica Labs)",0.9,Accept,Experimental Usage,"HALO Image Analysis Software (version 2.3, Indica Labs)"
PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,AXL immunohistochemistry was analyzed using the IHC Profiler plugin for ImageJ (version 1.47),0.9,Accept,Experimental Usage,IHC Profiler plugin for ImageJ (version 1.47)
PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,"The microelectronic biosensor XCELLigence Real Time Cell Analysis System (RTCA, Roche Diagnostics GmbH, Mannheim, Germany) was used to measure the resistance",0.9,Accept,Experimental Usage,XCELLigence Real Time Cell Analysis System (RTCA)
PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,Measurements were performed on epifluorescent images using Image J (NIH),0.8,Accept,Experimental Usage,ImageJ
PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,Data analysis was done using R [42],0.8,Accept,Experimental Usage,R statistical software
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,"...RNA isolation, probe generation, Affymetrix HU133 Plus 2.0 microarray hybridization and data normalization were described...",0.85,Accept,Experimental Usage,Affymetrix HU133 Plus 2.0 microarray
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,...cDNA synthesis (ABI High capacity archive kit) and RT-PCR (ABI 7500 Sequence Detection System) as described,0.9,Accept,Experimental Usage,ABI 7500 Sequence Detection System
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,Nuclei were labeled with DAPI (Sigma-Aldrich) and microscopic images acquired with ImageJ software (NIH),0.85,Accept,Experimental Usage,ImageJ software (NIH)
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,Flow cytometry was performed on a FACSCanto (Becton Dickinson) and analyzed using FlowJo software,0.85,Accept,Experimental Usage,FlowJo software
PMID:33767727,10.3389/fgene.2021.603195,Molecular Diagnosis of Neurofibromatosis by Multigene Panel Testing.,,Primers were designed based on the mutation sites found using Primer 3.0,0.8,Accept,Experimental Usage,Primer 3.0
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,The raw sequence reads were first trimmed using Trim Galore (version 0.6.10) to remove any primer adapter contamination...,0.9,Accept,Experimental Usage,Trim Galore (version 0.6.10)
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,The trimmed sequence reads were further analyzed using Broad's Genome Analysis ToolKit (version 4.6.0) following their Best Practices Guidelines,0.9,Accept,Experimental Usage,Broad's Genome Analysis ToolKit (version 4.6.0)
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,BWA (version 0.7.17-r1188) was used to align the trimmed sequences to GATKs hg38 genome from their Resource Bundle,0.85,Accept,Experimental Usage,BWA (version 0.7.17-r1188)
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,Duplicate reads were removed with Picard tools (version 3.2.0) and Base Quality Score Recalibration (BQSR) was then applied...,0.85,Accept,Experimental Usage,Picard tools (version 3.2.0)
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,Both Delly and Manta were used to identify structural variants from these alignments to identify any type of off-target effects,0.8,Accept,Experimental Usage,Delly
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,Both Delly and Manta were used to identify structural variants from these alignments to identify any type of off-target effects,0.8,Accept,Experimental Usage,Manta
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"The XCalibur RAW files were collected in profile mode, centroided and converted to MzXML using ReAdW v. 3.5.1",0.85,Accept,Experimental Usage,ReAdW v. 3.5.1
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,The mgf files were then created using MzXML2Search (included in TPP v. 3.5) for all scans,0.85,Accept,Experimental Usage,MzXML2Search (included in TPP v. 3.5)
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"The data were searched using MACOT for the global studies, and SEQUEST (Thermo Fisher Scientific) for the PPI studies",0.8,Accept,Experimental Usage,MACOT
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"The data were searched using MACOT for the global studies, and SEQUEST (Thermo Fisher Scientific) for the PPI studies",0.85,Accept,Experimental Usage,SEQUEST (Thermo Fisher Scientific)
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"The list of peptide IDs generated based on SEQUEST or MASCOT search results were filtered separately using Scaffold (Protein Sciences, Portland Oregon)",0.85,Accept,Experimental Usage,"Scaffold (Protein Sciences, Portland Oregon)"
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,"Subcellular localization was assessed for the PPI's using the Human Protein Atlas (proteinatlas.org) Subcellular section (Protein Atlas version 23.0, Release date: 2023.06.19, Ensembl version: 109)",0.85,Accept,Experimental Usage,Human Protein Atlas (proteinatlas.org) Subcellular section (Protein Atlas version 23.0)
PMID:39890807,10.1038/s41598-024-84493-y,Global proteomics and affinity mass spectrometry analysis of human Schwann cells indicates that variation in and loss of neurofibromin (NF1) alters protein expression and cellular and mitochondrial metabolism.,,Further Pathway analysis was conducted using QIAGEN Ingenuity Pathway Analysis (IPA). Canonical pathways analysis identified the pathways from the QIAGEN Ingenuity Pathway Analysis library,0.85,Accept,Experimental Usage,QIAGEN Ingenuity Pathway Analysis (IPA)
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,FlowJo software was used to determine cell purity.,0.8,Accept,Experimental Usage,FlowJo software
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,"The RNA sequencing data were mapped to the Ensembl Sus Scrofa genome 11.1, release 103 using HISAT2",0.8,Accept,Experimental Usage,HISAT2
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,using HISAT2 and quantified with StringTie.,0.8,Accept,Experimental Usage,StringTie
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,using Cell Profiler (v.3.1.9). All experiments were repeated three times,0.9,Accept,Experimental Usage,Cell Profiler (v.3.1.9)
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,Images were taken using a Zeiss Axio Imager M2 and quantified using ImageJ (v.2.0.0),0.9,Accept,Experimental Usage,ImageJ (v.2.0.0)
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,"The analysis for this Article was generated using Partek Flow software, v.9.0",0.9,Accept,Experimental Usage,Partek Flow software (v.9.0)
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,RNA-seq reads were aligned to the Ensembl release 100 top-level assembly with STAR v.2.7.3a,0.9,Accept,Experimental Usage,STAR (v.2.7.3a)
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,Differentially expressed gene analysis was then performed using DESeq2 method,0.85,Accept,Experimental Usage,DESeq2
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,imaged on a Bio-Rad Gel Doc imager using Image Lab software (v.6),0.9,Accept,Experimental Usage,Image Lab software (v.6)
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,and analysed using Image Studio Lite (v.5.0.21),0.9,Accept,Experimental Usage,Image Studio Lite (v.5.0.21)
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,Images were taken using a Zeiss Axio Imager M2 and the Stereo Investigator software (mbfbioscience v2019),0.9,Accept,Experimental Usage,Stereo Investigator software (mbfbioscience v2019)
PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,"Whole-cell voltage recordings were performed at room temperature on primary cultured hippocampal neurons using an EPC 10 Amplifier (HEKA Electronics, Germany)",0.85,Accept,Experimental Usage,EPC 10 Amplifier
PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,"Electrodes were pulled from thin-walled borosilicate glass capillaries (Warner Instruments, Hamden, CT) with a P-97 electrode puller (Sutter Instrument, Novato, CA)",0.85,Accept,Experimental Usage,P-97 electrode puller
PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,"fluorescence of resorufin was measured in a Victor 3 V multilabel plate reader (Perkin Elmer, Shelton, CT) using excitation at 530 nm and emission at 590 nm",0.85,Accept,Experimental Usage,Victor 3 V multilabel plate reader
PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,"Analysis was performed using Fitmaster and origin8.1 (OriginLab Corporation, MA)",0.8,Accept,Experimental Usage,Fitmaster
PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,"Analysis was performed using Fitmaster and origin8.1 (OriginLab Corporation, MA)",0.8,Accept,Experimental Usage,origin8.1
PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,The morphometric analysis of neurite lengths of transfected green fluorescent cells was performed with Nikon Elements software,0.85,Accept,Experimental Usage,Nikon Elements software
PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,Sholl analysis was performed with ImageJ using an automated Sholl analysis plugin,0.85,Accept,Experimental Usage,ImageJ
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"DNA and RNA were quantified using Nanodrop 1000 instrument (Thermo Scientific, USA)",0.8,Accept,Experimental Usage,Nanodrop 1000
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"integrity assessed by either agarose gel electrophoresis (DNA) or Agilent 2100 Bioanalyzer (RNA; Agilent, USA)",0.8,Accept,Experimental Usage,Agilent 2100 Bioanalyzer
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Generated raw methylation files were imported and preprocessed with the statistical programming language R using the minfi package (Bioconductor).,0.85,Accept,Experimental Usage,minfi package
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Unsupervised consensus hierarchical clustering was performed with ConsensusClusterPlus package (Bioconductor),0.85,Accept,Experimental Usage,ConsensusClusterPlus package
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Differentially methylated probes were identified using limma based modeling approach (Bioconductor),0.85,Accept,Experimental Usage,limma
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,read pairs were aligned to the hg19 reference genome using BWA-MEM v 0.7.12 with default parameters.,0.85,Accept,Experimental Usage,BWA-MEM v 0.7.12
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"PCR duplicate marking, indel realignment and base quality score recalibration were performed using Picard v1.72 and GATK v3.6.0",0.85,Accept,Experimental Usage,Picard v1.72
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"PCR duplicate marking, indel realignment and base quality score recalibration were performed using Picard v1.72 and GATK v3.6.0",0.85,Accept,Experimental Usage,GATK v3.6.0
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,We identified somatic mutations using Mutect V1.1.6 and Strelka v1.0.13 for 20 tumors with matched peripheral blood controls,0.85,Accept,Experimental Usage,Mutect V1.1.6
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,We identified somatic mutations using Mutect V1.1.6 and Strelka v1.0.13 for 20 tumors with matched peripheral blood controls,0.85,Accept,Experimental Usage,Strelka v1.0.13
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,and Mutect2 V1.1 for 35 unmatched tumor samples.,0.85,Accept,Experimental Usage,Mutect2 V1.1
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Sequence data was processed and aligned to human reference genome (hg38) using STAR aligner (v.2.6.0),0.85,Accept,Experimental Usage,STAR aligner (v.2.6.0)
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Reads were sorted using SamTools (v.1.3),0.85,Accept,Experimental Usage,SamTools (v.1.3)
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"Gene expression in raw counts for each sample was calculated by the algorithm ""featureCounts"" in the package Rsubread (v.1.5.0).",0.85,Accept,Experimental Usage,Rsubread (v.1.5.0)
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Data was normalized by counts-per-million (CPM) and then subjected to trimmed means of M (TMM) using edgeR (v.3.22.3).,0.85,Accept,Experimental Usage,edgeR (v.3.22.3)
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Fusion genes for cohort of PNSTs were identified using FusionCatcher v1.1.0 with default parameters,0.85,Accept,Experimental Usage,FusionCatcher v1.1.0
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"CellRanger (10× Genomics) analysis pipeline was used for library demultiplexing, read alignment to human genome GRCh38",0.85,Accept,Experimental Usage,CellRanger
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,"The raw gene expression matrix was normalized, and variance stabilized by SCTransform in Suerat version 3.0",0.85,Accept,Experimental Usage,Suerat version 3.0
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Principle components were corrected for batch effect using Harmony (v.01),0.85,Accept,Experimental Usage,Harmony (v.01)
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Pseudotime analysis was performed as previously described using Monocle2,0.85,Accept,Experimental Usage,Monocle2
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,CNAs of neoplastic and non-neoplastic cells were inferred from the snRNA-seq data using inferCNV (v.1.1.1),0.85,Accept,Experimental Usage,inferCNV (v.1.1.1)
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Cells were directly counted using Trypan blue and the Beckman Coulter Vi-CELL (12-sample carousel) Cell Viability Analyzer,0.8,Accept,Experimental Usage,Beckman Coulter Vi-CELL
PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,"Mouse optic glioma neurospheres, Nf1−/− TVZ NSCs (TVZ_Cre) and wild-type TVZ NSCs (TVZ_LacZ) RNA was subjected to Affymetrix GeneChip Mouse Genome 430 2.0 Array hybridization",0.85,Accept,Experimental Usage,Affymetrix GeneChip Mouse Genome 430 2.0 Array
PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,"subjected to Affymetrix GeneChip Mouse Genome 430 2.0 Array hybridization, and the resulting data analyzed using Partex Genomics Suite Version 6.6 beta",0.8,Accept,Experimental Usage,Partex Genomics Suite Version 6.6 beta
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,Densitometry quantification was done using ImageJ software and normalized to GAPDH,0.8,Accept,Experimental Usage,ImageJ software
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,The heatmap was generated using CRAN's pheatmap package ( http://cran.r-project.org/web/packages/pheatmap/index.html ),0.8,Accept,Experimental Usage,pheatmap package
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,Statistical comparisons were done using R/Bioconductor's Limma package ( http://www.bioconductor.org ),0.8,Accept,Experimental Usage,Limma package
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,Statistical comparisons were done using R/Bioconductor's Limma package ( http://www.bioconductor.org ) and GeneSpring GXv7.3.1 (Agilent Technologies),0.8,Accept,Experimental Usage,GeneSpring GXv7.3.1
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,"All data analysis was done using Calcusyn software (CalcuSyn Version 2.1, BioSoft)",0.85,Accept,Experimental Usage,"Calcusyn software (CalcuSyn Version 2.1, BioSoft)"
PMID:38173515,10.1016/j.heliyon.2023.e23445,Development of a semi-automatic segmentation technique based on mean magnetic resonance imaging intensity thresholding for volumetric quantification of plexiform neurofibromas.,,"The SSTMean method consisted of 4 main steps that were implemented in a Matlab script (Version 9.9.0, Natick, MA).",0.85,Accept,Development,"Matlab script (Version 9.9.0, Natick, MA)"
PMID:38173515,10.1016/j.heliyon.2023.e23445,Development of a semi-automatic segmentation technique based on mean magnetic resonance imaging intensity thresholding for volumetric quantification of plexiform neurofibromas.,,"For each MRI slice, the tumor was identified by drawing its contour(s) using the pencil tool from FSLeyes [25].",0.8,Accept,Experimental Usage,FSLeyes
PMID:38173515,10.1016/j.heliyon.2023.e23445,Development of a semi-automatic segmentation technique based on mean magnetic resonance imaging intensity thresholding for volumetric quantification of plexiform neurofibromas.,,A semi-automatic segmentation technique based on mean magnetic resonance imaging (MRI) intensity thresholding (SSTMean) was developed,0.9,Accept,Development,SSTMean
PMID:38173515,10.1016/j.heliyon.2023.e23445,Development of a semi-automatic segmentation technique based on mean magnetic resonance imaging intensity thresholding for volumetric quantification of plexiform neurofibromas.,,compared to a similar and previously published technique based on minimum image intensity thresholding (SSTMini),0.85,Accept,Experimental Usage,SSTMini
PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,...used fragment size analysis and ultra-low-pass whole genome sequencing (ULP-WGS) of plasma cell-free DNA (cfDNA) to distinguish between MPNST and PN...,0.85,Accept,Experimental Usage,ultra-low-pass whole genome sequencing (ULP-WGS)
PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,"...GC content and mappability bias correction, depth-based local copy number estimates, and copy number–based estimation of tumor fraction were then performed using the ichorCNA tool (Broad v.0.2.0)...",0.9,Accept,Experimental Usage,ichorCNA tool (Broad v.0.2.0)
PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,"...Constructed libraries were balanced, pooled, and sequenced using 150 bp paired-end reads on a NovaSeq (Illumina, San Diego, California)...",0.8,Accept,Experimental Usage,NovaSeq (Illumina)
PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,"...or HiSeq 4000 (Illumina, San Diego, California)...",0.8,Accept,Experimental Usage,HiSeq 4000 (Illumina)
PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,...raw reads were quality filtered using fastp v.0.2...,0.85,Accept,Experimental Usage,fastp v.0.2
PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,...Quality-filtered reads were then aligned to the hg19 human genome assembly using BWA v.0.7.17...,0.85,Accept,Experimental Usage,BWA v.0.7.17
PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,...Aligned reads were deduplicated with Samtools v.1.7...,0.85,Accept,Experimental Usage,Samtools v.1.7
PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,...Genomic coverage was estimated using MosDepth...,0.85,Accept,Experimental Usage,MosDepth
PMID:34464388,10.1371/journal.pmed.1003734,Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study.,,...read-pair fragment sizes for cfDNA samples were calculated using deepTools bamPEFragmentSize...,0.85,Accept,Experimental Usage,deepTools bamPEFragmentSize
PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,Single-guide RNAs (sgRNAs) were designed using CRISPOR software (http://crispor.tefor.net),0.85,Accept,Experimental Usage,CRISPOR software
PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,Analysis was performed on a MACSQuant ® system (Miltenyi Biotec),0.8,Accept,Experimental Usage,MACSQuant system (Miltenyi Biotec)
PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,Data were analyzed using FlowJo software (FlowJo LLC),0.8,Accept,Experimental Usage,FlowJo software
PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,PCR reactions were analyzed using a QuantStudio 12K Flex Real-Time PCR system (Applied Biosystems),0.8,Accept,Experimental Usage,QuantStudio 12K Flex Real-Time PCR system
PMID:38481529,10.3389/fcell.2024.1359561,Generation of heterozygous and homozygous NF1 lines from human-induced pluripotent stem cells using CRISPR/Cas9 to investigate bone defects associated with neurofibromatosis type 1.,,Immunoreactive protein bands were revealed using an Odyssey CLx Imager (LI-COR),0.8,Accept,Experimental Usage,Odyssey CLx Imager (LI-COR)
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,The time spent near each wire cup was recorded and scored with the automated AnyMaze software,0.85,Accept,Experimental Usage,AnyMaze software
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,neurofibromin-immunoreactive (NF1-ir) cells and pERK-immunoreactive (pERK-ir) cells were counted by a blinded observer using ImageJ software (NIH),0.85,Accept,Experimental Usage,ImageJ software
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,Analysis was performed using GraphPad Prism version 5.0d (GraphPad Software),0.8,Accept,Experimental Usage,GraphPad Prism version 5.0d
PMID:23432799,10.1186/1477-7525-11-21,"Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.",,internal consistency reliability was measured with Cronbach's alpha,0.85,Accept,Experimental Usage,Cronbach's alpha
PMID:23432799,10.1186/1477-7525-11-21,"Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.",,"Statistical analyses were done using SPSS 18 version for Windows (SPSS Inc., Chicago IL, USA)",0.9,Accept,Experimental Usage,SPSS 18
PMID:23432799,10.1186/1477-7525-11-21,"Development of the adult PedsQL™ neurofibromatosis type 1 module: initial feasibility, reliability and validity.",,"Statistical analyses were done using SPSS 18 version for Windows (SPSS Inc., Chicago IL, USA) and SAS 9.3 version for Windows (SAS Institute Inc., Cary, NC, USA)",0.9,Accept,Experimental Usage,SAS 9.3
PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,Acquisition and data analysis was performed using CellQuest Pro software (BD).,0.8,Accept,Experimental Usage,CellQuest Pro software
PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,"Graphing and statistical analysis was performed with Prism 4.0 (GraphPad Software, La Jolla, CA).",0.8,Accept,Experimental Usage,Prism 4.0
PMID:23175151,10.1038/bjc.2012.518,MicroRNA profiling of peripheral nerve sheath tumours identifies miR-29c as a tumour suppressor gene involved in tumour progression.,,"The live-cell imaging system, IncuCyte (Essen BioScience Ltd, Herts., UK) was used to monitor the migration of cells across the scratch for 60 h",0.9,Accept,Experimental Usage,"IncuCyte (Essen BioScience Ltd, Herts., UK)"
PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,"Smart-seq2 whole transcriptome amplification, library construction, and sequencing were performed as previously published",0.85,Accept,Experimental Usage,Smart-seq2
PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,"We performed Louvain clustering on the centered matrix with the top 7000 genes using the ""igraph"" package with default parameters.",0.8,Accept,Experimental Usage,igraph
PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,Doublets were identified by combining the results of two methods that were published recently and implemented in R packages—scdDblFinder,0.85,Accept,Experimental Usage,scdDblFinder
PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,"and the doubletCells algorithm from scran. Setting the expected doublet rate at 1%, per 500 cells per sample yielded no doublets in both methods.",0.85,Accept,Experimental Usage,doubletCells algorithm from scran
PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,Quantification of staining intensity was performed in QuPath. Nuclei were detected in tumor-rich regions of interest,0.85,Accept,Experimental Usage,QuPath
PMID:40217315,10.1186/s13073-025-01462-4,A single-cell atlas of Schwannoma across genetic backgrounds and anatomic locations.,,"were scored to a curated list of interferon genes (Fig. 4, using the ""sigScores"" function from",0.8,Accept,Experimental Usage,sigScores
PMID:33507258,10.1001/jamanetworkopen.2020.35479,Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases.,,...cancer samples...that have undergone clinical testing at Mayo Clinic Genomics Laboratory...were collected with ACE (Advanced Cohort Explorer).,0.85,Accept,Experimental Usage,ACE (Advanced Cohort Explorer)
PMID:33507258,10.1001/jamanetworkopen.2020.35479,Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases.,,"...targeted next generation sequencing data from 79 720 samples from 75 191 patients in GENIE database (v.7.0, public release: January 2020...",0.9,Accept,Experimental Usage,GENIE database (v.7.0)
PMID:33507258,10.1001/jamanetworkopen.2020.35479,Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases.,,"...176 nonduplicate studies available in cBioPortal (access date: March 24, 2020) including 46 697 samples from 44 347 patients...",0.9,Accept,Experimental Usage,cBioPortal
PMID:33507258,10.1001/jamanetworkopen.2020.35479,Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases.,,"...cancer genomics databases including GENIE...and databases in cBioPortal including TCGA (The Cancer Genome Atlas) (accessed March 24, 2020)...",0.85,Accept,Experimental Usage,TCGA (The Cancer Genome Atlas)
PMID:33507258,10.1001/jamanetworkopen.2020.35479,Assessment of RAS Dependency for BRAF Alterations Using Cancer Genomic Databases.,,...Variants with less than 2 Catalogue of Somatic Mutations in Cancer counts were excluded as passenger alterations.,0.8,Accept,Experimental Usage,Catalogue of Somatic Mutations in Cancer
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"Purity of DNA was assessed by spectrophotometry using NanoDrop 2000 (Thermo Fisher Scientific, Waltham, MA, USA).",0.85,Accept,Experimental Usage,NanoDrop 2000
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,DNA yields were determined using a double stranded DNA (dsDNA) broad range (BR) kit on a Qubit ® fluorometer (Thermo Fisher Scientific).,0.85,Accept,Experimental Usage,Qubit fluorometer
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"DNA was sheared into 200 bp fragments on a Bioruptor ® sonicator (Diagenode, Denville, NJ, USA), using two cycles of 15 min.",0.85,Accept,Experimental Usage,Bioruptor sonicator
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,NGS was performed on Ion Torrent Personal Genome Machine—Ion Torrent PGM™ (Thermo Fisher Scientific).,0.9,Accept,Experimental Usage,Ion Torrent Personal Genome Machine—Ion Torrent PGM
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"Primary analyses of NGS data were performed using Torrent Suite software on the Ion Torrent Browser (Thermo Fisher Scientific): base calling, quality score assignment",0.85,Accept,Experimental Usage,Torrent Suite software
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,Only high-quality reads (Q ≥ 20) were aligned to the reference sequence using TMAP (Torrent Mapping Alignment Program).,0.85,Accept,Experimental Usage,TMAP
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"For variant interpretation, Ingenuity ® Variant Analysis™ software (Qiagen) and SNPnexus web server were used.",0.9,Accept,Experimental Usage,Ingenuity Variant Analysis software
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"For variant interpretation, Ingenuity ® Variant Analysis™ software (Qiagen) and SNPnexus web server were used.",0.85,Accept,Experimental Usage,SNPnexus web server
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"Variants were also viewed manually on Integrative Genomics Viewer (IGV—version 2.3.40; Broad Institute, Cambridge, MA, USA)",0.9,Accept,Experimental Usage,Integrative Genomics Viewer (IGV—version 2.3.40)
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"and on Alamut ® Visual (version 2.6.1e; Interactive Biosoftware, Rouen, France) to eliminate strand bias and reduce false positive calls.",0.9,Accept,Experimental Usage,Alamut Visual (version 2.6.1e)
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"To predict the potential effect of the mutation on the structure and function of the protein codified by the NF1 gene (neurofibromin), PolyPhen2 and SIFT were applied",0.85,Accept,Experimental Usage,PolyPhen2
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"To predict the potential effect of the mutation on the structure and function of the protein codified by the NF1 gene (neurofibromin), PolyPhen2 and SIFT were applied",0.85,Accept,Experimental Usage,SIFT
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,we also used the online Human Splicing Finder ( http://www.umd.be/HSF/ ).,0.85,Accept,Experimental Usage,Human Splicing Finder
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,"All variants were confirmed by Sanger sequencing in an AB3130 Genetic Analyzer (Applied Biosystems, Carlsbad, CA, USA).",0.9,Accept,Experimental Usage,AB3130 Genetic Analyzer
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,Primers were designed using NCBI's Primer BLAST tool ( Table 2 ) and the sequences were analyzed with the Sequencing Analysis software,0.85,Accept,Experimental Usage,NCBI's Primer BLAST tool
PMID:27999334,10.3390/genes7120133,Hybridization Capture-Based Next-Generation Sequencing to Evaluate Coding Sequence and Deep Intronic Mutations in the NF1 Gene.,,the sequences were analyzed with the Sequencing Analysis software (version 5.4; Applied Biosystems).,0.9,Accept,Experimental Usage,Sequencing Analysis software (version 5.4)
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,"...and the cell number was determined using Countess II FL Automated Cell Counter (ThermoFisher Scientific, MA, USA)...",0.9,Accept,Experimental Usage,Countess II FL Automated Cell Counter
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,...Data was acquired using FACSCanto II (BD Bioscienses) flow cytometer and at least 20.000 events were analyzed...,0.9,Accept,Experimental Usage,FACSCanto II
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,"...analyzed with FACSDiva (BD Biosciences) or FlowJo 7.6.5 ( FlowJo.com ; Tree Star, OR, USA) software...",0.85,Accept,Experimental Usage,FACSDiva
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,"...analyzed with FACSDiva (BD Biosciences) or FlowJo 7.6.5 ( FlowJo.com ; Tree Star, OR, USA) software...",0.9,Accept,Experimental Usage,FlowJo 7.6.5
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,"...Glass slides were scanned with Aperio System (Leica Biosystems, CA, USA) at 40× and the results were descriptive...",0.85,Accept,Experimental Usage,Aperio System
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,"...Images were obtained using JEM-1011 (JEOL, MA, USA). In the ultrastructure analysis, production of extracellular matrix...",0.85,Accept,Experimental Usage,JEM-1011
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,"...Images were analyzed using ImageJ software v.1.49 (NIH, USA), and the percentage of stained area in each picture was obtained...",0.9,Accept,Experimental Usage,ImageJ software v.1.49
PMID:29941005,10.1186/s13023-018-0843-1,Increased extracellular matrix deposition during chondrogenic differentiation of dental pulp stem cells from individuals with neurofibromatosis type 1: an in vitro 2D and 3D study.,,"...Statistical analysis was performed using Statistical Package for Social Sciences software (SPSS v. 20.0; Chicago, IL, USA) at 5% significance level...",0.85,Accept,Experimental Usage,SPSS v. 20.0
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,"hiPSCs were karyotyped using the iScan machine (Illumina, CA, USA) and the Illumina platform OMNI-Express-8v1.6 Chip",0.75,Accept,Experimental Usage,iScan machine
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,The analysis was performed using the Karyostudio 1.3 software (Illumina) based on the information of the GRCh36/hg18 dataset,0.8,Accept,Experimental Usage,Karyostudio 1.3 software
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,"Duplicate quantitative PCR was performed using a 7500 Fast Real-Time thermocycler (Applied Biosystems, Carlsbad, USA)",0.75,Accept,Experimental Usage,7500 Fast Real-Time thermocycler
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,"Cell motility was assessed using the IncuCyte cell migration kit (Sartorius, Göttingen, Germany) and an Incucyte Zoom live cell analysis system",0.85,Accept,Experimental Usage,Incucyte Zoom live cell analysis system
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,"a conventional patch-clamp amplifier (EPC9, HEKA Elektronik, Lambrecht, Germany) and TIDA 5.23 software",0.8,Accept,Experimental Usage,EPC9
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,"a conventional patch-clamp amplifier (EPC9, HEKA Elektronik, Lambrecht, Germany) and TIDA 5.23 software (HEKA Elektronik)",0.85,Accept,Experimental Usage,TIDA 5.23 software
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,"RNA sequencing analysis was generated using Partek Flow software, v10.0 (https://www.partek.com/partek-flow/)",0.9,Accept,Experimental Usage,"Partek Flow software, v10.0"
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,RNA sequencing reads were aligned to the hg38 Ensembl release 105 assembly with STAR v2.7.8a,0.85,Accept,Experimental Usage,STAR v2.7.8a
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,"Differential genetic analysis was then performed using DESeq2 (Love et al., 2014) to analyze for differences between conditions",0.85,Accept,Experimental Usage,DESeq2
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,"Images were 3D-rendered using Imaris software (Imaris 9, Oxford Instruments, Abingdon, UK)",0.85,Accept,Experimental Usage,Imaris software (Imaris 9)
PMID:37990867,10.1242/dmm.049861,Neurofibromin 1 mutations impair the function of human induced pluripotent stem cell-derived microglia.,,"Using in-house developed Python software, cells were grouped as having 0, 0 to 1, 1 to 2, 2 to 3, or >3 beads per cell",0.75,Accept,Experimental Usage,in-house developed Python software
PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,We interrogated the methylation profiles of 45 CNFs and 17 PNFs from NF1 subjects with the Illumina EPIC 850K methylation array.,0.95,Accept,Experimental Usage,Illumina EPIC 850K methylation array
PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Data were analyzed using a modified workflow that is similar to the ChAMP methylation array analysis procedure in R (v3.5.1),0.85,Accept,Experimental Usage,ChAMP
PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,using a hierarchical generalized linear mixed model (GLMM) approach with a logit link function as implemented in glmmTMB (v0.2.2),0.85,Accept,Experimental Usage,glmmTMB
PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Differentially methylated regions were called using DMRcate (v1.18.0),0.85,Accept,Experimental Usage,DMRcate
PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Chromatin compartments were computed at 100 kb resolution as previously described and implemented in compartmap (v1.65.71),0.85,Accept,Experimental Usage,compartmap
PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Copy number alterations were computed using SeSAMe (v1.3.2) with minor modifications for plotting functionality,0.85,Accept,Experimental Usage,SeSAMe
PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,followed by alignment with STAR (v2.7.0f) to b37 (downloaded from the GATK resource bundle),0.85,Accept,Experimental Usage,STAR (v2.7.0f)
PMID:33436083,10.1186/s13072-020-00380-6,Distinctive epigenomic alterations in NF1-deficient cutaneous and plexiform neurofibromas drive differential MKK/p38 signaling.,,Reverse-stranded gene counts were read into R (v3.6.1) using edgeR (v3.27.14),0.85,Accept,Experimental Usage,edgeR (v3.27.14)
PMID:40437318,10.1186/s41747-025-00594-x,Quantitative MRI of dorsal root ganglion alterations in neurofibromatosis type 1 patients with or without pain.,,"Image postprocessing was performed via MATLAB (The MathWorks, Inc., 2024: MATLAB, version R2024a Update 3, retrieved from https://www.mathworks.com/)",0.8,Accept,Experimental Usage,MATLAB
PMID:40437318,10.1186/s41747-025-00594-x,Quantitative MRI of dorsal root ganglion alterations in neurofibromatosis type 1 patients with or without pain.,,"The two readers independently performed three-dimensional selection of the volume of interest by manual segmentation of the DRG of levels L5 and S1 via 3D Slicer (The Slicer Community 2024: 3D Slicer, version 5.6.2)",0.9,Accept,Experimental Usage,3D Slicer
PMID:29847659,10.1167/iovs.17-22588,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,,Central vessel dropout area was quantified from the digital images using the ImageJ software (http://imagej.nih.gov/ij/),0.85,Accept,Experimental Usage,ImageJ
PMID:29847659,10.1167/iovs.17-22588,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,,neovascular area was determined using the Swift_NV macro for ImageJ.,0.9,Accept,Experimental Usage,Swift_NV macro for ImageJ
PMID:29847659,10.1167/iovs.17-22588,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,,"Analysis was performed using GraphPad Prism version 6.0h (La Jolla, CA, USA).",0.8,Accept,Experimental Usage,GraphPad Prism version 6.0h
PMID:26822862,10.1038/srep20010,Capturing the wide variety of impaired fracture healing phenotypes in Neurofibromatosis Type 1 with eight key factors: a computational study.,,"The uniform designs were generated and analysed with JMP (SAS Institute Inc., Cary, North Carolina, USA) using a Gaussian process with a Gaussian covariance function.",0.85,Accept,Experimental Usage,JMP
PMID:26822862,10.1038/srep20010,Capturing the wide variety of impaired fracture healing phenotypes in Neurofibromatosis Type 1 with eight key factors: a computational study.,,"Next, the computer simulations were performed with these parameter combinations, utilizing high-performance computational resources provided by the VSC (Flemish Supercomputer Center).",0.75,Accept,Experimental Usage,VSC (Flemish Supercomputer Center)
PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,"Morphological analysis of microglia was performed on 3-dimensional fluorescence images using Imaris × 64 version 9.6–9.9 (Bitplane, Zurich, Switzerland)",0.9,Accept,Experimental Usage,Imaris × 64 version 9.6–9.9
PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,"IGOR Pro 6.37 (Lake Oswego, USA) was used for data analysis as in Davalos et al. [ 13 ] and Madry et al. [ 42 ]",0.85,Accept,Experimental Usage,IGOR Pro 6.37
PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,"For database search, MaxQuant version 1.6.10.43 [ 12 ] was used whilst enabling TMTpro 16-plex reporter ion quantitation",0.9,Accept,Experimental Usage,MaxQuant version 1.6.10.43
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,We performed exome sequencing on five malignant meningiomas on the Illumina HiSeq2000 platform using Agilent SureSelect Human All Exon kits.,0.85,Accept,Experimental Usage,Illumina HiSeq2000
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,"We used wANNOVAR web server to annotate and prioritize variants, identified candidate genes with recurrent mutations",0.85,Accept,Experimental Usage,wANNOVAR web server
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,We used SeqMule (http://seqmule.usc.edu/) pipeline as our primary variant calling pipeline.,0.85,Accept,Experimental Usage,SeqMule
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,"In SeqMule pipeline, BWA (Li and Durbin, 2009) was used for sequence alignment",0.8,Accept,Experimental Usage,BWA
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,"GATK (McKenna) and SAMtools (et al., 2010 Li) were used to generate variant calls and to identify consensus calls for analysis.",0.8,Accept,Experimental Usage,GATK
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,"GATK (McKenna) and SAMtools (et al., 2010 Li) were used to generate variant calls and to identify consensus calls for analysis.",0.8,Accept,Experimental Usage,SAMtools
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,we decided to use VarScan2 as our primary variant calling tools for targeted region sequencing data analysis given sufficient sequencing depth.,0.8,Accept,Experimental Usage,VarScan2
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,The sequencing traces were manually visualized in Codon Code Aligner software (http://www.codoncode.com/aligner/) to confirm the presence of candidate mutations.,0.8,Accept,Experimental Usage,Codon Code Aligner
PMID:25549701,,Exome sequencing on malignant meningiomas identified mutations in neurofibromatosis type 2 (NF2) and meningioma 1 (MN1) genes.,,Twelve pairs of primers were designed using primer 3 (v. 0.4.0) (http://bioinfo.ut.ee/primer3-0.4.0/).,0.8,Accept,Experimental Usage,primer 3 (v. 0.4.0)
PMID:27458360,10.3389/fnhum.2016.00334,COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1.,,"Genotyping was performed using a real-time PCR system in the allelic discrimination mode (Stratagene Mx3005 – MxPro QPCR-Software, 2007)",0.8,Accept,Experimental Usage,Stratagene Mx3005
PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,"The total integrated intensity of RFP was monitored over the course of 72 hours, taking measurements every 2 hours with the Incucyte ® S3 Live-Cell Analysis System",0.9,Accept,Experimental Usage,Incucyte S3 Live-Cell Analysis System
PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,We used the percent viability compared to untreated cells to calculate a synergy score for each of the analyzed combinations ( https://synergyfinder.fimm.fi/ ),0.85,Accept,Experimental Usage,synergyfinder.fimm.fi
PMID:20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,,"cDNA samples were then subjected to qPCR amplification on an ABI Prism 7000 Sequence Detection System (Applied Biosystems, version 1.1 software)",0.9,Accept,Experimental Usage,"ABI Prism 7000 Sequence Detection System (Applied Biosystems, version 1.1 software)"
PMID:20195187,10.1097/MAO.0b013e3181d2777f,Merlin knockdown in human Schwann cells: clues to vestibular schwannoma tumorigenesis.,,Images were acquired with an Olympus FV1000 point scanning confocal microscope,0.85,Accept,Experimental Usage,Olympus FV1000 point scanning confocal microscope
PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,"Samples were analyzed on a FACScan (Becton Dickinson, Franklin Lakes, NJ)",0.8,Accept,Experimental Usage,FACScan
PMID:18413802,10.1158/1535-7163.MCT-07-0518,Sorafenib inhibits growth and mitogen-activated protein kinase signaling in malignant peripheral nerve sheath cells.,,data were analyzed for DNA content using Flowjo software,0.85,Accept,Experimental Usage,Flowjo software
PMID:40352015,10.7759/cureus.82033,Development of a Machine Learning Algorithm for the Prediction of WHO Grade 1 Meningioma Recurrence.,,A new modeling method known as the Risk-Calibrated Superspase Linear Integer Model (Risk-SLIM) was created to reduce the variability in risk assessment using machine learning techniques.,0.85,Accept,Experimental Usage,Risk-calibrated Superspase Linear Integer Model (Risk-SLIM)
PMID:40352015,10.7759/cureus.82033,Development of a Machine Learning Algorithm for the Prediction of WHO Grade 1 Meningioma Recurrence.,,"All statistics and models were conducted in Python version 3.10 (Python Software Foundation, Wilmington, Delaware, US).",0.8,Accept,Experimental Usage,Python version 3.10
PMID:18632543,10.1001/jama.300.3.287,Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.,,"All data were analyzed using SPSS 12.0 (SPSS Inc, Chicago, Illinois)",0.8,Accept,Experimental Usage,SPSS 12.0
PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,,Bioluminescence signals from the virus-encoded luciferase activity were detected using an IVIS 50 system (Caliper),0.8,Accept,Experimental Usage,IVIS 50 system
PMID:22384355,10.1534/g3.111.000687,The SPRED1 Variants Repository for Legius Syndrome.,,...78 sequence variants have been found by searching PubMed (http://www.ncbi.nlm.nih.gov/sites/entrez) and Google...,0.85,Accept,Experimental Usage,PubMed
PMID:22384355,10.1534/g3.111.000687,The SPRED1 Variants Repository for Legius Syndrome.,,...78 sequence variants have been found by searching PubMed and Google (http://google.com/)...,0.8,Accept,Experimental Usage,Google
PMID:22384355,10.1534/g3.111.000687,The SPRED1 Variants Repository for Legius Syndrome.,,...the online batch position check tool Mutalyzer 2.0 (http://www.mutalyzer.nl/) was used to confirm genomic position of all SPRED1 gene variants...,0.9,Accept,Experimental Usage,Mutalyzer 2.0
PMID:22384355,10.1534/g3.111.000687,The SPRED1 Variants Repository for Legius Syndrome.,,"...SQL tables (MySQL, Inc.) were organized to represent SPRED1 mutation status, associated phenotype, literature references...",0.85,Accept,Experimental Usage,MySQL
PMID:22384355,10.1534/g3.111.000687,The SPRED1 Variants Repository for Legius Syndrome.,,...Graphics were generated using FusionCharts v3 (www.fusioncharts.com)...,0.85,Accept,Experimental Usage,FusionCharts v3
PMID:22384355,10.1534/g3.111.000687,The SPRED1 Variants Repository for Legius Syndrome.,,...SPRED1 mutations were added to the database and edited using phpmyadmin (www.phpmyadmin.net)...,0.85,Accept,Experimental Usage,phpmyadmin
PMID:37446790,10.3390/molecules28135128,Icariin Promotes Osteogenic Differentiation in a Cell Model with NF1 Gene Knockout by Activating the cAMP/PKA/CREB Pathway.,,DESeq2 (version 1.12.4) was used to determine differentially expressed genes (DEGs) between two samples,0.9,Accept,Experimental Usage,DESeq2 (version 1.12.4)
PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,,"acquired from four contiguous fields (2 × 2) using either an upright Zeiss LSM 780 confocal microscope (Carl Zeiss Microscopy, Jena, Germany)",0.85,Accept,Experimental Usage,Zeiss LSM 780 confocal microscope
PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,,"or an inverted Leica Stellaris 5 system (Leica Microsystems, Deerfield, IL, USA) equipped with a Tokai Hit stage-top incubator",0.85,Accept,Experimental Usage,Leica Stellaris 5 system
PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,,"Image stacks were processed and reconstructed in 3D using Volocity software (Version 7.0.0; PerkinElmer, Waltham, MA, USA)",0.9,Accept,Experimental Usage,Volocity software (Version 7.0.0)
PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,,"Fluorescence intensity of P-glycoprotein was quantified using ImageJ 1.54g software (National Institutes of Health, Bethesda, MD, USA).",0.85,Accept,Experimental Usage,ImageJ 1.54g software
PMID:40862755,10.3390/cells14161276,Fibroblasts Attenuate Anti-Tumor Drug Efficacy in Tumor Cells via Paracrine Interactions with Tumor Cells in 3D Plexiform Neurofibroma Cultures.,,"Absorbance was measured at 570 nm with background correction at 690 nm using a SpectraMax Plus 384 microplate reader (Molecular Devices, San Jose, CA, USA).",0.8,Accept,Experimental Usage,SpectraMax Plus 384 microplate reader
PMID:29958847,10.1016/j.neurad.2018.05.006,Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.,,The pipeline for PN identification was developed in-house using the Insight Toolkit ( www.itk.org/ ) interfacing with the medical imaging visualization suite,0.85,Accept,Experimental Usage,Insight Toolkit
PMID:29958847,10.1016/j.neurad.2018.05.006,Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.,,"using the Insight Toolkit ( www.itk.org/ ) interfacing with the medical imaging visualization suite, Slicer ( www.slicer.org/ )",0.85,Accept,Experimental Usage,Slicer
PMID:29958847,10.1016/j.neurad.2018.05.006,Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.,,Normality of the feature was tested using the Jarque-Bera normality test and the Levene's test was used to test for equal variances,0.8,Accept,Experimental Usage,Jarque-Bera normality test
PMID:29958847,10.1016/j.neurad.2018.05.006,Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.,,the Jarque-Bera normality test and the Levene's test was used to test for equal variances between the sets,0.8,Accept,Experimental Usage,Levene's test
PMID:29958847,10.1016/j.neurad.2018.05.006,Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.,,A Student's paired t-test compared the quantitative imaging features extracted from the PET-hot VOI to the PET-elevated VOI,0.75,Accept,Experimental Usage,Student's paired t-test
PMID:29958847,10.1016/j.neurad.2018.05.006,Radiomic biomarkers informative of cancerous transformation in neurofibromatosis-1 plexiform tumors.,,feature reduction was performed using k-medoid clustering to remove statistically significant features were highly inter-correlated,0.8,Accept,Experimental Usage,k-medoid clustering
PMID:28831766,10.1007/s12104-017-9768-1,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,,Collected data were processed with NMRPipe (Delaglio et al. 1995) and analyzed by using CcpNMR...,0.85,Accept,Experimental Usage,NMRPipe
PMID:28831766,10.1007/s12104-017-9768-1,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,,Collected data were processed with NMRPipe (Delaglio et al. 1995) and analyzed by using CcpNMR (Vranken et al. 2005) software.,0.85,Accept,Experimental Usage,CcpNMR
PMID:28831766,10.1007/s12104-017-9768-1,NMR resonance assignments of the EVH1 domain of neurofibromin's recruitment factor Spred1.,,"A TALOS+ prediction (Shen et al. 2009) was conducted using the HN, N, C', Cα, and Cβ chemical shifts of the protein...",0.85,Accept,Experimental Usage,TALOS+
PMID:24681606,10.18632/oncotarget.1609,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,,"All data analysis was done using Calcusyn software (CalcuSyn Version 2.1, BioSoft). A combination of Everolimus and PD-901 at varying dilutions... using Calcusyn software",0.8,Accept,Experimental Usage,CalcuSyn Version 2.1
PMID:24681606,10.18632/oncotarget.1609,Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity.,,Densitometry quantification was done using ImageJ software and normalized to GAPDH,0.8,Accept,Experimental Usage,ImageJ software
PMID:32107864,10.1002/mgg3.1180,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,,Sequence reads were aligned to the reference sequence (GRCh37) using bwa‐mem v0.7.10,0.8,Accept,Experimental Usage,bwa‐mem v0.7.10
PMID:32107864,10.1002/mgg3.1180,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,,"followed by variant calling using GATK, version 1.0.4705 (McKenna et al., 2010)",0.8,Accept,Experimental Usage,"GATK, version 1.0.4705"
PMID:32107864,10.1002/mgg3.1180,Expanding the Noonan spectrum/RASopathy NGS panel: Benefits of adding NF1 and SPRED1.,,"Copy number variants (CNVs) were identified via an NGS‐based detection tool (VisCap) (Pugh et al., 2016)",0.85,Accept,Experimental Usage,VisCap
PMID:38990917,10.1371/journal.pone.0305548,Optical coherence tomography of the macular ganglion cell layer in children with neurofibromatosis type 1 is a useful tool in the assessment for optic pathway gliomas.,,automated GC‐IPL analysis segmentation algorithm and optic disc 200×200 protocol incorporated into the Cirrus 6.0 software were used,0.85,Accept,Experimental Usage,Cirrus 6.0 software
PMID:34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,,Metabolic rate and activity were measured using the Sleep and Activity Metabolic Monitor (SAMM) system (Sable Systems International).,0.85,Accept,Experimental Usage,SAMM system
PMID:34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,,Images were captured every 15 min using a time-lapse image software (PhenoCapture 3.3),0.9,Accept,Experimental Usage,PhenoCapture 3.3
PMID:34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,,"analyzed using Fiji 2.0, measuring the liquid meniscus position in each capillary",0.85,Accept,Experimental Usage,Fiji 2.0
PMID:34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,,Total feeding was measured over 24 h and analyzed by Noah.py,0.9,Accept,Experimental Usage,Noah.py
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,...TALENs targeting FOXR2 were designed using TALE-NT and constructed as previously described...,0.8,Accept,Experimental Usage,TALE-NT
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,...Twelve images per cell line were taken and automated colony counts were done using ImageJ software...,0.8,Accept,Experimental Usage,ImageJ
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,...Images were acquired using AxioVision software...,0.8,Accept,Experimental Usage,AxioVision software
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"The sequenced reads were mapped to the hg19 by Burrows-Wheeler Aligner (BWA version 0.7.15, default parameters, BWA-MEM algorithm)",0.85,Accept,Experimental Usage,BWA version 0.7.15
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"Mutations were identified via GATK MuTect2 (version 4.1, default parameters)",0.85,Accept,Experimental Usage,GATK MuTect2 (version 4.1)
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"Mutations were annotated with software ANNOVAR (version 2016-02-01, default parameters)",0.85,Accept,Experimental Usage,ANNOVAR (version 2016-02-01)
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,The indel frequencies of TGFBR2 and PDCD1 were measured by TIDE (Tracking Indels by Decomposition) analysis,0.85,Accept,Experimental Usage,TIDE (Tracking Indels by Decomposition)
PMID:40025578,10.1186/s40478-025-01965-6,Development of CAR-T cell therapy for NF1/SWN-related nerve sheath tumor treatment.,,"A RTCA system, iCELLigence (ACEA Biosciences, San Diego, CA, USA), was used to assess the cytolytic effect of anti-HER1 CAR-T cells",0.9,Accept,Experimental Usage,iCELLigence (ACEA Biosciences)
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,"The qPCR reactions were performed with the CFX Connect System (Bio-Rad Laboratories, Hercules, CA, USA)",0.85,Accept,Experimental Usage,CFX Connect System
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,Chemiluminescence was detected using ChemiDoc XRS (Bio-Rad),0.85,Accept,Experimental Usage,ChemiDoc XRS
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,images were taken with EVOS Cell Imaging Systems (Thermo Fisher Scientific),0.85,Accept,Experimental Usage,EVOS Cell Imaging Systems
PMID:34011935,10.1038/s41419-021-03802-9,Metalloproteinase 1 downregulation in neurofibromatosis 1: Therapeutic potential of antimalarial hydroxychloroquine and chloroquine.,,"All analyses were performed using the JMP Pro software package (SAS Institute Japan Ltd., Tokyo, Japan)",0.85,Accept,Experimental Usage,JMP Pro software
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,"MRI monitoring was conducted using a 7 T scanner (BioSpec 70/30 USR; Bruker, USA)",0.8,Accept,Experimental Usage,BioSpec 70/30 USR
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,"Following co-registration of a preclinical LP-100 FUS system (FUS Instruments, Canada) with the MRI scanner",0.85,Accept,Experimental Usage,LP-100 FUS system
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,MRI images were transferred into MATLAB with Aedes software for manual segmentation,0.75,Accept,Experimental Usage,MATLAB
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,MRI images were transferred into MATLAB with Aedes software for manual segmentation of DRG schwannomas,0.85,Accept,Experimental Usage,Aedes software
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,"All statistical analyses were conducted using SAS 9.4 (SAS Institute, Cary, NC)",0.8,Accept,Experimental Usage,SAS 9.4
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,The cell-cycle stage was determined with the Cell Cycle tool in FlowJo v10.7.1 software (BD Life Sciences),0.85,Accept,Experimental Usage,FlowJo v10.7.1 software
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,RNA sequencing (RNA-seq) data were analyzed as follows: quality trimming via Trimmomatic (v0.33),0.8,Accept,Experimental Usage,Trimmomatic (v0.33)
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,alignment via HISAT2 (v2.1.0) to the GRCh38 Ensembl assembly,0.8,Accept,Experimental Usage,HISAT2 (v2.1.0)
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,gene count quantification via StringTie (v1.3.4d),0.8,Accept,Experimental Usage,StringTie (v1.3.4d)
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,"Differential expression analysis was performed using R statistical software (v4.3.1), tidyverse (v2.0.0), and DESeq2 (v1.42.0)",0.8,Accept,Experimental Usage,DESeq2 (v1.42.0)
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,Pathway analysis was performed using GeneAnalytics(v),0.75,Accept,Experimental Usage,GeneAnalytics(v)
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,Combination index (CI) values were calculated using CalcuSyn software (BioSoft),0.8,Accept,Experimental Usage,CalcuSyn software (BioSoft)
PMID:30055648,10.1186/s13104-018-3630-0,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,,Staining was performed in the automated staining system Ventana BenchMark XT,0.8,Accept,Experimental Usage,Ventana BenchMark XT
PMID:30055648,10.1186/s13104-018-3630-0,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,,colonies were counted using the cell counter tool of ImageJ (NIH United States 2014),0.8,Accept,Experimental Usage,ImageJ
PMID:30055648,10.1186/s13104-018-3630-0,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,,The SPSS program (IBM SPSS Statistics Standard) was applied,0.8,Accept,Experimental Usage,IBM SPSS Statistics Standard
PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,"MALDI IMS experiments were performed on a Bruker AutoFlex III mass spectrometer (Bruker Daltonics Billerica, MA, USA) using a SmartBeam 1 kHz laser",0.85,Accept,Experimental Usage,Bruker AutoFlex III mass spectrometer
PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,"The 2-D IMS data sets were collected using FlexImaging 4.0 (Bruker Daltonics), amounting to a total of about 51 GB of raw IMS data",0.9,Accept,Experimental Usage,FlexImaging 4.0
PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,"LC-MS/MS experiments were performed on a Thermo LTQ Velos Orbitrap mass spectrometer (Thermo Scientific, Waltham, MA, USA)",0.85,Accept,Experimental Usage,Thermo LTQ Velos Orbitrap mass spectrometer
PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,sequence tags of around 4–5 amino acids that were subsequently searched using TagIdent (http://web.expasy.org/tagident/) specifying Mus as the organism,0.9,Accept,Experimental Usage,TagIdent
PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,"Scaffold (Proteome Software, Portland, Oregon, USA) was used to analyze and validate protein identifications derived from SEQUEST database searching",0.9,Accept,Experimental Usage,Scaffold
PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,"validate protein identifications derived from SEQUEST (Thermo Scientific, Waltham, MA, USA) database searching of the MS/MS spectra",0.85,Accept,Experimental Usage,SEQUEST
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,The gene expression profile GSE108524 of the NF2-associated VSs and normal nerve groups was obtained from the NCBI GEO database.,0.85,Accept,Experimental Usage,GSE108524
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,These microarray data were based on GPL17586 Platform [HTA-2_0] Affymetrix Human Transcriptome Array 2.0 [transcript (gene) version],0.9,Accept,Experimental Usage,GPL17586 Platform [HTA-2_0] Affymetrix Human Transcriptome Array 2.0
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,"GEO2R (http://www.ncbi.nlm.nih.gov/geo/geo2r/), a web tool based on the analysis of variance or t-test, was used to identify DEGs",0.85,Accept,Experimental Usage,GEO2R
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,"The Database for Annotation, Visualization, and Integrated Discovery (DAVID) (Version 6.8, https://david.ncifcrf.gov/) was used to perform GO and KEGG pathway enrichment analysis",0.9,Accept,Experimental Usage,DAVID (Version 6.8)
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,"We submitted DEGs in Search Tool for the Retrieval of Interacting Genes database (STRING, http://www.string-db.org/) to screen the PPI pairs",0.85,Accept,Experimental Usage,STRING
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,visualized the interaction using Cytoscape software (Version 3.7.0.),0.9,Accept,Experimental Usage,Cytoscape software (Version 3.7.0)
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,"Finally, CentiScaPe and Molecular Complex Detection (MCODE), a Cytoscape plugin, were utilized to screen PPI network key genes.",0.85,Accept,Experimental Usage,CentiScaPe
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,"Finally, CentiScaPe and Molecular Complex Detection (MCODE), a Cytoscape plugin, were utilized to screen PPI network key genes.",0.85,Accept,Experimental Usage,MCODE
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,the hub genes were mapped onto the Drug-Gene Interaction database (DGIdb; http://www.dgidb.org) to obtain potential drug target genes,0.85,Accept,Experimental Usage,DGIdb
PMID:32733557,10.1155/2020/5976465,"Gene Expression, Network Analysis, and Drug Discovery of Neurofibromatosis Type 2-Associated Vestibular Schwannomas Based on Bioinformatics Analysis.",,Statistical analysis was conducted by SPSS 20.0 software.,0.8,Accept,Experimental Usage,SPSS 20.0 software
PMID:24980480,10.1186/1479-7364-8-10,Novel age-dependent targets in vestibular schwannomas.,,"RNA was extracted and cRNA were hybridized to Human Genome U133 Plus 2.0 Array (Affymetrix) for analysis of over 47,000 transcripts",0.9,Accept,Experimental Usage,Human Genome U133 Plus 2.0 Array (Affymetrix)
PMID:24980480,10.1186/1479-7364-8-10,Novel age-dependent targets in vestibular schwannomas.,,"RT-qPCR was performed in the DNA Engine Opticon 2 Continuous Fluorescence Detection System (Bio-Rad, Hercules, CA, USA)",0.9,Accept,Experimental Usage,DNA Engine Opticon 2 Continuous Fluorescence Detection System (Bio-Rad)
PMID:24980480,10.1186/1479-7364-8-10,Novel age-dependent targets in vestibular schwannomas.,,The Bioconductor limma package [20] was used to preprocess the expression data from Human Genome U133 Plus 2.0 Affymetrix Array,0.85,Accept,Experimental Usage,Bioconductor limma package
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,"Combination Index values for the combinations were calculated using CompuSyn Software, based on Chou-Talalay calculations",0.8,Accept,Experimental Usage,CompuSyn Software
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,"The IC50 was calculated using GraphPad Prism Version 6 (La Jolla, CA)",0.8,Accept,Experimental Usage,GraphPad Prism Version 6
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"Optical sections of 9 or 16 contiguous fields, unless otherwise indicated, through the entire depth of the 3D structures were acquired using Zeiss LSM 780 (Carl Zeiss Microscopy, Jena, Germany)",0.8,Accept,Experimental Usage,Zeiss LSM 780
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"were acquired using Zeiss LSM 780 (Carl Zeiss Microscopy, Jena, Germany) or Stellaris 5 (Leica Microsystems, Deerfield, IL, USA) confocal microscopes.",0.8,Accept,Experimental Usage,Stellaris 5
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"Images were reconstructed in 3D using Volocity software 7.0.0 (PerkinElmer, Waltham, MA, USA). The number of total cells was quantified using Volocity.",0.9,Accept,Experimental Usage,Volocity software 7.0.0
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"sEV depletion was determined by version 3.3 Dev Build 3.3.104 Nanoparticle Tracking Analysis software (Malvern Panalytical Ltd., Malvern, UK) installed in NanoSight NS300",0.85,Accept,Experimental Usage,NanoSight NS300
PMID:39061138,10.3390/cancers16142498,A Fibroblast-Derived Secretome Stimulates the Growth and Invasiveness of 3D Plexiform Neurofibroma Spheroids.,,"The optical density (OD) was measured at a wavelength of 570 nm with the background absorbance read at 690 nm by an ELISA plate reader (SpectraMax Plus 384 microplate reader; Molecular Devices, San Jose, CA, USA).",0.8,Accept,Experimental Usage,SpectraMax Plus 384 microplate reader
PMID:18636037,10.1097/MAO.0b013e31817f7398,The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.,,"To calculate the tumor volume, the surface area of the tumor on each sequential image was determined using the measurement tool on Image J software (NIH, Bethesda, MD)",0.8,Accept,Experimental Usage,Image J software
PMID:18636037,10.1097/MAO.0b013e31817f7398,The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.,,"Digital images were captured on a Leica DMIRE2 epifluorescence microscope (Bannockburn, IL) equipped with a CCD camera and Leica FW4000 software.",0.8,Accept,Experimental Usage,Leica FW4000 software
PMID:40842873,10.3389/fradi.2025.1618261,Evaluating the effect of voxel size on the accuracy of 3D volumetric analysis measurements of brain tumors.,,"Three researchers (M.S., N.J., and S.L.) independently segmented the 17 original tumors using Simpleware (Synopsys, Mountain View, CA) ""Paint by Threshold"" tool.",0.85,Accept,Experimental Usage,Simpleware
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,Analysis for pS6 staining intensity was performed using the Acumen eX3 laser-scanning fluorescence microplate cytometer,0.8,Accept,Experimental Usage,Acumen eX3 laser-scanning fluorescence microplate cytometer
PMID:26219339,10.18632/oncotarget.4858,A high-throughput kinome screen reveals serum/glucocorticoid-regulated kinase 1 as a therapeutic target for NF2-deficient meningiomas.,,"Growth curves were plotted using GraphPad Prism 6.0 software (San Diego, CA)",0.8,Accept,Experimental Usage,GraphPad Prism 6.0
PMID:15255999,10.1186/1476-4598-3-20,"Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.",,"...detected by the laser detector of the ABI Prism 7700 Sequence Detection System (Perkin-Elmer Applied Biosystems, Foster City, CA), using PE Biosystems analysis software...",0.85,Accept,Experimental Usage,ABI Prism 7700 Sequence Detection System
PMID:15255999,10.1186/1476-4598-3-20,"Molecular profiling of malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1, based on large-scale real-time RT-PCR.",,"...Primers for TBP, RPLP0 and the 489 target genes (List in annex; supplementary information) were chosen with the assistance of the Oligo 5.0 computer program (National Biosciences, Plymouth, MN)...",0.85,Accept,Experimental Usage,Oligo 5.0 computer program
PMID:40737523,10.2196/71728,Clinician Perspectives of a Magnetic Resonance Imaging-Based 3D Volumetric Analysis Tool for Neurofibromatosis Type 2-Related Schwannomatosis: Qualitative Pilot Study.,,Surveys were conducted via Qualtrics and included 25 statements organized into eight categories,0.85,Accept,Experimental Usage,Qualtrics
PMID:40737523,10.2196/71728,Clinician Perspectives of a Magnetic Resonance Imaging-Based 3D Volumetric Analysis Tool for Neurofibromatosis Type 2-Related Schwannomatosis: Qualitative Pilot Study.,,Audio recordings from the FGDs and individual interviews were then transcribed verbatim by Zoom's transcription feature,0.8,Accept,Experimental Usage,Zoom's transcription feature
PMID:40737523,10.2196/71728,Clinician Perspectives of a Magnetic Resonance Imaging-Based 3D Volumetric Analysis Tool for Neurofibromatosis Type 2-Related Schwannomatosis: Qualitative Pilot Study.,,The codes assigned to each quote were then reviewed for a final time by the first author as part of entering the coded transcripts using Dedoose,0.85,Accept,Experimental Usage,Dedoose
PMID:40529476,10.1016/j.xjidi.2025.100380,Using Durometers to Quantify Stiffness as an Outcome Measure for Cutaneous Neurofibroma in Neurofibromatosis Type 1.,,"Statistical analyses were performed using R 4.4.2 software (R Foundation for Statistical Computing, Vienna, Austria)",0.85,Accept,Experimental Usage,R 4.4.2 software
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,"samples were labeled for the GeneChip Human Transcriptome Array 2.0 (HTA 2.0, Affymetrix)",0.85,Accept,Experimental Usage,GeneChip Human Transcriptome Array 2.0
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,Densitometry was performed using Li-COR Image Studio Lite 5.0,0.9,Accept,Experimental Usage,Li-COR Image Studio Lite 5.0
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,We used python 3.5.1 and Sci-kit Learn for machine learning implementations,0.8,Accept,Experimental Usage,python 3.5.1
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,We used python 3.5.1 and Sci-kit Learn for machine learning implementations,0.85,Accept,Experimental Usage,Sci-kit Learn
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,We performed all preprocessing steps using R version 3.2.3,0.8,Accept,Experimental Usage,R version 3.2.3
PMID:28166733,10.1186/s12864-017-3519-7,A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.,,"using the 'collapseRows()' function with the ""maxmean"" method from the R package WGCNA",0.85,Accept,Experimental Usage,WGCNA
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,"PamChip peptide arrays (PamGene International BV, 's-Hertogenbosch, the Netherlands) measure the ability of active kinases in a protein lysate sample",0.9,Accept,Experimental Usage,PamChip peptide arrays
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,software-based image analysis (BioNavigator software V.6.3 from PamGene) integrates the signals obtained within the time course,0.9,Accept,Experimental Usage,BioNavigator software V.6.3
PMID:39225289,10.1111/srt.70020,Comparing 3D imaging devices for the measurement of cutaneous neurofibromas in patients with Neurofibromatosis Type 1.,,Statistical analyses were conducted using IBM SPSS Statistics (version 27.01). Friedman tests and Dunn–Bonferroni post hoc tests were performed,0.85,Accept,Experimental Usage,IBM SPSS Statistics (version 27.01)
PMID:41411243,10.1371/journal.pgen.1011976,PERADIGM: Phenotype embedding similarity-based rare disease gene mapping.,,"Here, we introduce PERADIGM ( Phenotype Embedding similarity-based RAre DIsease Gene Mapping), a novel framework that leverages natural language processing techniques",0.95,Accept,Development,PERADIGM
PMID:41411243,10.1371/journal.pgen.1011976,PERADIGM: Phenotype embedding similarity-based rare disease gene mapping.,,"We utilized the UK Biobank 200K dataset [ 4 , 50 ] in our analysis. To mitigate potential confounding effects due to population stratification",0.85,Accept,Experimental Usage,UK Biobank 200K dataset
PMID:41411243,10.1371/journal.pgen.1011976,PERADIGM: Phenotype embedding similarity-based rare disease gene mapping.,,"In our embedding analysis, we applied the CBOW Word2Vec model to embed the ICD-10 phenotype data from the UK Biobank",0.8,Accept,Experimental Usage,Word2Vec
PMID:41411243,10.1371/journal.pgen.1011976,PERADIGM: Phenotype embedding similarity-based rare disease gene mapping.,,"In our embedding analysis, we applied the CBOW Word2Vec model to embed the ICD-10 phenotype data from the UK Biobank",0.75,Accept,Experimental Usage,CBOW
PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",,"...Bone samples were analyzed with low (6 µm voxel) or high (up to 1 µm voxel) resolution microCT from skyscan 1172 (skyscan, Belgium)...",0.85,Accept,Experimental Usage,skyscan 1172
PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",,"...The samples were further sectioned in an UV laser micro-dissection system (PALM MicroBeam C, P.A.L.M. Microlaser Technologies GmbH, Bernried, Germany)...",0.85,Accept,Experimental Usage,PALM MicroBeam C
PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",,"...Samples were measured using a custom-made scanning acoustic microscope (SAM200Ex, Q-BAM, Halle, Germany)...",0.85,Accept,Experimental Usage,SAM200Ex
PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",,"...Analysis of EDX images was performed with ImageJ (Rasband WS. ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA, imagej.nih.gov/ij/, 1997–2012)...",0.8,Accept,Experimental Usage,ImageJ
PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",,"...Histomorphometric analysis was performed with AxioVision Software (Zeiss, Germany)...",0.8,Accept,Experimental Usage,AxioVision Software
PMID:26904939,10.1016/j.celrep.2016.01.074,Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,"Amplicon sequencing using the GS20 Flex pyrosequencing machine (Roche, Indianapolis, IN)",0.8,Accept,Experimental Usage,"GS20 Flex pyrosequencing machine (Roche, Indianapolis, IN)"
PMID:26904939,10.1016/j.celrep.2016.01.074,Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,We used the Genemania algorithm to generate gene-gene association networks,0.85,Accept,Experimental Usage,Genemania algorithm
PMID:18974932,10.1007/s11060-008-9721-3,A role for the p53 pathway in the pathology of meningiomas with NF2 loss.,,"Medical records review was performed using the Research Patient Database Registry, an internal research tool providing access to demographic information",0.75,Accept,Experimental Usage,Research Patient Database Registry
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,Data were analyzed by the Seurat V3.0 package in the R programming environment,0.9,Accept,Experimental Usage,Seurat V3.0
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,The raw transcript counts were aligned to Refseq related to the build GRCh38-mm10 using STAR 2.4.2.8 by default settings,0.9,Accept,Experimental Usage,STAR 2.4.2.8
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,Differentially expressed genes between GFP+ and GFP- tumor populations were analyzed by paired experiment design in the DeSeq2 package,0.85,Accept,Experimental Usage,DeSeq2 package
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,The ssgesa was calculated by the GSVA package with default settings,0.85,Accept,Experimental Usage,GSVA package
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,Limma package was used for generating the human 621-MPNST signature on the data from Miller et al.,0.85,Accept,Experimental Usage,Limma package
PMID:18242513,10.1016/j.ccr.2008.01.003,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,,"Flow-cytometry was performed with a FACSVantage SE-dual laser, three-line flow-cytometer (Becton-Dickinson)",0.85,Accept,Experimental Usage,FACSVantage SE-dual laser flow-cytometer
PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,The effects of mutations on protein functions were analyzed using the PredictSNP2 tool (https://loschmidt.chemi.muni.cz/predictsnp/),0.9,Accept,Experimental Usage,PredictSNP2
PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,"The iStable-integrated server, accessible at predictor.nchu.edu.tw/iStable, features two machine learning-based tools",0.9,Accept,Experimental Usage,iStable
PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,Align-GVGD (http://agvgd.hci.utah.edu/agvgd_input.php) is another tool that applies the Grantham difference across multiple sequence alignments,0.9,Accept,Experimental Usage,Align GVGD
PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,"we utilized AlphaFold3 to simulate both the wild-type and mutant NF1 structures, revealing the significant effects of the R1000C mutation",0.9,Accept,Experimental Usage,AlphaFold3
PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,"These mutations were subjected to further phenotyping analysis using SNPeffect 4.0, which predicted disturbances in the protein's chaperone binding sites",0.9,Accept,Experimental Usage,SNPeffect 4.0
PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,We selected the iMutant 2.0 and MUpro algorithms to predict the thermodynamic parameter changes caused by the mutations,0.85,Accept,Experimental Usage,iMutant 2.0
PMID:39373898,10.1007/s12031-024-02271-x,Identification of Pathogenic Missense Mutations of NF1 Using Computational Approaches.,,MUpro combines SVM and neural network technologies to analyze the effect of mutations on protein stability,0.85,Accept,Experimental Usage,MUpro
PMID:21216928,10.1158/1535-7163.MCT-10-0654,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,,"Densitometry analysis was performed with Gel-Pro Analyzer 4.0 software (Media Cybernetics; Silver Spring, MD)",0.85,Accept,Experimental Usage,Gel-Pro Analyzer 4.0 software
PMID:21216928,10.1158/1535-7163.MCT-10-0654,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,,All the analyses were implemented by the comprehensive statistical package R (http://cran.r-project.org/),0.8,Accept,Experimental Usage,R statistical package
PMID:25917366,10.1038/mp.2015.48,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.,,Cumulative miniature and spontaneous synaptic currents amplitude and inter-event interval distributions were analyzed...using the Kolmogorov–Smirnov test (Mini Analysis),0.8,Accept,Experimental Usage,Mini Analysis
PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,"Libraries were sequenced on a Genome Analyzer IIx (Illumina, San Diego, CA)",0.8,Accept,Experimental Usage,Genome Analyzer IIx
PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,Alignment and analysis was performed using a Galaxy server and open source Chipster software (http://chipster.csc.fi/),0.8,Accept,Experimental Usage,Chipster software
PMID:29787563,10.1371/journal.pone.0190001,Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.,,"With the Rembrandt data, the network was built using the ARACNe-AP algorithm. The ARACNe-AP algorithm reconstructs gene regulatory networks from large-scale gene expression data",0.9,Accept,Experimental Usage,ARACNe-AP algorithm
PMID:29787563,10.1371/journal.pone.0190001,Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.,,Centrality measures were calculated using the igraph package in R,0.8,Accept,Experimental Usage,igraph package in R
PMID:29787563,10.1371/journal.pone.0190001,Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.,,The differential expression and fold change calculations on the RNA-Seq datasets were performed using the R package DESeq2 version 1.18.1,0.85,Accept,Experimental Usage,DESeq2 version 1.18.1
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,The concentration of the gDNA was estimated using the Qubit 2.0 Fluorometer (Invitrogen); samples with less than 500 ng were discarded.,0.8,Accept,Experimental Usage,Qubit 2.0 Fluorometer
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,"The samples were then sonicated on the Covaris LE220 (Covaris Inc, Woburn, MA, USA) to achieve an average target size of 400 bp.",0.85,Accept,Experimental Usage,Covaris LE220
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,"QC analysis of the post-sonicated material was done using Caliper LabChip GX (Perkin Elmer, Hopkinton, MA, USA).",0.8,Accept,Experimental Usage,Caliper LabChip GX
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,"the library concentration was estimated by utilizing a DNA 1,000 Chip on an Agilent 2,100 Bioanalyzer.",0.8,Accept,Experimental Usage,"Agilent 2,100 Bioanalyzer"
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,"Each sample was then sequenced on an individual lane on an Illumina HiSeqX sequencer (Illumina, Inc., San Diego, CA, USA).",0.85,Accept,Experimental Usage,Illumina HiSeqX sequencer
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,Reads were mapped to the genome and variants identified using the Dragen program with default settings.,0.8,Accept,Experimental Usage,Dragen
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,The resulting VCF files were then sorted and updated to remove errors and analysed using the GATK pipeline,0.8,Accept,Experimental Usage,GATK pipeline
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,Somatic mutations were called from BAM files exported by the Dragen alignment using the Java version of VarDict in paired mode,0.8,Accept,Experimental Usage,VarDict
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,Samples were analysed by GenomeStudio and exported to text,0.8,Accept,Experimental Usage,GenomeStudio
PMID:28398289,10.1038/sdata.2017.45,A high-throughput molecular data resource for cutaneous neurofibromas.,,"Paired-end sequencing was performed using a 200 Cycle TruSeq SBS HS v4 Kit on an Illumina HiSeq2500 sequencer (Illumina, Inc., San Diego, CA, USA).",0.85,Accept,Experimental Usage,Illumina HiSeq2500 sequencer
PMID:29670214,10.1038/s41598-018-24310-5,Restoring functional neurofibromin by protein transduction.,,the detected protein bands were quantified using the ImageJ software (https://imagej.nih.gov/ij/),0.85,Accept,Experimental Usage,ImageJ
PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,...We acquired cell suspensions in a dual-laser (Argon 488 and dye laser 630 or HeNe 633) FACSCanto (Becton–Dickinson)...,0.85,Accept,Experimental Usage,FACSCanto (Becton–Dickinson)
PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,...All the probe sets on Affymetrix Mouse Gene 2.0 ST array (Mogene-2_0-st-v1.na33.2.mm10) were summarized...,0.9,Accept,Experimental Usage,Affymetrix Mouse Gene 2.0 ST array (Mogene-2_0-st-v1.na33.2.mm10)
PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,...data from two batches were combined and their batch effects were corrected using ComBat method implemented in Bioconductor's sva package...,0.85,Accept,Experimental Usage,ComBat method implemented in Bioconductor's sva package
PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,...The Bioconductor/R limma package was used to define DEGs between two groups...,0.85,Accept,Experimental Usage,Bioconductor/R limma package
PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,...Gene set enrichment analysis was performed using the WebGestalt webserver (http://bioinfo.vanderbilt.edu/webgestalt/)...,0.85,Accept,Experimental Usage,WebGestalt webserver
PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,...A modified version of NetWalk algorithm was used to handle bi-cellular interaction...,0.85,Accept,Experimental Usage,NetWalk algorithm
PMID:28589254,10.1007/s00259-017-3733-1,Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of ,,"The reconstructed PET datasets were imported into in-house texture analysis software implemented in MATLAB (Release 2016a, The MathWorks, Inc., Natick, MA, USA).",0.85,Accept,Experimental Usage,"MATLAB (Release 2016a, The MathWorks, Inc., Natick, MA, USA)"
PMID:28589254,10.1007/s00259-017-3733-1,Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of ,,"Statistical analysis was performed using SPSS (v22, Chicago, IL, USA) and MedCalc (v16.8.4, Ostend, Belgium) software.",0.8,Accept,Experimental Usage,"SPSS (v22, Chicago, IL, USA)"
PMID:28589254,10.1007/s00259-017-3733-1,Characterisation of malignant peripheral nerve sheath tumours in neurofibromatosis-1 using heterogeneity analysis of ,,"Statistical analysis was performed using SPSS (v22, Chicago, IL, USA) and MedCalc (v16.8.4, Ostend, Belgium) software.",0.8,Accept,Experimental Usage,"MedCalc (v16.8.4, Ostend, Belgium)"
PMID:31053133,10.1186/s13023-019-1067-8,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,,"The data were analyzed using SAS software Version 9.4 (SAS Institute, Cary, NC, USA), with the significance level set at 0.05",0.85,Accept,Experimental Usage,SAS software Version 9.4
PMID:31053133,10.1186/s13023-019-1067-8,Burden of adult neurofibromatosis 1: development and validation of a burden assessment tool.,,"Higher order factor confirmatory analysis was performed to confirm that the dimensions created could be combined into one single score. PROC CALIS procedure, SAS 9.4, was employed",0.8,Accept,Experimental Usage,PROC CALIS procedure
PMID:33082502,10.1038/s41598-020-74920-1,Image segmentation of plexiform neurofibromas from a deep neural network using multiple b-value diffusion data.,,"Using the multispectral neural network (MSNN) modeling tool available in Analyze 12.0 (AnalyzeDirect, Overland Park, KS)",0.85,Accept,Experimental Usage,Analyze 12.0
PMID:33082502,10.1038/s41598-020-74920-1,Image segmentation of plexiform neurofibromas from a deep neural network using multiple b-value diffusion data.,,"Measurements were made on a commercially available image analysis software (MIM Encore 6.9.3, MIM Software INC, Cleveland, OH)",0.9,Accept,Experimental Usage,MIM Encore 6.9.3
PMID:33082502,10.1038/s41598-020-74920-1,Image segmentation of plexiform neurofibromas from a deep neural network using multiple b-value diffusion data.,,"Calculation of IVIM parameters were performed on a molecular kinetic modeling software (eLucidate, Paul R. Territo, Ph.D, Indiana University, Indianapolis, USA)",0.85,Accept,Experimental Usage,eLucidate
PMID:33082502,10.1038/s41598-020-74920-1,Image segmentation of plexiform neurofibromas from a deep neural network using multiple b-value diffusion data.,,"All MRI sequences were performed on a 1.5 T scanner (Magnetom Avanto, Siemens Healthineers, Erlangen, Germany)",0.8,Accept,Experimental Usage,Magnetom Avanto
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,for hybridization to the whole-genome Affymetrix GeneChip HU133 Plus 2.0 using the Affymetrix protocol,0.9,Accept,Experimental Usage,Affymetrix GeneChip HU133 Plus 2.0
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,that were normalized using the Robust Multichip Analysis (RMA) algorithm as implemented in Bioconductor/R,0.85,Accept,Experimental Usage,Robust Multichip Analysis (RMA) algorithm
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,Statistical comparisons and data visualization were performed using GeneSpring GX v7.3.1 (Agilent Technologies),0.95,Accept,Experimental Usage,GeneSpring GX v7.3.1 (Agilent Technologies)
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,"using the Database for Annotation, Visualization and Integrated Discovery (DAVID) 2007 at the National Institute of Allergy and Infectious Diseases",0.9,Accept,Experimental Usage,"Database for Annotation, Visualization and Integrated Discovery (DAVID) 2007"
PMID:20049725,10.1002/emmm.200900027,Integrative genomic analyses of neurofibromatosis tumours identify SOX9 as a biomarker and survival gene.,,We used Genome TraFac 3 for genome-wide detection of compositionally similar cis-clusters in gene orthologues between mouse and human,0.9,Accept,Experimental Usage,Genome TraFac 3
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"high-throughput sequencing of the NF1 locus was also employed, utilizing the Ion S5 system (ThermoFisher Scientific, Waltham, MA)",0.85,Accept,Experimental Usage,Ion S5 system
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"Automated template preparation and loading onto Ion 520 Chip was performed using Ion Chef system, and DNA was sequenced on the Ion S5 sequencer",0.8,Accept,Experimental Usage,Ion Chef system
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,libraries were subsequently constructed with a Kapa Hyper amplified kit (Roche) and sequenced using a NovaSeq 6000 S4 (Illumina) with ~200 × coverage,0.85,Accept,Experimental Usage,NovaSeq 6000 S4
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,WES and WGS data processing was performed with a modified version of the Nextflow nf-core 'sarek' data processing pipeline (v2.7.1),0.9,Accept,Experimental Usage,nf-core sarek v2.7.1
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,The pipeline was modified to add DeepVariant as an additional variant-calling method [27]. Details about all processing steps,0.85,Accept,Experimental Usage,DeepVariant
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"Whole exome variant calling was performed with FreeBayes [36], Mutect2, Strelka2 [37], and DeepVariant [27]",0.8,Accept,Experimental Usage,FreeBayes
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"Whole exome variant calling was performed with FreeBayes [36], Mutect2, Strelka2 [37], and DeepVariant [27]",0.8,Accept,Experimental Usage,Mutect2
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"Whole exome variant calling was performed with FreeBayes [36], Mutect2, Strelka2 [37], and DeepVariant [27]",0.8,Accept,Experimental Usage,Strelka2
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,"In addition, copy-number alterations were determined using Control-FREEC (whole genome data only) [38]",0.8,Accept,Experimental Usage,Control-FREEC
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,Transcriptomic data processing was performed using the nf-core 'rnaseq' data processing pipeline (v3.5) [45],0.9,Accept,Experimental Usage,nf-core rnaseq v3.5
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,Germline variant pathogenicity classification was performed by AutoGVP [23],0.8,Accept,Experimental Usage,AutoGVP
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,somatic variant calling was performed using either MuTect (https://github.com/broadinstitute/mutect) or TVC with relaxed stringency,0.8,Accept,Experimental Usage,MuTect
PMID:41564118,10.1371/journal.pone.0340183,Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.,,Variant calling of the germline samples was performed using The Genome Analysis Toolkit (https://gatk.broadinstitute.org) and IonTorrent Variant Caller (TVC,0.8,Accept,Experimental Usage,IonTorrent Variant Caller
PMID:38603731,10.1371/journal.pone.0302017,Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma.,,...Extraction of the pure Raman spectra from the mean raw spectra...was performed using the SERDS and U-Net deep neural network data processing methods developed in-house...,0.85,Accept,Experimental Usage,U-Net convolutional neural network
PMID:38603731,10.1371/journal.pone.0302017,Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma.,,"...we introduce Shifted-Excitation Raman Spectroscopy in combination with deep neural networks for the future perspective of objective, real-time diagnosis...",0.8,Accept,Experimental Usage,Shifted-Excitation Raman Spectroscopy
PMID:38603731,10.1371/journal.pone.0302017,Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma.,,"...guiding the signals from the Raman probe to the spectrometer (Ventana-785-Raman, Ocean Optics, Rochester, New York, USA)...",0.9,Accept,Experimental Usage,Ventana-785-Raman spectrometer
PMID:38603731,10.1371/journal.pone.0302017,Raman difference spectroscopy and U-Net convolutional neural network for molecular analysis of cutaneous neurofibroma.,,"...an excitation laser beam (power 115 mW) is guided from the diode laser (Littman/Metcalf, Sacher Lasertechnik, Marburg, Germany)...",0.85,Accept,Experimental Usage,Littman/Metcalf diode laser
PMID:28725547,10.1016/j.nicl.2017.06.032,Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity.,,"FMRI data analyses were performed using the FMRIB software library (www.fmrib.ox.ac.uk/fsl), version 5.0 (Smith et al., 2004)",0.9,Accept,Experimental Usage,FMRIB software library (FSL) version 5.0
PMID:28725547,10.1016/j.nicl.2017.06.032,Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity.,,Analyses of neuropsychological and clinical data were performed using SPSS software v. 21 (IBM),0.75,Accept,Experimental Usage,SPSS software v. 21
PMID:28725547,10.1016/j.nicl.2017.06.032,Spatial working memory in neurofibromatosis 1: Altered neural activity and functional connectivity.,,Brain regions were identified using the Harvard-Oxford cortical and subcortical probabilistic atlases as well as associated Brodmann areas,0.8,Accept,Experimental Usage,Harvard-Oxford cortical and subcortical probabilistic atlases
PMID:39881370,10.1186/s13065-024-01353-6,"Spectrophotometric and computational characterization of charge transfer complex of selumetinib with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and its utilization in developing an innovative green and high throughput microwell assay for analysis of bulk form and pharmaceutical formulation.",,"A multi-mode microplate reader (Spectramax ® M5: Molecular Devices, California, USA) was used to measure the UV-VIS absorbance.",0.85,Accept,Experimental Usage,Spectramax M5
PMID:39881370,10.1186/s13065-024-01353-6,"Spectrophotometric and computational characterization of charge transfer complex of selumetinib with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and its utilization in developing an innovative green and high throughput microwell assay for analysis of bulk form and pharmaceutical formulation.",,"The SpectraMax M5 reader is controlled and operated by using the SoftMax ® Pro Enterprise software, a leading data acquisition and analysis software",0.8,Accept,Experimental Usage,SoftMax Pro Enterprise software
PMID:39881370,10.1186/s13065-024-01353-6,"Spectrophotometric and computational characterization of charge transfer complex of selumetinib with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and its utilization in developing an innovative green and high throughput microwell assay for analysis of bulk form and pharmaceutical formulation.",,Quantum mechanics/molecular mechanics (QM/MM) computations...were performed using the General Atomic and Molecular Electronic Structure System (GAMESS software),0.85,Accept,Experimental Usage,GAMESS software
PMID:39881370,10.1186/s13065-024-01353-6,"Spectrophotometric and computational characterization of charge transfer complex of selumetinib with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and its utilization in developing an innovative green and high throughput microwell assay for analysis of bulk form and pharmaceutical formulation.",,"Mutiwfn 3.7, VMD, and the GAMESS-optimized SEL-DDQ complex were used in the hirshfeld surface HS study",0.9,Accept,Experimental Usage,Mutiwfn 3.7
PMID:39881370,10.1186/s13065-024-01353-6,"Spectrophotometric and computational characterization of charge transfer complex of selumetinib with 2,3-dichloro-5,6-dicyano-1,4-benzoquinone and its utilization in developing an innovative green and high throughput microwell assay for analysis of bulk form and pharmaceutical formulation.",,"Mutiwfn 3.7, VMD, and the GAMESS-optimized SEL-DDQ complex were used in the hirshfeld surface HS study",0.8,Accept,Experimental Usage,VMD
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,The light scattering measurements were performed using DynaPro NanoStar (Wyatt Technology Corporation),0.85,Accept,Experimental Usage,DynaPro NanoStar
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,"DYNAMIC software (V7.1.4) was used to obtain the normalized time autocorrelation function, polydispersity, and the absolute molecular mass",0.9,Accept,Experimental Usage,DYNAMIC software (V7.1.4)
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,CD experiments were performed on a J-180 JASCO circular dichroism spectropolarimeter equipped with a temperature controlled cell holder,0.85,Accept,Experimental Usage,J-180 JASCO circular dichroism spectropolarimeter
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,using the Spectra Manager control (V1. 17.00) and application (V1.3.00) software package (JASCO),0.85,Accept,Experimental Usage,Spectra Manager control (V1. 17.00)
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,Data deconvolution and normalization were carried out using DichroWeb,0.85,Accept,Experimental Usage,DichroWeb
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,"Surface plasmon resonance (SRP) experiments were performed on a Biacore X100 (GE Life Sciences, NJ)",0.85,Accept,Experimental Usage,Biacore X100
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,ITC experiments were run in a MicroCal™ Auto-iTC 200 system at 25 °C,0.85,Accept,Experimental Usage,MicroCal™ Auto-iTC 200
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,"The data were analyzed using the manufacturer provided software Bindworks (version 3.1.5, Calorimetry Sciences Corp. Lindon, UT)",0.9,Accept,Experimental Usage,Bindworks (version 3.1.5)
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,Data reduction followed standard procedures that are implemented in MantidPlot (http://www.mantidproject.org/),0.85,Accept,Experimental Usage,MantidPlot
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,"The length distribution function P(r), radius of gyration Rg, the forward scattering intensity I(0), and the maximum dimension Dmax were calculated from the scattering data using the program GNOM",0.85,Accept,Experimental Usage,GNOM
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,The 3-D dummy bead coordinates were generated using the program DAMMIN. Multiple calculations were performed using DAMMIN,0.85,Accept,Experimental Usage,DAMMIN
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,the generated 10 structures were averaged and filtered using the program DAMAVER and DAMFILT,0.85,Accept,Experimental Usage,DAMAVER
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,the generated 10 structures were averaged and filtered using the program DAMAVER and DAMFILT,0.85,Accept,Experimental Usage,DAMFILT
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,The 3-D density map was generated from the averaged coordinates using the program Situs. The fitting and docking of the high-resolution structure to the density map were performed using Situs,0.85,Accept,Experimental Usage,Situs
PMID:24882693,10.1016/j.jmb.2014.05.011,Molecular conformation of the full-length tumor suppressor NF2/Merlin--a small-angle neutron scattering study.,,The fitting and docking of the high-resolution structure to the density map were performed using Situs or UCS Chimera,0.85,Accept,Experimental Usage,UCS Chimera
PMID:17924978,10.1111/j.1750-3639.2007.00105.x,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,,"MR study was performed on a 4.7 Tesla microimaging system (Biospec, Bruker BioSpin MRI, Inc., Ertlingen, Germany)",0.8,Accept,Experimental Usage,Biospec 4.7 Tesla microimaging system
PMID:17924978,10.1111/j.1750-3639.2007.00105.x,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,,"Thin sections were cut with an LKB8801 ultramicrotome and diamond knife, stained with Sato's lead",0.75,Accept,Experimental Usage,LKB8801 ultramicrotome
PMID:17924978,10.1111/j.1750-3639.2007.00105.x,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,,"stained with Sato's lead, and examined in a Phillips 301 transmission electron microscope",0.75,Accept,Experimental Usage,Phillips 301 transmission electron microscope
PMID:37608248,10.1186/s11689-023-09492-y,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,MATLAB (2019a) and SPM12 (version 7771) were used to conduct data analyses,0.8,Accept,Experimental Usage,MATLAB (2019a)
PMID:37608248,10.1186/s11689-023-09492-y,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,MATLAB (2019a) and SPM12 (version 7771) were used to conduct data analyses,0.85,Accept,Experimental Usage,SPM12 (version 7771)
PMID:37608248,10.1186/s11689-023-09492-y,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,Custom functions calling several functions from EEGLAB (version 13.6.5b) and FieldTrip (embedded in SPM release) were used,0.85,Accept,Experimental Usage,EEGLAB (version 13.6.5b)
PMID:37608248,10.1186/s11689-023-09492-y,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,Custom functions calling several functions from EEGLAB (version 13.6.5b) and FieldTrip (embedded in SPM release) were used,0.8,Accept,Experimental Usage,FieldTrip
PMID:37608248,10.1186/s11689-023-09492-y,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,Post hoc analysis of Ribeiro et al.'s resting state theta effect in NF1 using G*Power suggests that n = 17 participants per group would result in 79% power,0.8,Accept,Experimental Usage,G*Power
PMID:37608248,10.1186/s11689-023-09492-y,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,Statistical analyses were conducted using SPSS (Version 25). The alpha level was set to 0.05,0.8,Accept,Experimental Usage,SPSS (Version 25)
PMID:37608248,10.1186/s11689-023-09492-y,Aberrant oscillatory activity in neurofibromatosis type 1: an EEG study of resting state and working memory.,,"spatially filtered using the Surface Laplacian, implemented using the laplacian_perrinX function in MATLAB",0.8,Accept,Experimental Usage,laplacian_perrinX function
PMID:41602242,10.7759/cureus.100193,Perspectives of Patients and Providers on Chronic Pain Assessment in Neurofibromatosis Type 1 (NF1): A Qualitative Study.,,...completed an online screening survey administered via Qualtrics ( www.qualtrics.com ) that collected demographic information...,0.85,Accept,Experimental Usage,Qualtrics
PMID:41602242,10.7759/cureus.100193,Perspectives of Patients and Providers on Chronic Pain Assessment in Neurofibromatosis Type 1 (NF1): A Qualitative Study.,,"...The coded transcripts were entered into ATLAS.ti (Version 9; Kansas City, MO). Using thematic analysis [ 25 , 26 ], the team examined patterns across the full data set...",0.9,Accept,Experimental Usage,ATLAS.ti (Version 9)
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,"Weighted Gene Co-expression Network Analysis, WGCNA ( 15 , 17 ) was applied to explore gene expression as an undirected co-expression network and reduce its dimensionality.",0.85,Accept,Experimental Usage,"Weighted Gene Co-expression Network Analysis, WGCNA"
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,files were downloaded from GEO and analyzed the Affymetrix Genotyping Console software ( Affymetrix ),0.85,Accept,Experimental Usage,Affymetrix Genotyping Console
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,summarized into an R eset class object using functions of the affy package ( 22 ),0.8,Accept,Experimental Usage,affy package
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,Array quality was determined with the arrayQualityMetrics package ( 23 ),0.8,Accept,Experimental Usage,arrayQualityMetrics package
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,Cytoscape ( 26 ) was used to create a graphic representation of the pink-module,0.85,Accept,Experimental Usage,Cytoscape
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,"Using the CentiScape plug-in ( 27 ), we analyzed several network parameters, such as degree and betweenness centrality",0.8,Accept,Experimental Usage,CentiScape plug-in
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,The ClueGO plug-in ( 28 ) was utilized to create pathway and Gene Ontology ( 29 ) enrichment networks,0.8,Accept,Experimental Usage,ClueGO plug-in
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,"Gene ontology analysis for hub genes was performed with DAVID web tool ( 33 , 34 )",0.8,Accept,Experimental Usage,DAVID web tool
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,with the function spn.lhs.tests implemented in the package snpStats ( 35 ),0.8,Accept,Experimental Usage,snpStats package
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,mQTL putative genes were obtained from the HaploReg v2 web browser ( 36 ),0.85,Accept,Experimental Usage,HaploReg v2
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,mQTL enrichment in TFBS was studied using oPPOSUM Single Site Analysis tool ( 37 ),0.8,Accept,Experimental Usage,oPPOSUM Single Site Analysis tool
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,The PPI database STRING ( 39 ) was used to test for known interactions among the proteins encoded by the mQTL genes,0.8,Accept,Experimental Usage,STRING database
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,batches were removed with the ComBat function implemented in the package sva ( 42 ),0.75,Accept,Experimental Usage,ComBat function
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,Linear models of the limma package ( 43 ) were applied to determine differential gene expression between tumor stages,0.8,Accept,Experimental Usage,limma package
PMID:25003081,10.3389/fonc.2014.00147,An integrative analysis of meningioma tumors reveals the determinant genes and pathways of malignant transformation.,,"Gene-expression standard deviation was determined with the function rowSds , part of the package matrixStats ( 25 )",0.75,Accept,Experimental Usage,matrixStats package
PMID:38499890,10.1186/s41687-024-00714-y,"The PlexiQoL, a patient-reported outcome measure on quality of life in neurofibromatosis type 1-associated plexiform neurofibroma: translation, cultural adaptation and validation into the Dutch language for the Netherlands.",,The statistical analyses were conducted using SPSS version 28.0,0.85,Accept,Experimental Usage,SPSS version 28.0
PMID:20551058,10.1158/0008-5472.CAN-09-3769,Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,Cells expressing PDE4A1 constructs were sorted and collected based on mCherry expression by high-speed fluorescence-activated cell sorting (MoFlo High-Performance Cell Sorter; DAKO),0.75,Accept,Experimental Usage,MoFlo High-Performance Cell Sorter
PMID:41023593,10.1186/s10020-025-01353-9,Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors.,,Mice were randomized into treatment groups using the randomizr package that arranges animals to achieve the best-case distribution,0.85,Accept,Experimental Usage,randomizr package
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,"Gene expression analysis was conducted on the nCounter Sprint Profiler (NanoString Technologies, Inc.) using the nCounter human PanCancer IO360 probe set",0.9,Accept,Experimental Usage,nCounter Sprint Profiler
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,"Quality control, normalization, differential expression and pathway analysis were performed using nSolver Advanced Analysis Software (version 4.0, Nanostring Technologies, Inc.)",0.95,Accept,Experimental Usage,nSolver Advanced Analysis Software (version 4.0)
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,Raw count matrices with sample metadata deposited on GEO were reanalyzed using the Omics Playground v2.7.18 Platform,0.95,Accept,Experimental Usage,Omics Playground v2.7.18
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,Publicly available RNA sequencing data was also obtained from the TARGET TCGA GTEx database using the UCSC Xena browser (RRID:SCR_018938),0.95,Accept,Experimental Usage,UCSC Xena browser (RRID:SCR_018938)
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,"Principal Component Analysis (PCA) PCA was conducted in IDEP.92 using log2 transformed, normalized counts as input under default settings",0.9,Accept,Experimental Usage,IDEP.92
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,Data preprocessing and visualization was performed using Scanpy (RRID:SCR_018139) in Python,0.95,Accept,Experimental Usage,Scanpy (RRID:SCR_018139)
PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,"...response data (dat0–dat10) and concentration (C0–C10, in μM) were downloaded and analyzed using a 4-parameter fit in SigmaPlot...",0.8,Accept,Experimental Usage,SigmaPlot
PMID:38136356,10.3390/cancers15245811,Drug Responses in Plexiform Neurofibroma Type I (PNF1) Cell Lines Using High-Throughput Data and Combined Effectiveness and Potency.,,...analyzed using a 4-parameter fit in SigmaPlot and with the DREA web tool...The DREA web tool recreates our final compound rankings...,0.85,Accept,Experimental Usage,DREA web tool
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,"Here, we optimized our random forest-based predictor RENOVO for NF1 variant interpretation. RENOVO was developed using an approach of 'database archaeology'",0.95,Accept,Development,RENOVO-NF1
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,ClinVar data for NF1 variants were extracted from the ClinVar version 2024-07-03 available at: https://ftp.ncbi.nlm.nih.gov/pub/clinvar/vcf_GRCh37/archive_2.0/2024/,0.85,Accept,Experimental Usage,ClinVar
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,"Constitutional NF1 variants were determined by standard techniques using targeted NGS panel including NF1, NF2, SPRED1, SMARCB1 and LZTR1 genes on Ion Torrent",0.8,Accept,Experimental Usage,Ion Torrent
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,The effects on genes and proteins of the variants identified were predicted based on the Mutation Taster (http://www.mutationtaster.org),0.8,Accept,Experimental Usage,Mutation Taster
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,"predicted based on the Mutation Taster and HGMD (Human Genome Mutation Database—Institute of Medical Genetics, Cardiff, Wales, UK; http://www.hgmd.cf.ac.uk/ac/index.php",0.8,Accept,Experimental Usage,HGMD
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,and LOVD. (Leiden Open Variation Database; http://www.LOVD.nl.NF1). Novel variants with amino acid changes were further examined,0.8,Accept,Experimental Usage,LOVD
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,Novel variants with amino acid changes were further examined for their disease causing. potential using PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/bgi.shtml),0.8,Accept,Experimental Usage,PolyPhen-2
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,with the Human Splicing Finder (HSF; http://www.umd.be/HSF/) and the ESE Finder tools,0.8,Accept,Experimental Usage,Human Splicing Finder
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,Human Splicing Finder (HSF; http://www.umd.be/HSF/) and the ESE Finder (http://rulai.cshl.edu/cgibin/tools/ESE3/esefinder.cgi?process=home) tools,0.8,Accept,Experimental Usage,ESE Finder
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,predicted the functional consequence of missense variants using ANNOVAR which included prediction scores from 20 prediction algorithms,0.85,Accept,Experimental Usage,ANNOVAR
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,"In order to assess the frequencies of the variants in the general population, the GnomAD v.2.1.1 (https://gnomad.broadinstitute.org) and 1000 genomes databases were used",0.8,Accept,Experimental Usage,GnomAD v.2.1.1
PMID:40887659,10.1186/s40246-025-00803-z,RENOVO-NF1 accurately predicts NF1 missense variant pathogenicity.,,"For threshold optimization, we used cutpointR version 1.1.2, maximizing the 'accuracy' metric",0.85,Accept,Experimental Usage,cutpointR version 1.1.2
PMID:32839340,10.1073/pnas.2008391117,Brain-wide structural and functional disruption in mice with oligodendrocyte-specific ,,"Diffusion-weighted images were preprocessed using ExplorDTI (68), with tensors calculated using a robust estimation algorithm",0.9,Accept,Experimental Usage,ExplorDTI
PMID:32839340,10.1073/pnas.2008391117,Brain-wide structural and functional disruption in mice with oligodendrocyte-specific ,,"template, B0, for both controls and Plp-Nf1 fl/+ animals was created using Advanced Normalization Tools (ANTs) (70)",0.9,Accept,Experimental Usage,Advanced Normalization Tools (ANTs)
PMID:32839340,10.1073/pnas.2008391117,Brain-wide structural and functional disruption in mice with oligodendrocyte-specific ,,The control template was registered to the Allen Brain Atlas (71),0.85,Accept,Experimental Usage,Allen Brain Atlas
PMID:35735230,10.1093/database/baac045,Centralizing neurofibromatosis experimental tool knowledge with the NF Research Tools Database.,,"...the NF Research Tools Database, is an open-access database that enables the exploration and discovery of information about NF type 1-relevant animal models, cell lines, antibodies...",0.95,Accept,Development,NF Research Tools Database
PMID:35735230,10.1093/database/baac045,Centralizing neurofibromatosis experimental tool knowledge with the NF Research Tools Database.,,"...This schema was processed with the 'schematic' Python library (11, 12) to generate a MySQL database as well as data intake spreadsheets...",0.85,Accept,Experimental Usage,schematic Python library
PMID:35735230,10.1093/database/baac045,Centralizing neurofibromatosis experimental tool knowledge with the NF Research Tools Database.,,...We then built the application using the React JavaScript library and the Synapse React Client (13)...,0.8,Accept,Experimental Usage,React JavaScript library
PMID:35735230,10.1093/database/baac045,Centralizing neurofibromatosis experimental tool knowledge with the NF Research Tools Database.,,...We then built the application using the React JavaScript library and the Synapse React Client (13)...,0.85,Accept,Experimental Usage,Synapse React Client
PMID:35735230,10.1093/database/baac045,Centralizing neurofibromatosis experimental tool knowledge with the NF Research Tools Database.,,"...We constructed a JSON-LD schema from the data model to make it machine-readable (version 2.0.0 at the time of writing, available from https://github.com/nf-osi/nf-research-tools-schema)...",0.8,Accept,Development,JSON-LD schema
PMID:30192842,10.1371/journal.pone.0203520,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,,"PET images were spatially processed using the Statistical Parametric Mapping toolbox (SPM8, Wellcome Trust Centre for Neuroimaging, 2008)",0.9,Accept,Experimental Usage,SPM8
PMID:30192842,10.1371/journal.pone.0203520,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,,"implemented within Matlab 7.12.0 (MathWorks, Natick, MA, USA)",0.85,Accept,Experimental Usage,Matlab 7.12.0
PMID:30192842,10.1371/journal.pone.0203520,Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1.,,we used the Gaussian Process regression (GPR) implementation available within kernlab R library,0.85,Accept,Experimental Usage,kernlab R library
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Key packages used include ""tidyverse"" [ 33 ], ""PLIER"" [ 26 ], ""synapser"" [ 34 ], ""tximport"" [ 35 ], ""immundeconv"" [ 35 ], and ""viper"" [ 32 ].",0.85,Accept,Experimental Usage,tidyverse
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Key packages used include ""tidyverse"" [ 33 ], ""PLIER"" [ 26 ], ""synapser"" [ 34 ], ""tximport"" [ 35 ], ""immundeconv"" [ 35 ], and ""viper"" [ 32 ].",0.9,Accept,Experimental Usage,PLIER
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Key packages used include ""tidyverse"" [ 33 ], ""PLIER"" [ 26 ], ""synapser"" [ 34 ], ""tximport"" [ 35 ], ""immundeconv"" [ 35 ], and ""viper"" [ 32 ].",0.85,Accept,Experimental Usage,synapser
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Key packages used include ""tidyverse"" [ 33 ], ""PLIER"" [ 26 ], ""synapser"" [ 34 ], ""tximport"" [ 35 ], ""immundeconv"" [ 35 ], and ""viper"" [ 32 ].",0.85,Accept,Experimental Usage,tximport
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Key packages used include ""tidyverse"" [ 33 ], ""PLIER"" [ 26 ], ""synapser"" [ 34 ], ""tximport"" [ 35 ], ""immundeconv"" [ 35 ], and ""viper"" [ 32 ].",0.9,Accept,Experimental Usage,immunedeconv
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Key packages used include ""tidyverse"" [ 33 ], ""PLIER"" [ 26 ], ""synapser"" [ 34 ], ""tximport"" [ 35 ], ""immundeconv"" [ 35 ], and ""viper"" [ 32 ].",0.9,Accept,Experimental Usage,viper
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,raw fastq files were downloaded from Synapse and transcripts were quantified using the Salmon pseudo-alignment tool [ 36 ] with Gencode V29 transcriptome.,0.85,Accept,Experimental Usage,Salmon
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Variant call format (VCF) files were processed using ""vcf2maf"" ( https://github.com/mskcc/vcf2maf ) according to the workflow",0.85,Accept,Experimental Usage,vcf2maf
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Salmon output files (quant.sf) files were imported into an R session and converted to HUGO gene names using the ""tximport"" [ 35 ] and ""org.Hs.eg.db"" [ 40 ] packages.",0.85,Accept,Experimental Usage,org.Hs.eg.db
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"We analyzed transcriptomic data from NF in the context of latent variables from MultiPLIER, a machine learning resource designed to aid in rare disease analyses [ 27 ].",0.9,Accept,Experimental Usage,MultiPLIER
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"The main algorithm was implemented using the ""caret"" and ""randomforest"" packages in R [ 44 , 45 ].",0.85,Accept,Experimental Usage,caret
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"The main algorithm was implemented using the ""caret"" and ""randomforest"" packages in R [ 44 , 45 ].",0.85,Accept,Experimental Usage,randomforest
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"we used two tumor deconvolution methods: CIBERSORT and MCP-counter, as implemented through the ""immunedeconv"" R package [ 29 , 30 , 31 ].",0.9,Accept,Experimental Usage,CIBERSORT
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"we used two tumor deconvolution methods: CIBERSORT and MCP-counter, as implemented through the ""immunedeconv"" R package [ 29 , 30 , 31 ].",0.9,Accept,Experimental Usage,MCP-counter
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,We applied the metaVIPER algorithm [ 32 ] to infer protein regulatory activity based on the tissue gene expression profiles.,0.9,Accept,Experimental Usage,metaVIPER
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"A heatmap and subclusters of latent variables that had similar VIPER protein predictions were generated using the ""pheatmap"" R package [ 47 ].",0.85,Accept,Experimental Usage,pheatmap
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"we used gene set enrichment analysis (via the ""clusterProfiler"" R package [ 48 ]) to assess whether drug targets were enriched",0.85,Accept,Experimental Usage,clusterProfiler
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Results were plotted using ""ggplot"" and ""enrichplot"" packages [ 33 , 50 ].",0.85,Accept,Experimental Usage,ggplot
PMID:32098059,10.3390/genes11020226,Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1.,,"Results were plotted using ""ggplot"" and ""enrichplot"" packages [ 33 , 50 ].",0.85,Accept,Experimental Usage,enrichplot
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,We retrieved the mRNA expression profiles (GSE108524 and GSE141801) of NF2-VS from the database,0.85,Accept,Experimental Usage,GSE108524
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,We retrieved the mRNA expression profiles (GSE108524 and GSE141801) of NF2-VS from the database,0.85,Accept,Experimental Usage,GSE141801
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,"GSE108524, compiled using the GPL17586 platform of the Affymetrix GeneChip Human Genome HTA_2_0 Array",0.8,Accept,Experimental Usage,GPL17586
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,"GSE141801, compiled using the GPL13667 Affymetrix Human Genome U219 Array",0.8,Accept,Experimental Usage,GPL13667
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,Data standardization was performed using the R 4.0.3,0.9,Accept,Experimental Usage,R 4.0.3
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,"WGCNA, an R package, was used to conduct WGCNA",0.9,Accept,Experimental Usage,WGCNA
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,The pickSoftThreshold tool was employed for the soft-thresholding power measurement,0.85,Accept,Experimental Usage,pickSoftThreshold
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,we performed FEA of the strongly associated modules using the clusterProfiler package of the R software,0.9,Accept,Experimental Usage,clusterProfiler
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,The key module genes were uploaded to STRING (https://string-db.org/) to generate the PPI axis,0.9,Accept,Experimental Usage,STRING
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,the results were visualized using the Cytoscape (v3.8.2) software,0.95,Accept,Experimental Usage,Cytoscape (v3.8.2)
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,"we retrieved miRNA information from the miRTarBase database, including, over 50,000 experimentally validated miRNA-target associations",0.9,Accept,Experimental Usage,miRTarBase
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,DEGs were identified between NF2-Vs and normal nerves using the R package limma,0.9,Accept,Experimental Usage,limma
PMID:38115252,10.1097/MD.0000000000036696,Identification of hub genes and drug candidates for NF2-related vestibular schwannoma by bioinformatics tools.,,we uploaded our list of up- and down-regulated genes into the connectivity map (CMap) database,0.9,Accept,Experimental Usage,connectivity map (CMap)
PMID:28848060,10.1136/jmedgenet-2017-104519,Genetic Severity Score predicts clinical phenotype in NF2.,,Statistical analyses were undertaken using SPSS V.23. Genetic severity and hearing grades were treated as ordinal variables.,0.75,Accept,Experimental Usage,SPSS V.23
PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,"Variants were validated by Sanger sequencing and analyzed using CLC-workbench (Qiagen, Hilden, Germany)",0.8,Accept,Experimental Usage,CLC-workbench
PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,Analyses of in silico protein modifications by the exon skipping were performed using the web-server version of PredictProtein,0.85,Accept,Experimental Usage,PredictProtein
PMID:36420221,10.1016/j.omtn.2022.10.026,Antisense oligonucleotides targeting exon 11 are able to partially rescue the NF2-related schwannomatosis phenotype ,,Statistical analysis was carried out using GraphPad Prism software v7,0.8,Accept,Experimental Usage,GraphPad Prism software v7
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,Ganglia were imaged on a SP5 Leica confocal microscope and the number of EdU-positive nuclei was quantified,0.8,Accept,Experimental Usage,SP5 Leica confocal microscope
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,Dissected ganglia were also used to measure the ganglia volume using confocal stacks and the Amira software,0.85,Accept,Experimental Usage,Amira software
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,The percentage of EdU-positive cells to S100-positive nuclei were counted by 20× microscopic fields using the cell counting feature of MetaMorph software package,0.85,Accept,Experimental Usage,MetaMorph software package
PMID:18367665,10.1124/jpet.107.135830,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,,"DNA content was analyzed using a FACScalibur instrument (BD Biosciences, San Jose, CA). A minimum of 10^4 cells/sample were analyzed",0.85,Accept,Experimental Usage,FACScalibur instrument (BD Biosciences)
PMID:18367665,10.1124/jpet.107.135830,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,,"A minimum of 10^4 cells/sample were analyzed to determine the percentage of apoptotic cells and cells in G1, S, and G2/M phase (MODFIT; Variety Software, Topsham, ME)",0.85,Accept,Experimental Usage,MODFIT (Variety Software)
PMID:18367665,10.1124/jpet.107.135830,Induction of apoptosis in neurofibromatosis type 1 malignant peripheral nerve sheath tumor cell lines by a combination of novel farnesyl transferase inhibitors and lovastatin.,,Images were immediately acquired with an Axiovert 200M fluorescence microscope (Carl Zeiss),0.85,Accept,Experimental Usage,Axiovert 200M fluorescence microscope (Carl Zeiss)
PMID:24559228,10.1186/1866-1955-6-4,Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits.,,"Stimuli were generated with MATLAB (R2008a, MathWorks, Natick, MA, USA) and presented with the stimulation software STIM 2",0.85,Accept,Experimental Usage,"MATLAB (R2008a, MathWorks, Natick, MA, USA)"
PMID:24559228,10.1186/1866-1955-6-4,Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits.,,"presented with the stimulation software STIM 2 (Neuroscan, Charlotte, NC, USA) with a display resolution of 1,280 × 1,024 × 32",0.9,Accept,Experimental Usage,"STIM 2 (Neuroscan, Charlotte, NC, USA)"
PMID:24559228,10.1186/1866-1955-6-4,Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits.,,"EEG signal was recorded from six parieto-occipital channels (PO3, POZ, PO4, O1, OZ and O2) using a 64-channel Neuroscan system",0.85,Accept,Experimental Usage,64-channel Neuroscan system
PMID:24559228,10.1186/1866-1955-6-4,Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits.,,Data analysis was performed with Scan 4.5 (Neuroscan). We started the analysis by correcting the eye blinking artifacts,0.9,Accept,Experimental Usage,Scan 4.5 (Neuroscan)
PMID:24559228,10.1186/1866-1955-6-4,Abnormal late visual responses and alpha oscillations in neurofibromatosis type 1: a link to visual and attention deficits.,,"All statistical analyses were performed with IBM SPSS Statistics, version 19, software (IBM Corporation, Armonk, NY, USA)",0.85,Accept,Experimental Usage,"IBM SPSS Statistics, version 19"
PMID:33356508,10.1177/0963689720964383,C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas.,,"The phenotype of C6 cells was analyzed using flow cytometry with the MACSQuant flow cytometer (Miltenyi, San Diego, CA, USA)",0.75,Accept,Experimental Usage,MACSQuant flow cytometer
PMID:33356508,10.1177/0963689720964383,C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas.,,"Electronic image files were processed using MATLAB software (MathWorks Inc., R2019a, USA)",0.8,Accept,Experimental Usage,MATLAB software
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,"The publically accessible variant databases included were Leiden Open Variation Database (LOVD) ( www.lovd.nl ) (Fokkema et al., 2021)",0.85,Accept,Experimental Usage,Leiden Open Variation Database (LOVD)
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,"ClinVar NCBI ( www.ncbi.nlm.nih.gov/clinvar ) (Landrum et al., 2018)",0.85,Accept,Experimental Usage,ClinVar NCBI
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,"the Human Gene Mutation Database (HGMD) ( www.hgmd.cf.ac.uk/ac/all.php ) (Stenson et al., 2020)",0.85,Accept,Experimental Usage,Human Gene Mutation Database (HGMD)
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,Clinical Interpretation of Variants in Cancer (CIViC) ( https://civicdb.org/home ),0.85,Accept,Experimental Usage,Clinical Interpretation of Variants in Cancer (CIViC)
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,Mastermind Genomic Search Engine ( https://www.genomenon.com/mastermind ),0.85,Accept,Experimental Usage,Mastermind Genomic Search Engine
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,"An extra literature mining step was conducted using LitVar to capture any missing variants (Allot et al., 2018)",0.85,Accept,Experimental Usage,LitVar
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,Variants were imported into the clinical prediction software Alamut Visual version 2.15 (SOPHiA GENETICS),0.9,Accept,Experimental Usage,Alamut Visual version 2.15
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,"Results from the following tools were exported from Alamut and factored into classification analysis: Align‐GVGD (Mathe et al., 2006)",0.85,Accept,Experimental Usage,Align-GVGD
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,"SIFT (Kumar et al., 2009), PolyPhen‐2 (Adzhubei et al., 2010)",0.85,Accept,Experimental Usage,SIFT
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,"SIFT (Kumar et al., 2009), PolyPhen‐2 (Adzhubei et al., 2010)",0.85,Accept,Experimental Usage,PolyPhen-2
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,"MutationTaster2 (Schwarz et al., 2014), SpliceSiteFinder‐like tool",0.85,Accept,Experimental Usage,MutationTaster2
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,"MutationTaster2 (Schwarz et al., 2014), SpliceSiteFinder‐like tool (Zhang, 1998)",0.85,Accept,Experimental Usage,SpliceSiteFinder-like tool
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,"MaxEntScan (Yeo & Burge, 2004). Variant frequencies and ExAC constraint metrics",0.85,Accept,Experimental Usage,MaxEntScan
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,Variant frequencies and ExAC constraint metrics were obtained from gnomAD v2.1.1 ( gnomad.broadinstitute.org ),0.9,Accept,Experimental Usage,gnomAD v2.1.1
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,UCSC LiftOver tool was used for any genomic co‐ordinate conversions between genome builds GRCh37/hg19 and GRCh38/hg38,0.85,Accept,Experimental Usage,UCSC LiftOver tool
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,Maximum credible population allele frequency was determined using the alleleFrequencyApp ( cardiodb.org/allelefrequencyapp ),0.85,Accept,Experimental Usage,alleleFrequencyApp
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,"The DECIPHER database (Firth et al., 2009) was used to investigate possible mutational hotspots",0.85,Accept,Experimental Usage,DECIPHER database
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,meta‐predictor REVEL (Rare Exome Variant Ensemble Learner) was used as the deciding score for evidence use (PP3 and BP4),0.9,Accept,Experimental Usage,REVEL (Rare Exome Variant Ensemble Learner)
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,"ClinPred (Alirezaie et al., 2018) meta‐predictor scores were also produced for variants",0.85,Accept,Experimental Usage,ClinPred
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,"COSMIC ( www.cancer.sanger.ac.uk ) (Tate et al., 2019) was used in the investigation of variants that were observed in somatic samples",0.85,Accept,Experimental Usage,COSMIC
PMID:35332608,10.1002/humu.24370,Re-evaluation of missense variant classifications in NF2.,,CanVar‐UK cancer predisposition gene variant database ( www.canvaruk.org ) was used in the search for further variant information,0.85,Accept,Experimental Usage,CanVar-UK cancer predisposition gene variant database
PMID:15240917,10.1155/S1110724304308107,Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone.,,"digital photomicrographs were obtained utilizing a high-resolution CCD digital camera (SPOT II, Diagnostic Instruments, Sterling Heights, Mich) mounted to the microscope and SPOT II software",0.75,Accept,Experimental Usage,SPOT II software
PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,,"Quantitation was performed using the Beta Imager 2000Z Digital Beta Imaging System (Biospace, France)",0.9,Accept,Experimental Usage,Beta Imager 2000Z Digital Beta Imaging System
PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,,"data acquired as 1h dynamic scans using the Siemens Focus F220 and Inveon scanners (Siemens Medical Solutions USA, Inc.)",0.9,Accept,Experimental Usage,Siemens Focus F220
PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,,"data acquired as 1h dynamic scans using the Siemens Focus F220 and Inveon scanners (Siemens Medical Solutions USA, Inc.)",0.9,Accept,Experimental Usage,Siemens Inveon scanner
PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,,regions of interest (ROI) for the striatum and cerebellum were manually drawn with the software Acquisition Sinogram Image PROcessing using IDL's Virtual Machine ™ (ASIPro VM ™),0.85,Accept,Experimental Usage,ASIPro VM
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,sequenced using the paired-end 100bp protocol (SeqCap) or the paired-end 150bp (TruSeq) protocol on the Illumina HiSeq 2000/2500,0.8,Accept,Experimental Usage,Illumina HiSeq 2000/2500
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,Sequence reads were mapped using the Burrow-Wheeler aligner (9) and final alignments generated after multiple quality controls,0.75,Accept,Experimental Usage,Burrow-Wheeler aligner
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,"final alignments generated after multiple quality controls steps applied using the Genome Analysis Toolkit (10), Samtools (11) and Picard",0.75,Accept,Experimental Usage,Genome Analysis Toolkit
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,"quality controls steps applied using the Genome Analysis Toolkit (10), Samtools (11) and Picard",0.75,Accept,Experimental Usage,Samtools
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,"using the Genome Analysis Toolkit (10), Samtools (11) and Picard. Somatic mutations were identified after comparison",0.75,Accept,Experimental Usage,Picard
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,Sequence reads were mapped to the human reference genome (b37) using TopHat. Low quality reads were filtered,0.75,Accept,Experimental Usage,TopHat
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,Gene expression levels were calculated using BEDtools software. Differential expression analysis was performed,0.75,Accept,Experimental Usage,BEDtools
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,Differential expression analysis was performed using EdgeR software (12) implemented in the R statistical framework,0.8,Accept,Experimental Usage,EdgeR
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,"Gene Ontology and Pathway enrichment were performed using Partek Genomics Suite software (Partek, St. Louis, MO)",0.85,Accept,Experimental Usage,Partek Genomics Suite
PMID:24932921,10.1002/jbmr.2298,Neurofibromin deficiency-associated transcriptional dysregulation suggests a novel therapy for tibial pseudoarthrosis in NF1.,,"Flow cytometry was performed using an INFLUX cell sorter (BD Biosciences, CA, USA). A 640 nm laser operating at 120mW",0.85,Accept,Experimental Usage,INFLUX cell sorter
PMID:40304934,10.1186/s41687-025-00877-2,Development of patient reported outcome measures assessing tumor pain intensity and tumor pain interference for individuals with neurofibromatosis type 1 and plexiform neurofibromas: qualitative findings.,,"...Qualitative concept elicitation data from transcripts were coded, analyzed using NVivo software, and thematic analysis was conducted...",0.85,Accept,Experimental Usage,NVivo software
PMID:22961690,10.1002/pbc.24281,Phase I trial and pharmacokinetic study of sorafenib in children with neurofibromatosis type I and plexiform neurofibromas.,,"Post-processing was performed using CADvue software (iCAD, Inc. Nashua, NH) employing the Tofts pharmacokinetic model to quantify vascular permeability...",0.8,Accept,Experimental Usage,CADvue software
PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,gRNAs for zebrafish nf2a and nf2b (Table S1) were designed using CHOP-CHOP.,0.9,Accept,Experimental Usage,CHOP-CHOP
PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,"At least 10,000 high-quality reads were analyzed for each sample using CRISPResso2 (Clement et al., 2019).",0.9,Accept,Experimental Usage,CRISPResso2
PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,"Quantifications for meningeal proliferation (Fig. 4H), Schwann cell hyperplasia (Fig. 5J,K), and nf2b HCR signal in cranial neural crest cells and pLLn SCs (Fig. S1L, M) were performed using ImageJ cell counter feature",0.85,Accept,Experimental Usage,ImageJ
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,"images were further analyzed using Cellpose (Stringer et al., 2021) and ImageJ",0.8,Accept,Experimental Usage,Cellpose
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,WES sequencing FASTQ files were trimmed using Trimmomatic v 0.39,0.8,Accept,Experimental Usage,Trimmomatic v 0.39
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,aligned against reference sequence hg38 via BWA-MEM,0.8,Accept,Experimental Usage,BWA-MEM
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,GATK V4.2 base quality score recalibration (BQSR) was used to process BAM files,0.8,Accept,Experimental Usage,GATK V4.2
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,Xenosplit was used to filter mouse-derived reads using mouse (GRCm38) and human (hg38) reference genomes,0.8,Accept,Experimental Usage,Xenosplit
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,"detected using VarScan2, Strelka2, MuTect2, and Pindel",0.8,Accept,Experimental Usage,VarScan2
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,"detected using VarScan2, Strelka2, MuTect2, and Pindel",0.8,Accept,Experimental Usage,Strelka2
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,"detected using VarScan2, Strelka2, MuTect2, and Pindel",0.8,Accept,Experimental Usage,MuTect2
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,"detected using VarScan2, Strelka2, MuTect2, and Pindel",0.8,Accept,Experimental Usage,Pindel
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,Variant filtering and annotation were done using Variant Effect Predictor (VEP),0.8,Accept,Experimental Usage,Variant Effect Predictor (VEP)
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,Somatic variant plots were created with maftools v2.10.0,0.8,Accept,Experimental Usage,maftools v2.10.0
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,CNVkit V2.0 was used to infer and visualize copy number,0.8,Accept,Experimental Usage,CNVkit V2.0
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,which includes quantitation with the Salmon algorithm,0.8,Accept,Experimental Usage,Salmon algorithm
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,Gene counts and transcript counts were normalized by using the DESeq2 package,0.8,Accept,Experimental Usage,DESeq2 package
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,Immunohistochemical staining for FAP was performed on a Ventana BenchMark ULTRA platform using the iVIEW DAB detection system,0.85,Accept,Experimental Usage,Ventana BenchMark ULTRA platform
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,Illumina EPIC DNA methylation profiling was performed with application of the Heidelberg sarcoma classifier,0.85,Accept,Experimental Usage,Heidelberg sarcoma classifier
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,Expression matrices and corresponding phenotype metadata were processed using the GEOquery and Biobase R packages,0.8,Accept,Experimental Usage,GEOquery R package
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,Expression matrices and corresponding phenotype metadata were processed using the GEOquery and Biobase R packages,0.8,Accept,Experimental Usage,Biobase R package
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,"We processed the data using Seurat [36, 37] (Version: 5.3.0, https://satijalab.org/seurat/) in R (Version: 4.4.0)",0.9,Accept,Experimental Usage,Seurat (Version: 5.3.0)
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,"To explore differentiation trajectories among tumor clusters, we applied Slingshot [39] (Version: 2.12.0)",0.85,Accept,Experimental Usage,Slingshot (Version: 2.12.0)
PMID:41591566,10.1007/s00401-026-02979-7,FAP expression as a marker of malignant transformation enabling in vivo characterization in peripheral nerve sheath tumors: a multimodal and translational study.,,"Raw UMI count matrices were loaded via Read10X, filtered to remove cells with < 200 or > 9,000 genes",0.75,Accept,Experimental Usage,Read10X
PMID:32642740,10.1093/noajnl/vdaa003,Quality of life in patients with neurofibromatosis type 1 and 2 in Canada.,,All analyses were done with R statistical software version 3.5.1,0.85,Accept,Experimental Usage,R statistical software version 3.5.1
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,Single nuclei generated from PN were analyzed using 10 × Genomics Chromium 3′ gene expression.,0.85,Accept,Experimental Usage,10x Genomics Chromium 3' gene expression
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,Raw sequencing reads were processed using CellRanger (10 × Genomics) and Seurat 3.1.0.,0.9,Accept,Experimental Usage,CellRanger
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,Raw sequencing reads were processed using CellRanger (10 × Genomics) and Seurat 3.1.0.,0.9,Accept,Experimental Usage,Seurat 3.1.0
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,Cells from individual subpopulations were reanalyzed separately using Harmony alignment,0.85,Accept,Experimental Usage,Harmony alignment
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,Presto was used for determining differential expression and marker gene identification,0.85,Accept,Experimental Usage,Presto
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,CellChatDB [ 4 ] (version 1.5.0) was used to infer ligand–receptor interactions between and within individual subpopulations,0.9,Accept,Experimental Usage,CellChatDB version 1.5.0
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,"Sequencing data were processed with Space Ranger (10 × genomics, v1.2.1), followed by analysis in R using the Seurat (v4.0.1) tool suite.",0.9,Accept,Experimental Usage,Space Ranger v1.2.1
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,followed by analysis in R using the Seurat (v4.0.1) tool suite,0.9,Accept,Experimental Usage,Seurat v4.0.1
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,followed by sample integration with Harmony (v1.0) using 30 principal components and theta = 2,0.9,Accept,Experimental Usage,Harmony v1.0
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,Clustering results at different resolution settings were evaluated through Clustree (v0.4.3) visualizations.,0.9,Accept,Experimental Usage,Clustree v0.4.3
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,"mounted on spatial transcriptomic capture slides (Visium, 10 × Genomics)",0.85,Accept,Experimental Usage,Visium spatial transcriptomics
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,"ontological analysis using DAVID (Database for Annotation, Visualization, and Integrated Discovery: https://david.ncifcrf.gov ; version 6.8)",0.9,Accept,Experimental Usage,DAVID version 6.8
PMID:37770931,10.1186/s40478-023-01639-1,"Integration of single-nuclei RNA-sequencing, spatial transcriptomics and histochemistry defines the complex microenvironment of NF1-associated plexiform neurofibromas.",,ST cluster overlays on H&E image were produced in the Loupe Browser (10 × Genomics).,0.85,Accept,Experimental Usage,Loupe Browser
PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,"Next, an in-house developed tool (QURNAs) was used to calculate the enrichment score (ERS) for each splicing event...QURNAs is available at https://dataverse.nl/dataset.xhtml?persistentId=hdl:10411/LY8ZQ4",0.95,Accept,Development,QURNAs
PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,RNAseq reads were mapped with the STAR mapper (Version 2.4.1d) and an index created from HS.GRCh37,0.9,Accept,Experimental Usage,STAR mapper (Version 2.4.1d)
PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,Duplicate read pair detection was carried out with Picard tools (https://github.com/broadinstitute/picard),0.85,Accept,Experimental Usage,Picard tools
PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,Alamut v2.15 (Interactive Biosoftware) was used to identify true splice-donor and acceptor sites based on in silico prediction,0.9,Accept,Experimental Usage,Alamut v2.15 (Interactive Biosoftware)
PMID:34782607,10.1038/s41525-021-00258-w,Pathogenic neurofibromatosis type 1 (NF1) RNA splicing resolved by targeted RNAseq.,,Regions with alternative splicing were further inspected in the BAM file in a genome browser (IGV and Alamut),0.85,Accept,Experimental Usage,IGV
PMID:39669605,10.1016/j.gimo.2024.101816,Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,,"The CNV analysis tool exome hidden Markov model (XHMM) was used for exon CNV calling. First, at least 20 libraries analyzed in the same flow cell were used to build a baseline reference set",0.85,Accept,Experimental Usage,exome hidden Markov model (XHMM)
PMID:39669605,10.1016/j.gimo.2024.101816,Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,,"Finally, sequence ready target libraries were analyzed on the Novaseq6000 platform (Illumina) using the 150 bp pair-end sequencing mode",0.8,Accept,Experimental Usage,Novaseq6000 platform
PMID:39669605,10.1016/j.gimo.2024.101816,Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,,"FASTQ files were first aligned to the human reference genome (hg19) by the Burrows-Wheeler Aligner (bwa-0.7.15), and PCR duplications",0.85,Accept,Experimental Usage,Burrows-Wheeler Aligner (bwa-0.7.15)
PMID:39669605,10.1016/j.gimo.2024.101816,Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,,PCR duplications that cause bias in copy-number analysis were filtered out using Sambamba (v0.6.6),0.85,Accept,Experimental Usage,Sambamba (v0.6.6)
PMID:39669605,10.1016/j.gimo.2024.101816,Next-generation variant exon screening: Moving forward in routine genetic disease investigations.,,SNVs/indel variants and SNPs were called using version 3.8 of the Genome Analysis Toolkit (GATK). Annotation databases utilized included,0.85,Accept,Experimental Usage,Genome Analysis Toolkit (GATK) version 3.8
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,Pathogenic variants were collected from the Leiden Open Variation Database (LOVD) database,0.85,Accept,Experimental Usage,Leiden Open Variation Database (LOVD)
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,each variant's allele frequency in three different databases of healthy populations: The 1000 Genomes Project,0.8,Accept,Experimental Usage,1000 Genomes Project
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,"The 1000 Genomes Project, The Exome Aggregation Consortium (ExAC) and the Genome Aggregation Database",0.8,Accept,Experimental Usage,Exome Aggregation Consortium (ExAC)
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,The Exome Aggregation Consortium (ExAC) and the Genome Aggregation Database (gnomAD),0.8,Accept,Experimental Usage,Genome Aggregation Database (gnomAD)
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,Variant annotation was performed using SnpEff and included annotations gathered in dbNSFP,0.85,Accept,Experimental Usage,SnpEff
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,Variant annotation was performed using SnpEff and included annotations gathered in dbNSFP,0.85,Accept,Experimental Usage,dbNSFP
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,"prediction scores from 16 prediction algorithms (SIFT, Polyphen2, LRT, MutationTaster",0.8,Accept,Experimental Usage,SIFT
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,"prediction scores from 16 prediction algorithms (SIFT, Polyphen2, LRT, MutationTaster",0.8,Accept,Experimental Usage,Polyphen2
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,"MutationAssessor, FATHMM, MetaSVM, MetaLR, CADD, VEST, PROVEAN",0.8,Accept,Experimental Usage,CADD
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,NF1 protein domain annotation was performed using Interpro and Nextprot,0.8,Accept,Experimental Usage,Interpro
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,NF1 protein domain annotation was performed using Interpro and Nextprot,0.8,Accept,Experimental Usage,Nextprot
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,Models were trained and validated using the H2O R package,0.85,Accept,Experimental Usage,H2O R package
PMID:30274822,10.1016/j.ebiom.2018.09.039,Exhaustive non-synonymous variants functionality prediction enables high resolution characterization of the neurofibromin architecture.,,"The webserver was developed using the shiny web application framework, and published on shinyapps.io",0.8,Accept,Development,shiny web application framework
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,Genotyping for the CALM1 samples was performed on Illumina Infinium HumanOmni‐1Quad bead‐chips.,0.85,Accept,Experimental Usage,Illumina Infinium HumanOmni-1Quad bead-chips
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,Genotyping for the replication cohort CALM2 samples was performed on Illumina Infinium Omni2.5 bead‐chips.,0.85,Accept,Experimental Usage,Illumina Infinium Omni2.5 bead-chips
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"multidimensional scaling (MDS) analysis estimating pairwise identity by descent (IBD) for all pairs of founders using independent SNPs in PLINK (Purcell et al., 2007)",0.8,Accept,Experimental Usage,PLINK
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"LitfOver (Hinrichs et al., 2006) was used to convert genome positions in the CALM1 cohort (NCBI build 36, UCSC hg18) to corresponding positions in the CALM2 cohort",0.8,Accept,Experimental Usage,LitfOver
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"Targeted sequencing of candidate loci was carried out in 171 European–American samples using the AmpliSeq/IonTorrent platform, as per the manufacturer's instructions.",0.85,Accept,Experimental Usage,AmpliSeq/IonTorrent platform
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,Quality control for targeted gene sequencing data was done using SNP & Variation Suite v8.3.4 (http://goldenhelix.com/products/SNP_Variation/index.html) and PLINK,0.9,Accept,Experimental Usage,SNP & Variation Suite v8.3.4
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"tests of association between each SNP and log‐transformed CALM number, adjusted for age, sex, and body surface area, were performed with EMMAX (Kang et al., 2010)",0.8,Accept,Experimental Usage,EMMAX
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"Meta‐analyses between the CALM1 and CALM2 cohort studies were performed with METAL (Willer, Li, & Abecasis, 2010)",0.8,Accept,Experimental Usage,METAL
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"The second approach for corroboration of SNP associations used ComPaSS‐GWAS (Sabourin et al., 2018), a method based on complementary pairs stability selection",0.85,Accept,Experimental Usage,ComPaSS-GWAS
PMID:32869517,10.1002/mgg3.1400,Genome-wide association study of café-au-lait macule number in neurofibromatosis type 1.,,"Haploview 4.2 (Barrett, Fry, Maller, & Daly, 2005) was used to generate LD plots across the genome based on D' and r2 values",0.85,Accept,Experimental Usage,Haploview 4.2
PMID:19144871,10.3181/0809-RM-275,Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin.,,"Protein-protein interactions were quantified using the BIAcore 1000 system (Pharmacia Biacore AB, Uppsala, Sweden/GE Healthcare)",0.9,Accept,Experimental Usage,BIAcore 1000 system
PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,The UCSF Genome Core using Peak Scanner software from Applied Biosystems performed PCR fragment analyses.,0.8,Accept,Experimental Usage,Peak Scanner software
PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,"Allelic discrimination plots generated by SDS3.0, an Applied Biosystems program used to make genotyping calls.",0.8,Accept,Experimental Usage,SDS3.0
PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,"The Catalogue of Somatic Mutations in Cancer Database (COSMIC, www.sanger.ac.uk/genetics/CGP/cosmic , Wellcome Trust Sanger Institute, United Kingdom)",0.85,Accept,Experimental Usage,COSMIC Database
PMID:36241865,10.1038/s12276-022-00850-9,Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,"Then, the electrodes were connected to a BL-410E Data Acquisition Analysis System for Life Science (Chengdu, China)",0.8,Accept,Experimental Usage,BL-410E Data Acquisition Analysis System
PMID:24817309,10.1371/journal.pone.0097320,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,,"the size (diameter/cell growth) and number (clonogenic expansion) of the resulting secondary neurospheres was determined using Metamorph analysis software (Molecular Devices, Sunnyvale CA)",0.85,Accept,Experimental Usage,Metamorph analysis software
PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,"Lengths, areas and the number of cells were quantified using the ImageJ software package",0.9,Accept,Experimental Usage,ImageJ software
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,"Fluorescent signals were then read on a Canto 2 flow cytometer (BD Biosciences, Franklin Lakes, NJ, USA) as mean fluorescence intensities (MFI)",0.8,Accept,Experimental Usage,Canto 2 flow cytometer
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,FACSDiva v6.1 and FlowJo software v10.0.8 (BD Biosciences) were used to collect and analyze data.,0.85,Accept,Experimental Usage,FACSDiva v6.1
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,FACSDiva v6.1 and FlowJo software v10.0.8 (BD Biosciences) were used to collect and analyze data.,0.85,Accept,Experimental Usage,FlowJo software v10.0.8
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,The IC50s for each of the cell lines were determined using GraphPad Prism v8.3 (nonlinear regression and dose–response curve fitting),0.85,Accept,Experimental Usage,GraphPad Prism v8.3
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,"Image acquisition was performed using a Zeiss LSM 880 with Airyscan confocal microscope (Zeiss, Oberkochen, Germany)",0.8,Accept,Experimental Usage,Zeiss LSM 880 with Airyscan confocal microscope
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,analyses performed with ZEN imaging software v2.3 at the Harvard University Center for Bioimaging.,0.85,Accept,Experimental Usage,ZEN imaging software v2.3
PMID:40507334,10.3390/cancers17111852,Development of a Novel Biomarker Platform for Profiling Key Protein-Protein Interactions to Predict the Efficacy of BH3-Mimetic Drugs.,,"Tissues were scored for extent and intensity of staining using the HALO image analysis software v3.2, which generates a ""mean cytoplasmic optical density"" (MCOD)",0.85,Accept,Experimental Usage,HALO image analysis software v3.2
PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,"Resulting FASTQ files were analyzed with CLC Genomics Workbench 22 (QIAGEN, Hilden, Germany)",0.9,Accept,Experimental Usage,CLC Genomics Workbench 22
PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,numerical and graphical analysis was done using the CosinorPy Python package,0.9,Accept,Experimental Usage,CosinorPy Python package
PMID:41001593,10.1080/23723556.2025.2561292,Loss of Schwann cell's normal rhythmic core clock gene expression and gain of rhythmic expression of oncogenic driver genes in malignant NF1-associated peripheral nerve sheath tumor.,,using a freely available online tool (https://cosinor.online/app/cosinor.php),0.85,Accept,Experimental Usage,https://cosinor.online/app/cosinor.php
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,A MultiClamp 700B patch-clamp amplifier and pCLAMP 9.2 software (MDS Analytical Technologies) were used to acquire data,0.85,Accept,Experimental Usage,MultiClamp 700B patch-clamp amplifier
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,A MultiClamp 700B patch-clamp amplifier and pCLAMP 9.2 software (MDS Analytical Technologies) were used to acquire data,0.85,Accept,Experimental Usage,pCLAMP 9.2 software
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,"To acquire high resolution z-stack images of the calyces, a laser scanning confocal microscope (LSM 700; Zeiss) equipped with krypton-argon and helium-neon lasers was used",0.8,Accept,Experimental Usage,LSM 700 confocal microscope
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,The number of swellings per calyx was counted on 3D-rendered (Volocity 4.2; Improvision) images of calyces,0.85,Accept,Experimental Usage,Volocity 4.2
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,images of calyx terminals were binary thresholded using the built-in thresholding function of ImageJ 1.46 (isodata algorithm),0.85,Accept,Experimental Usage,ImageJ 1.46
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,Electrophysiological data was analyzed with a custom written program in Igor 6.22A (WaveMetrics),0.8,Accept,Experimental Usage,Igor 6.22A
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,"Electrophysiological data was analyzed with a custom written program in Igor 6.22A (WaveMetrics) NeuroMatic (version 2.00, kindly provided by Dr. J. Rothman)",0.85,Accept,Experimental Usage,NeuroMatic version 2.00
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,"To align the reads, we employed HISAT2 version 2.2.1 against the GRCh38 human genome",0.85,Accept,Experimental Usage,HISAT2 version 2.2.1
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,Read counts were normalized by StringTie version 2.2.1,0.85,Accept,Experimental Usage,StringTie version 2.2.1
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,Differential expression analysis was analyzed by DEGseq version 1.48.0,0.85,Accept,Experimental Usage,DEGseq version 1.48.0
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,the GSEA KEGG method with ClusterProfiler version 4.2.2 was applied,0.85,Accept,Experimental Usage,ClusterProfiler version 4.2.2
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,protein–protein interaction analysis using STRING version 11.5,0.85,Accept,Experimental Usage,STRING version 11.5
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,The data were analyzed by v10.8 of FlowJo™ software,0.85,Accept,Experimental Usage,FlowJo™ software v10.8
PMID:38203448,10.3390/ijms25010277,FT895 Impairs Mitochondrial Function in Malignant Peripheral Nerve Sheath Tumor Cells.,,"The analysis was performed with Seahorse Wave Pro software (Agilent Technologies, Santa Clara, CA, USA)",0.85,Accept,Experimental Usage,Seahorse Wave Pro software
PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,Fragmented gDNAs were tested for size distribution and concentration using an Agilent Tapestation 4200 and Qubit dsDNA High Sensitivity kit.,0.8,Accept,Experimental Usage,Agilent Tapestation 4200
PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,"The samples were then sequenced on an Illumina NextSeq550Dx, which generated paired-end reads of 151 bp.",0.85,Accept,Experimental Usage,Illumina NextSeq550Dx
PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,"Candidate somatic variants, consisting of point mutations, insertions, and deletions were sorted out with Varsome Clinical Software v.12.3.2 (Saphetor, Lausanne, Switzerland).",0.9,Accept,Experimental Usage,Varsome Clinical Software v.12.3.2
PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,The VAF plot was generated using Plotly v4.9.3 in the R environment (available from https://plotly-r.com).,0.8,Accept,Experimental Usage,Plotly v4.9.3
PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,"Finally, to determine the profiles of the alterations in the number of copies, the CNV calling was also performed using the CNVKit version 0.9.11.",0.85,Accept,Experimental Usage,CNVKit version 0.9.11
PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,The output was then visualized using ggplot2 v3.5.1 (https://ggplot2.tidyverse.org).,0.8,Accept,Experimental Usage,ggplot2 v3.5.1
PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,"Kaplan–Meier survival curves were generated using GEPIA (http://gepia.cancer-pku.cn/) on the TCGA-SARC, TCGA-LUAD and TCGA-LUSC RNA-seq expression dataset.",0.85,Accept,Experimental Usage,GEPIA
PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,"Gene Ontology (GO) and pathway enrichment analysis was performed using Cluster Profiler v.4.0, selecting statistically significant terms and pathways.",0.85,Accept,Experimental Usage,Cluster Profiler v.4.0
PMID:39409151,10.3390/ijms251910822,Proof of Concept for Genome Profiling of the Neurofibroma/Sarcoma Sequence in Neurofibromatosis Type 1.,,Visualization of intersecting sets was performed with UpSetR Version 1.4.0 (R package).,0.8,Accept,Experimental Usage,UpSetR Version 1.4.0
PMID:39845289,10.1093/jamiaopen/ooae157,Evaluating dimensionality reduction of comorbidities for predictive modeling in individuals with neurofibromatosis type 1.,,"We compared the performance of logistic regression, XGBoost, and random forest models utilizing each feature set...XGBoost-based predictive models were most successful",0.85,Accept,Experimental Usage,XGBoost
PMID:39845289,10.1093/jamiaopen/ooae157,Evaluating dimensionality reduction of comorbidities for predictive modeling in individuals with neurofibromatosis type 1.,,"Yellowbrick, a ML visualization library, was used for this purpose. For k-means clustering, we used the Lloyd algorithm",0.8,Accept,Experimental Usage,Yellowbrick
PMID:39845289,10.1093/jamiaopen/ooae157,Evaluating dimensionality reduction of comorbidities for predictive modeling in individuals with neurofibromatosis type 1.,,"HoloViews, a data analysis and visualization library, was used to generate the shared feature plots",0.8,Accept,Experimental Usage,HoloViews
PMID:39845289,10.1093/jamiaopen/ooae157,Evaluating dimensionality reduction of comorbidities for predictive modeling in individuals with neurofibromatosis type 1.,,"using raw International Classification of Diseases codes, Clinical Classifications Software Refined, and Phecode mapping schemes",0.85,Accept,Experimental Usage,Clinical Classifications Software Refined
PMID:39845289,10.1093/jamiaopen/ooae157,Evaluating dimensionality reduction of comorbidities for predictive modeling in individuals with neurofibromatosis type 1.,,"We used Phecode and CCSR, aggregation and reduction methods that group ICD-10 codes into standardized, clinically meaningful concepts",0.85,Accept,Experimental Usage,Phecode
PMID:32948135,10.1186/s12885-020-07397-w,Anti-cancer agent 3-bromopyruvate reduces growth of MPNST and inhibits metabolic pathways in a representative in-vitro model.,,"Ki67 labelling was analysed conventionally as well as using analysis software pathoZoom® (smart in media, Köln, Germany)",0.8,Accept,Experimental Usage,pathoZoom®
PMID:33085177,10.1002/mgg3.1530,The development of the PlexiQoL: A patient-reported outcome measure for adults with neurofibromatosis type 1-associated plexiform neurofibromas.,,"Rasch analysis was conducted using the RUMM2030 programme (Andrich et al., 2010).",0.85,Accept,Experimental Usage,RUMM2030 programme
PMID:25639352,10.1002/jbmr.2447,Neural Crest-Specific TSC1 Deletion in Mice Leads to Sclerotic Craniofacial Bone Lesion.,,"analyzed by microcomputed tomography using an eXplore Locus SP (GE Healthcare Pre-Clinical Imaging, London, ON, Canada)",0.9,Accept,Experimental Usage,eXplore Locus SP (GE Healthcare Pre-Clinical Imaging)
PMID:25639352,10.1002/jbmr.2447,Neural Crest-Specific TSC1 Deletion in Mice Leads to Sclerotic Craniofacial Bone Lesion.,,Cells were analyzed on a FACSCanto (BD Biosciences) instrument,0.9,Accept,Experimental Usage,FACSCanto (BD Biosciences)
PMID:25639352,10.1002/jbmr.2447,Neural Crest-Specific TSC1 Deletion in Mice Leads to Sclerotic Craniofacial Bone Lesion.,,quantified with the multipoint tool and segmented line measurement function of Image J software,0.85,Accept,Experimental Usage,Image J software
PMID:36604703,10.1186/s13023-022-02607-z,The German version of the neurofibromatosis 2 impact on quality of life questionnaire correlates with severity of depression and physician-reported disease severity.,,"R Studio version 2022.02.3 was utilised for descriptive statistics, Cronbach's α and Pearson's correlation analyses",0.85,Accept,Experimental Usage,R Studio version 2022.02.3
PMID:38170419,10.1007/s11136-023-03574-z,Development of the PROMIS pediatric stigma and extension to the PROMIS pediatric stigma: skin item banks.,,"...DIF was conducted using lordif, a hybrid logistic ordinal regression/IRT ability score framework...",0.85,Accept,Experimental Usage,lordif
PMID:18188004,10.4161/epi.3.1.5469,Real-time PCR analysis of candidate imprinted genes on mouse chromosome 11 shows balanced expression from the maternal and paternal chromosomes and strain-specific variation in expression levels.,,We designed Taqman assays for these SNPs using Assay-by-Design or Primer-Express software as described previously.,0.8,Accept,Experimental Usage,Assay-by-Design
PMID:18188004,10.4161/epi.3.1.5469,Real-time PCR analysis of candidate imprinted genes on mouse chromosome 11 shows balanced expression from the maternal and paternal chromosomes and strain-specific variation in expression levels.,,We designed Taqman assays for these SNPs using Assay-by-Design or Primer-Express software as described previously.,0.8,Accept,Experimental Usage,Primer-Express software
PMID:18188004,10.4161/epi.3.1.5469,Real-time PCR analysis of candidate imprinted genes on mouse chromosome 11 shows balanced expression from the maternal and paternal chromosomes and strain-specific variation in expression levels.,,we determined the third order polynomial function for each assay using the LINEST function in Excel or regression analysis in GraphPad Prism 4.0a,0.8,Accept,Experimental Usage,GraphPad Prism 4.0a
PMID:18769552,10.1155/2008/849156,Frequent EGFR Positivity and Overexpression in High-Grade Areas of Human MPNSTs.,,"Statistical analyses were performed with the SAS 8.2 software package (SAS Institute Inc, Cary, NC, USA).",0.8,Accept,Experimental Usage,"SAS 8.2 software package (SAS Institute Inc, Cary, NC, USA)"
PMID:34573290,10.3390/genes12091308,Performance Evaluation of SpliceAI for the Prediction of Splicing of ,,"SpliceAI, a web-based interface (https://spliceailookup.broadinstitute.org/#, accessed on 1 July 2021), was used for splicing prediction",0.95,Accept,Experimental Usage,SpliceAI
PMID:34573290,10.3390/genes12091308,Performance Evaluation of SpliceAI for the Prediction of Splicing of ,,"allele frequencies were reviewed using gnomAD (v2.1.1, https://gnomad.broadinstitute.org/, accessed on 1 July 2021)",0.9,Accept,Experimental Usage,gnomAD (v2.1.1)
PMID:34573290,10.3390/genes12091308,Performance Evaluation of SpliceAI for the Prediction of Splicing of ,,Previous reports of NF1 variants were reviewed using Human Genome Variation Database (HGMD® Professional release 2021.2),0.9,Accept,Experimental Usage,Human Genome Variation Database (HGMD Professional release 2021.2)
PMID:34573290,10.3390/genes12091308,Performance Evaluation of SpliceAI for the Prediction of Splicing of ,,"Previous reports of NF1 variants were reviewed using...ClinVar (https://www.ncbi.nlm.nih.gov/clinvar/, accessed on 1 July 2021)",0.9,Accept,Experimental Usage,ClinVar
PMID:34573290,10.3390/genes12091308,Performance Evaluation of SpliceAI for the Prediction of Splicing of ,,"Leiden Open Variation Database (LOVD; https://databases.lovd.nl/shared/variants/NF1, accessed on 1 July 2021)",0.9,Accept,Experimental Usage,Leiden Open Variation Database (LOVD)
PMID:34573290,10.3390/genes12091308,Performance Evaluation of SpliceAI for the Prediction of Splicing of ,,"The concentration and purity of the DNA were measured using NanoDrop (Thermo Fisher Scientific, Waltham, MA, USA)",0.85,Accept,Experimental Usage,NanoDrop (Thermo Fisher Scientific)
PMID:34573290,10.3390/genes12091308,Performance Evaluation of SpliceAI for the Prediction of Splicing of ,,Amplification of NF1 cDNA was performed through 24 overlapping fragments using the GeneAmp PCR System 9700 Thermal Cycler,0.85,Accept,Experimental Usage,GeneAmp PCR System 9700 Thermal Cycler (Applied Biosystems)
PMID:34573290,10.3390/genes12091308,Performance Evaluation of SpliceAI for the Prediction of Splicing of ,,sequence traces were obtained on an ABI 3730xl DNA Analyzer (Applied Biosystems),0.85,Accept,Experimental Usage,ABI 3730xl DNA Analyzer (Applied Biosystems)
PMID:34573290,10.3390/genes12091308,Performance Evaluation of SpliceAI for the Prediction of Splicing of ,,"Sequence variations were detected through Sequencher software (Gene Codes, Ann Arbor, MI, USA)",0.85,Accept,Experimental Usage,Sequencher software (Gene Codes)
PMID:34573290,10.3390/genes12091308,Performance Evaluation of SpliceAI for the Prediction of Splicing of ,,"MES and SSF, two commonly used algorithms, were conducted using Alamut® Visual v.2.15 software (SOPHiA GENETICS)",0.85,Accept,Experimental Usage,Alamut Visual v.2.15 software (SOPHiA GENETICS)
PMID:34573290,10.3390/genes12091308,Performance Evaluation of SpliceAI for the Prediction of Splicing of ,,"Statistical analyses were performed using MedCalc Statistical Software version 19.0.5 (MedCalc Software, Ostend, Belgium)",0.85,Accept,Experimental Usage,MedCalc Statistical Software version 19.0.5
PMID:22811580,10.1158/1078-0432.CCR-12-1072,Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target.,,All statistical comparisons and data visualization were performed using GeneSpring GX v7.3.1 (Agilent Technologies),0.85,Accept,Experimental Usage,GeneSpring GX v7.3.1
PMID:22811580,10.1158/1078-0432.CCR-12-1072,Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target.,,quantitative PCR performed on a LightCycler® 480 Instrument (Roche Applied Science),0.9,Accept,Experimental Usage,LightCycler® 480 Instrument
PMID:22811580,10.1158/1078-0432.CCR-12-1072,Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target.,,QRT-PCR (ABI 7500 Sequence Detection System),0.9,Accept,Experimental Usage,ABI 7500 Sequence Detection System
PMID:22811580,10.1158/1078-0432.CCR-12-1072,Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target.,,Absorbance was read at 490 nm in a Spectramax M2 plate reader (Molecular Devices),0.9,Accept,Experimental Usage,Spectramax M2 plate reader
PMID:22811580,10.1158/1078-0432.CCR-12-1072,Ras-driven transcriptome analysis identifies aurora kinase A as a potential malignant peripheral nerve sheath tumor therapeutic target.,,"Sections were photographed on the Zeiss LSM 510 scanning confocal microscope equipped with an argon-ion multi line, HeNe 543, and HeNe 633 lasers",0.9,Accept,Experimental Usage,Zeiss LSM 510 scanning confocal microscope
PMID:26657314,10.1371/journal.pone.0144620,Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.,,"RNA from SWN tumor samples, SWN cell lines, and normal primary Human Schwann cells were analyzed using the Illumina Human HT-12 microarray covering more than 47,000 transcripts",0.9,Accept,Experimental Usage,Illumina Human HT-12 microarray
PMID:26657314,10.1371/journal.pone.0144620,Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.,,"Differences in expression between the two groups were identified using the Ingenuity iReport software, and Nexus Gene expression software.",0.85,Accept,Experimental Usage,Ingenuity iReport software
PMID:26657314,10.1371/journal.pone.0144620,Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.,,"Differences in expression between the two groups were identified using the Ingenuity iReport software, and Nexus Gene expression software.",0.85,Accept,Experimental Usage,Nexus Gene expression software
PMID:26657314,10.1371/journal.pone.0144620,Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis Patients.,,Functional gene groupings were complied using DAVID gene ontology software www.david.abcc.ncifcrf.gov,0.8,Accept,Experimental Usage,DAVID gene ontology software
PMID:34604751,10.1093/noajnl/vdab116,Feasibility of magnetic resonance-guided high-intensity focused ultrasound treatment targeting distinct nodular lesions in neurofibromatosis type 1.,,"Osirix software (Pixmeo SARL; v10.0.0) was used for all evaluations and measurements. Whole-body MRIs were closely examined, identifying all lesions meeting criteria for DNL.",0.9,Accept,Experimental Usage,Osirix software (Pixmeo SARL; v10.0.0)
PMID:32193437,10.1038/s41598-020-61251-4,Longitudinal phenotype development in a minipig model of neurofibromatosis type 1.,,...skeletal measurements were taken with tools available in 3D Slicer (https://www.slicer.org/) to identify any developmental abnormalities...,0.85,Accept,Experimental Usage,3D Slicer
PMID:21980365,10.1371/journal.pone.0024917,The haploinsufficient hematopoietic microenvironment is critical to the pathological fracture repair in murine models of neurofibromatosis type 1.,,"using Image Pro Plus version 4.1 software (Media Cybernetics, Silver Spring, MD)",0.85,Accept,Experimental Usage,Image Pro Plus version 4.1
PMID:22916147,10.1371/journal.pone.0042682,Applying microsatellite multiplex PCR analysis (MMPA) for determining allele copy-number status and percentage of normal cells within tumors.,,PCR fragments were separated by capillary electrophoresis on an ABI 3130 xl Genetic Analyzer,0.9,Accept,Experimental Usage,ABI 3130 xl Genetic Analyzer
PMID:22916147,10.1371/journal.pone.0042682,Applying microsatellite multiplex PCR analysis (MMPA) for determining allele copy-number status and percentage of normal cells within tumors.,,Peak height values for each microsatellite allele were extracted using Peak Scanner software (Applied Biosystems),0.9,Accept,Experimental Usage,Peak Scanner software (Applied Biosystems)
PMID:22916147,10.1371/journal.pone.0042682,Applying microsatellite multiplex PCR analysis (MMPA) for determining allele copy-number status and percentage of normal cells within tumors.,,This automated analysis has been implemented using the Ruby programming language in a script named mmpa.rb,0.95,Accept,Development,mmpa.rb
PMID:22916147,10.1371/journal.pone.0042682,Applying microsatellite multiplex PCR analysis (MMPA) for determining allele copy-number status and percentage of normal cells within tumors.,,by applying a Global Parameter Hidden Markov Model (GPHMM) algorithm that quantitatively models signal baseline shift,0.8,Accept,Experimental Usage,Global Parameter Hidden Markov Model (GPHMM) algorithm
PMID:20739432,10.1158/1078-0432.CCR-10-0613,Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.,,Relative levels of RNA were measured by quantitative real-time PCR (qPCR) using the ABI 7500 Sequence Detection System default settings.,0.9,Accept,Experimental Usage,ABI 7500 Sequence Detection System
PMID:20739432,10.1158/1078-0432.CCR-10-0613,Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.,,We obtained primer sequences using Primer3 software ( http://frodo.wi.mit.edu/cgi-bin/primer3/primer3_www.cgi ),0.85,Accept,Experimental Usage,Primer3 software
PMID:20739432,10.1158/1078-0432.CCR-10-0613,Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.,,The area of tube formation was then quantified using ImageJ software.,0.85,Accept,Experimental Usage,ImageJ software
PMID:20739432,10.1158/1078-0432.CCR-10-0613,Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.,,All statistical comparisons and data visualizations were done using GeneSpring GX v7.3.1 (Agilent Technologies).,0.9,Accept,Experimental Usage,GeneSpring GX v7.3.1 (Agilent Technologies)
PMID:20739432,10.1158/1078-0432.CCR-10-0613,Gene expression analysis identifies potential biomarkers of neurofibromatosis type 1 including adrenomedullin.,,normalized samples using the Robust Multichip Analysis algorithm as implemented in Bioconductor/R,0.8,Accept,Experimental Usage,Bioconductor/R
PMID:25475340,10.1186/s13023-014-0202-9,Validity and interexaminer reliability of a new method to quantify skin neurofibromas of neurofibromatosis 1 using paper frames.,,"...All the pictures were analyzed using the software Paint® (Microsoft Corporation, Redmond, WA, USA)...",0.8,Accept,Experimental Usage,Paint® software
PMID:24997609,10.1038/nm.3583,"Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.",,"μCT analyses were performed using a Scanco μCT 40 system (Scanco Medical, Bassersdorf, Switzerland)",0.9,Accept,Experimental Usage,Scanco μCT 40 system
PMID:24997609,10.1038/nm.3583,"Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.",,"Static histomorphometry measurements were performed...using the Bioquant Analysis System (Nashville, TN, USA)",0.9,Accept,Experimental Usage,Bioquant Analysis System
PMID:24997609,10.1038/nm.3583,"Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.",,"Radiographs were obtained using a digital cabinet X-ray system (LX-60, Faxitron X-Ray, USA)",0.85,Accept,Experimental Usage,"LX-60, Faxitron X-Ray"
PMID:24997609,10.1038/nm.3583,"Asfotase-α improves bone growth, mineralization and strength in mouse models of neurofibromatosis type-1.",,"Force and displacement was measured from a 100 N load cell, and from the linear variable displacement transformer of the material testing system (Dynamight 8841, Instron, Canton, OH)",0.85,Accept,Experimental Usage,"Dynamight 8841, Instron"
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,Single-cell clones were validated using Western blotting and Synthego's Inference of CRISPR Edits analysis tool (https://ice.synthego.com),0.9,Accept,Experimental Usage,Synthego's Inference of CRISPR Edits analysis tool
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,Sequencing was performed on a NovaSeq 6000 (Illumina) generating approximately 20 million reads/sample,0.85,Accept,Experimental Usage,NovaSeq 6000
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,RNA-seq data was trimmed and aligned with Trimmomatic and HISAT2 to the human genome (hg38),0.8,Accept,Experimental Usage,Trimmomatic
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,RNA-seq data was trimmed and aligned with Trimmomatic and HISAT2 to the human genome (hg38),0.8,Accept,Experimental Usage,HISAT2
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,Reads were counted using featureCounts. Differentially expressed genes were identified using DESeq2,0.8,Accept,Experimental Usage,featureCounts
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,Differentially expressed genes were identified using DESeq2. Inclusion criteria for differentially expressed genes were an absolute fold change,0.85,Accept,Experimental Usage,DESeq2
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,Pathway analysis was performed using EnrichR and gene set enrichment analysis (GSEA) as previously described,0.8,Accept,Experimental Usage,EnrichR
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,"gene set enrichment analysis (GSEA) as previously described with the R package, clusterProfiler",0.85,Accept,Experimental Usage,clusterProfiler
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,Differential methylation of probes was identified with limma. Filtering and normalization were performed using minfi,0.8,Accept,Experimental Usage,limma
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,Differential methylation of probes was identified with limma. Filtering and normalization were performed using minfi,0.8,Accept,Experimental Usage,minfi
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,"Data were analyzed with Spectrum Mill MS Proteomics Workbench. Differential protein abundance analysis was performed using the R package, limma",0.85,Accept,Experimental Usage,Spectrum Mill MS Proteomics Workbench
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,Combination index values were determined with the median-effect principle using CalcuSyn software (Biosoft),0.85,Accept,Experimental Usage,CalcuSyn software
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,Data were acquired using a CytoFLEX flow cytometer (Beckman Coulter) and 10 000 single cells were analyzed per sample. Data were analyzed using FlowJo,0.8,Accept,Experimental Usage,FlowJo
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,Data were acquired using a CytoFLEX flow cytometer (Beckman Coulter) and 10 000 single cells were analyzed per sample,0.85,Accept,Experimental Usage,CytoFLEX flow cytometer
PMID:39620202,10.1093/noajnl/vdae188,Multiomic analyses reveal new targets of polycomb repressor complex 2 in Schwann lineage cells and malignant peripheral nerve sheath tumors.,,qPCR reaction was performed on a CFX96 Touch Real-Time PCR Detection System (Bio-Rad),0.85,Accept,Experimental Usage,CFX96 Touch Real-Time PCR Detection System
PMID:39016685,10.1242/jcs.262343,Chemical genetic screens reveal defective lysosomal trafficking as synthetic lethal with NF1 loss.,,Raw data were searched using COMET against a target-decoy version of the human (Homo sapiens) proteome sequence database,0.8,Accept,Experimental Usage,COMET
PMID:21157378,10.1097/NEN.0b013e3182032d37,Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.,,Images were acquired using an Olympus multichannel confocal microscope in the Washington University Bakewell Neuroimaging Core Facility and Image J image analysis software,0.9,Accept,Experimental Usage,Image J image analysis software
PMID:21157378,10.1097/NEN.0b013e3182032d37,Neurofibromatosis-1 heterozygosity increases microglia in a spatially and temporally restricted pattern relevant to mouse optic glioma formation and growth.,,"data were subsequently analyzed using FlowJo (Tree Star, Inc., Ashland, OR). Viable cells were gated by FSC and SSC characteristics",0.9,Accept,Experimental Usage,"FlowJo (Tree Star, Inc., Ashland, OR)"
PMID:32858845,10.3390/cancers12092416,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,,The complete list of NF1 gene ontologies (GO) and phenotype ontologies were obtained in the AmiGO and Human Phenotype Ontology (HPO) databases,0.85,Accept,Experimental Usage,AmiGO
PMID:32858845,10.3390/cancers12092416,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,,The complete list of NF1 gene ontologies (GO) and phenotype ontologies were obtained in the AmiGO and Human Phenotype Ontology (HPO) databases,0.85,Accept,Experimental Usage,Human Phenotype Ontology (HPO)
PMID:32858845,10.3390/cancers12092416,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,,"Networks were generated using STRING database v.11, comprising protein–protein interactions (PPI) for Homo sapiens",0.9,Accept,Experimental Usage,STRING database v.11
PMID:32858845,10.3390/cancers12092416,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,,"The assembled networks were transferred to Cytoscape v.3.7.2 software, with which the network statistics was obtained",0.9,Accept,Experimental Usage,Cytoscape v.3.7.2
PMID:32858845,10.3390/cancers12092416,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,,Comparison between networks was performed with DyNet application for Cytoscape v.3.7.2,0.85,Accept,Experimental Usage,DyNet application
PMID:32858845,10.3390/cancers12092416,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,,"Complex networks comprising HPO selected phenotypes, gene expression, and PPI networks were assembled using the PhenomeScape app, also in Cytoscape v.3.7.2",0.85,Accept,Experimental Usage,PhenomeScape app
PMID:32858845,10.3390/cancers12092416,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,,RNA-seq and microarray secondary analysis were performed using studies selected in Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases,0.85,Accept,Experimental Usage,Gene Expression Omnibus (GEO)
PMID:32858845,10.3390/cancers12092416,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,,RNA-seq and microarray secondary analysis were performed using studies selected in Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases,0.85,Accept,Experimental Usage,The Cancer Genome Atlas (TCGA)
PMID:32858845,10.3390/cancers12092416,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,,the robust multiarray averaging (RMA) normalization was applied using oligo or affy R packages (R v.3.6.2),0.85,Accept,Experimental Usage,oligo R package
PMID:32858845,10.3390/cancers12092416,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,,the robust multiarray averaging (RMA) normalization was applied using oligo or affy R packages (R v.3.6.2),0.85,Accept,Experimental Usage,affy R package
PMID:32858845,10.3390/cancers12092416,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,,The differentially expressed genes were obtained using the limma package (R v.3.6.2),0.85,Accept,Experimental Usage,limma package
PMID:32858845,10.3390/cancers12092416,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,,The gene expression analysis for TCGA data was performed by extracting the data with TCGAbiolinks package,0.85,Accept,Experimental Usage,TCGAbiolinks package
PMID:32858845,10.3390/cancers12092416,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,,evaluating differential gene expression with edgeR package. All analyses were performed in R v.3.6.2,0.85,Accept,Experimental Usage,edgeR package
PMID:32858845,10.3390/cancers12092416,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,,"The heterogeneous networks comprising both the genes and phenotypes selected were assembled in the RandomWalkRestartMH package, in R v.3.6.2",0.85,Accept,Experimental Usage,RandomWalkRestartMH package
PMID:32858845,10.3390/cancers12092416,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,,"Other databases consulted to obtain data for the potential NF1 phenotype-modifier genes were: (1) BioGrid, for curated protein interactions",0.85,Accept,Experimental Usage,BioGrid
PMID:32858845,10.3390/cancers12092416,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,,"(2) PINOT tool, for literature data on curated protein interactions",0.85,Accept,Experimental Usage,PINOT tool
PMID:32858845,10.3390/cancers12092416,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,,"(4) The Human Reference Protein Interactome (HuRI), for the binary protein–protein interactions",0.85,Accept,Experimental Usage,The Human Reference Protein Interactome (HuRI)
PMID:32858845,10.3390/cancers12092416,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,,we consulted The Genome Aggregation Database (gnomAD) v 2.1.1 and the ClinVar archive,0.9,Accept,Experimental Usage,The Genome Aggregation Database (gnomAD) v 2.1.1
PMID:32858845,10.3390/cancers12092416,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,,we consulted The Genome Aggregation Database (gnomAD) v 2.1.1 and the ClinVar archive,0.85,Accept,Experimental Usage,ClinVar archive
PMID:32858845,10.3390/cancers12092416,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,,"an additional analysis was performed consulting the 79,720 tumor samples made available by the AACR Project GENIE",0.85,Accept,Experimental Usage,AACR Project GENIE
PMID:32858845,10.3390/cancers12092416,Systems Biology Approaches Reveal Potential Phenotype-Modifier Genes in Neurofibromatosis Type 1.,,using the cBioPortal for Cancer Genomics. Samples were filtered according to their mutational status,0.85,Accept,Experimental Usage,cBioPortal for Cancer Genomics
PMID:19430883,10.1007/s11060-009-9867-7,Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma.,,"Tumor volumetry will typically be performed centrally in multicenter trials, and should be performed using post-contrast images through the internal auditory canal with the Vitrea2 (Vital Images, Minnetonka, MN) semi-automated segmentation software (or comparable software), edited manually as needed by the reviewer.",0.85,Accept,Experimental Usage,"Vitrea2 (Vital Images, Minnetonka, MN) semi-automated segmentation software"
PMID:18984165,10.1016/j.cell.2008.09.060,Neurofibromin regulation of ERK signaling modulates GABA release and learning.,,"Blots were quantitated using ECL + and the Storm 860 phosphorimager system (Molecular Dynamics, Sunnyvale, CA)",0.85,Accept,Experimental Usage,Storm 860 phosphorimager system (Molecular Dynamics)
PMID:18984165,10.1016/j.cell.2008.09.060,Neurofibromin regulation of ERK signaling modulates GABA release and learning.,,Sections were analyzed with a Zeiss LSM 510 confocal laser-scanning microscope using a 40× numerical aperture objective,0.85,Accept,Experimental Usage,Zeiss LSM 510 confocal laser-scanning microscope
PMID:18984165,10.1016/j.cell.2008.09.060,Neurofibromin regulation of ERK signaling modulates GABA release and learning.,,"Whole-cell voltage-clamp recordings using an Axopatch 200B amplifier (Axon Instruments, Foster City, CA) or a 3900A Integrating Patch Clamp Amplifier",0.85,Accept,Experimental Usage,Axopatch 200B amplifier (Axon Instruments)
PMID:18984165,10.1016/j.cell.2008.09.060,Neurofibromin regulation of ERK signaling modulates GABA release and learning.,,"Axopatch 200B amplifier (Axon Instruments, Foster City, CA) or a 3900A Integrating Patch Clamp Amplifier (Dagan, Minneapolis, MN)",0.85,Accept,Experimental Usage,3900A Integrating Patch Clamp Amplifier (Dagan)
PMID:18984165,10.1016/j.cell.2008.09.060,Neurofibromin regulation of ERK signaling modulates GABA release and learning.,,"All recordings were low-pass filtered at 2 kHz and on-line digitized at 10 kHz using a PCI-MIO 16E-4 data acquisition board (National Instruments, Austin, TX)",0.85,Accept,Experimental Usage,PCI-MIO 16E-4 data acquisition board (National Instruments)
PMID:25877069,10.1007/s11626-015-9885-z,Establishment of immortalized murine mesothelial cells and a novel mesothelioma cell line.,,"Proliferation was monitored using the Incucyte Live Cell Imaging System (Essen Bioscience, Michigan). After passaging, cells were seeded at a very low density",0.9,Accept,Experimental Usage,Incucyte Live Cell Imaging System
PMID:33574490,10.1038/s41598-021-83152-w,Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation.,,Neurite extension was measured by determining the length of at least 10–20 neurites per field using the ImageJ (versions 1.45 s and 1.8.0_172),0.8,Accept,Experimental Usage,ImageJ (versions 1.45 s and 1.8.0_172)
PMID:33574490,10.1038/s41598-021-83152-w,Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation.,,using the ImageJ (versions 1.45 s and 1.8.0_172; https://imagej.nih.gov/ij/download.html) plugin NeuronJ,0.85,Accept,Experimental Usage,NeuronJ
PMID:33574490,10.1038/s41598-021-83152-w,Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation.,,was analyzed using the online tool SpliceAid 2 to determine RNA sequences predicted to be bound by splicing proteins in humans,0.85,Accept,Experimental Usage,SpliceAid 2
PMID:33574490,10.1038/s41598-021-83152-w,Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation.,,Sequencing data was quality trimmed with Trimmomatic v0.3 then processed with TopHat v 2.0.9,0.8,Accept,Experimental Usage,Trimmomatic v0.3
PMID:33574490,10.1038/s41598-021-83152-w,Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation.,,"Sequencing data was quality trimmed with Trimmomatic v0.3 then processed with TopHat v 2.0.9, mapping with Bowtie2",0.8,Accept,Experimental Usage,TopHat v 2.0.9
PMID:33574490,10.1038/s41598-021-83152-w,Using antisense oligonucleotides for the physiological modulation of the alternative splicing of NF1 exon 23a during PC12 neuronal differentiation.,,"then processed with TopHat v 2.0.9, mapping with Bowtie2 against the Rattus norvergicus reference genome Rnor 6.0",0.8,Accept,Experimental Usage,Bowtie2
PMID:18632626,10.1158/0008-5472.CAN-08-0190,Merlin is a potent inhibitor of glioma growth.,,"Probe intensity data were imported to ArrayAssist Lite version 3.4 (Stratagene), and expression values for the probe sets were calculated using GCRMA",0.85,Accept,Experimental Usage,ArrayAssist Lite version 3.4 (Stratagene)
PMID:18632626,10.1158/0008-5472.CAN-08-0190,Merlin is a potent inhibitor of glioma growth.,,The data were then imported back to GeneSpringGX version 7.3.1 (Agilent) and filtered based on P in at least two of six samples,0.85,Accept,Experimental Usage,GeneSpringGX version 7.3.1 (Agilent)
PMID:18632626,10.1158/0008-5472.CAN-08-0190,Merlin is a potent inhibitor of glioma growth.,,"Finally, SAM version 2.2.1 (Stanford University) was applied using a two-class unpaired analysis, and differentially expressed genes were identified",0.85,Accept,Experimental Usage,SAM version 2.2.1 (Stanford University)
PMID:18632626,10.1158/0008-5472.CAN-08-0190,Merlin is a potent inhibitor of glioma growth.,,bioluminescence images of the intracranial tumors were acquired by using IVIS-200 imaging system (Xenogen) at In vivo Molecular Imaging Shared Facility,0.85,Accept,Experimental Usage,IVIS-200 imaging system (Xenogen)
PMID:37817770,10.3389/fonc.2023.1253659,Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model.,,...Experiment data were demultiplexed using the Cell Ranger Single Cell Software Suite...,0.85,Accept,Experimental Usage,Cell Ranger Single Cell Software Suite
PMID:37817770,10.3389/fonc.2023.1253659,Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model.,,...Analysis was performed with R Statistical Software (v4.1.3) and Seurat (v4.2.0)...,0.9,Accept,Experimental Usage,Seurat (v4.2.0)
PMID:37817770,10.3389/fonc.2023.1253659,Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model.,,...which were automatically identified with ScType using a modified marker list...,0.85,Accept,Experimental Usage,ScType
PMID:37817770,10.3389/fonc.2023.1253659,Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model.,,...Seurat objects for each dataset were merged then split to create lists that can be transformed and normalized using SCTransform...,0.85,Accept,Experimental Usage,SCTransform
PMID:37817770,10.3389/fonc.2023.1253659,Single-cell RNA sequencing of neurofibromas reveals a tumor microenvironment favorable for neural regeneration and immune suppression in a neurofibromatosis type 1 porcine model.,,...The Fast Gene Set Enrichment Analysis (fgsea) package was used to analyze enriched pathways...,0.85,Accept,Experimental Usage,fgsea package
PMID:28542306,10.1371/journal.pone.0178316,Gene signature associated with benign neurofibroma transformation to malignant peripheral nerve sheath tumors.,,Each microarray was preprocessed and evaluated independently using the R/BioConductor software environment [63].,0.85,Accept,Experimental Usage,R/BioConductor software environment
PMID:28542306,10.1371/journal.pone.0178316,Gene signature associated with benign neurofibroma transformation to malignant peripheral nerve sheath tumors.,,"Methylation data were downloaded from GEO, and inspected and analyzed using the MEDIPS R package [68].",0.85,Accept,Experimental Usage,MEDIPS R package
PMID:28542306,10.1371/journal.pone.0178316,Gene signature associated with benign neurofibroma transformation to malignant peripheral nerve sheath tumors.,,The over-representation test for GO terms...was performed through PANTHER v.10 (release 20160715; [64]),0.9,Accept,Experimental Usage,PANTHER v.10
PMID:28542306,10.1371/journal.pone.0178316,Gene signature associated with benign neurofibroma transformation to malignant peripheral nerve sheath tumors.,,"The EnrichNet tool [65] was used to inspect KEGG, BioCarta, Wiki Pathways and Reactome databases",0.85,Accept,Experimental Usage,EnrichNet tool
PMID:28542306,10.1371/journal.pone.0178316,Gene signature associated with benign neurofibroma transformation to malignant peripheral nerve sheath tumors.,,Genes were grouped using SOTA [66] implemented in the analysis and visualization tool MultiexperimentViewer MeV v. 4.9,0.8,Accept,Experimental Usage,SOTA
PMID:28542306,10.1371/journal.pone.0178316,Gene signature associated with benign neurofibroma transformation to malignant peripheral nerve sheath tumors.,,Genes were grouped using SOTA [66] implemented in the analysis and visualization tool MultiexperimentViewer MeV v. 4.9 [67].,0.9,Accept,Experimental Usage,MultiexperimentViewer MeV v. 4.9
PMID:28542306,10.1371/journal.pone.0178316,Gene signature associated with benign neurofibroma transformation to malignant peripheral nerve sheath tumors.,,The search for opposite and similar gene signatures in CMap-DrugMatrix and GEO databases in NFFinder was performed as described [20].,0.85,Accept,Experimental Usage,NFFinder
PMID:39863790,10.1038/s41746-025-01454-z,A multicenter study of neurofibromatosis type 1 utilizing deep learning for whole body tumor identification.,,"U-Net, a convolutional neural network (CNN), was utilized to perform automatic segmentation. The runtime environment for our model was on Python 3.7.1",0.85,Accept,Experimental Usage,U-Net
PMID:39863790,10.1038/s41746-025-01454-z,A multicenter study of neurofibromatosis type 1 utilizing deep learning for whole body tumor identification.,,"ResNet 18, an 18-layer deep CNN model, was employed for our differential diagnosis model. The model was developed using PyTorch.",0.85,Accept,Experimental Usage,ResNet 18
PMID:39863790,10.1038/s41746-025-01454-z,A multicenter study of neurofibromatosis type 1 utilizing deep learning for whole body tumor identification.,,"Another deep learning algorithm, You Only Look Once-v5 (YOLO-v5), was adopted and improved to establish a PNF/MPNST detection and diagnosis system.",0.85,Accept,Experimental Usage,YOLO-v5
PMID:39863790,10.1038/s41746-025-01454-z,A multicenter study of neurofibromatosis type 1 utilizing deep learning for whole body tumor identification.,,The model was developed using PyTorch.,0.8,Accept,Experimental Usage,PyTorch
PMID:39863790,10.1038/s41746-025-01454-z,A multicenter study of neurofibromatosis type 1 utilizing deep learning for whole body tumor identification.,,"using RectLabel (Ryo Kawamura, San Francisco, USA) and Colabeler (Kuaiyi Technology Co., Ltd, Hangzhou, China)",0.85,Accept,Experimental Usage,RectLabel
PMID:39863790,10.1038/s41746-025-01454-z,A multicenter study of neurofibromatosis type 1 utilizing deep learning for whole body tumor identification.,,"using RectLabel (Ryo Kawamura, San Francisco, USA) and Colabeler (Kuaiyi Technology Co., Ltd, Hangzhou, China)",0.85,Accept,Experimental Usage,Colabeler
PMID:39863790,10.1038/s41746-025-01454-z,A multicenter study of neurofibromatosis type 1 utilizing deep learning for whole body tumor identification.,,The Gradient-weighted Class Activation Mapping can visualize the predictive basis of CNN-based deep learning models by generating saliency maps,0.8,Accept,Experimental Usage,Grad-CAM
PMID:16524466,10.1186/1471-2202-7-22,Cognitive dysfunction in NF1 knock-out mice may result from altered vesicular trafficking of APP/DRD3 complex.,,"Gene expression analysis was performed for hippocampal samples dissected from postnatal day 10, 15, and 20 mice utilizing the Affymetrix Mouse Genome chip (Murine 430 2.0).",0.9,Accept,Experimental Usage,Affymetrix Mouse Genome chip (Murine 430 2.0)
PMID:16524466,10.1186/1471-2202-7-22,Cognitive dysfunction in NF1 knock-out mice may result from altered vesicular trafficking of APP/DRD3 complex.,,Data was extracted from the array images using Affymetrix Microarray Suite version 5.1 software (MAS5.0).,0.9,Accept,Experimental Usage,Affymetrix Microarray Suite version 5.1 software (MAS5.0)
PMID:16524466,10.1186/1471-2202-7-22,Cognitive dysfunction in NF1 knock-out mice may result from altered vesicular trafficking of APP/DRD3 complex.,,The modified gene expression data for each individual array was imported into GeneSpring v 5.0 (Agilent Technologies).,0.9,Accept,Experimental Usage,GeneSpring v 5.0 (Agilent Technologies)
PMID:16524466,10.1186/1471-2202-7-22,Cognitive dysfunction in NF1 knock-out mice may result from altered vesicular trafficking of APP/DRD3 complex.,,"The GeneGo network building algorithms (GeneGo, Inc) were used in an iterative fashion to build gene/protein interaction pathways between known NF1 pathway members",0.85,Accept,Experimental Usage,"GeneGo network building algorithms (GeneGo, Inc)"
PMID:16524466,10.1186/1471-2202-7-22,Cognitive dysfunction in NF1 knock-out mice may result from altered vesicular trafficking of APP/DRD3 complex.,,Resulting cDNA was amplified on the Chromo4 Four-Color Real-Time System (MJ Research) using the DyNAmo HS SYBR Green qPCR Kit,0.85,Accept,Experimental Usage,Chromo4 Four-Color Real-Time System (MJ Research)
PMID:31033921,10.1097/MAO.0000000000002272,[18F]fluorothymidine and [18F]fluorodeoxyglucose PET Imaging Demonstrates Uptake and Differentiates Growth in Neurofibromatosis 2 Related Vestibular Schwannoma.,,...were made on T1-weighted (T1W) postcontrast imaging using the semiautomatic segmentation tool within the Brainlab iPlan software (Brainlab AG Germany)...,0.8,Accept,Experimental Usage,Brainlab iPlan software
PMID:31033921,10.1097/MAO.0000000000002272,[18F]fluorothymidine and [18F]fluorodeoxyglucose PET Imaging Demonstrates Uptake and Differentiates Growth in Neurofibromatosis 2 Related Vestibular Schwannoma.,,"...Using SPM 8 (http://www.fil.ion.ucl.ac.uk/spm), contrast enhanced T1W MRIs were coregistered to the 30 minutes motion corrected PET images...",0.8,Accept,Experimental Usage,SPM 8
PMID:31033921,10.1097/MAO.0000000000002272,[18F]fluorothymidine and [18F]fluorodeoxyglucose PET Imaging Demonstrates Uptake and Differentiates Growth in Neurofibromatosis 2 Related Vestibular Schwannoma.,,"...All manual outlining was done using Analyze version 11 and was performed under the supervision of AJ and ID, consultant neuroradiologists...",0.8,Accept,Experimental Usage,Analyze version 11
PMID:31033921,10.1097/MAO.0000000000002272,[18F]fluorothymidine and [18F]fluorodeoxyglucose PET Imaging Demonstrates Uptake and Differentiates Growth in Neurofibromatosis 2 Related Vestibular Schwannoma.,,"...For the TrueV scanner, the Siemens offline reconstruction package ""e7_tools"" was used with an image zoom of two resulting in images...",0.75,Accept,Experimental Usage,e7_tools
PMID:31033921,10.1097/MAO.0000000000002272,[18F]fluorothymidine and [18F]fluorodeoxyglucose PET Imaging Demonstrates Uptake and Differentiates Growth in Neurofibromatosis 2 Related Vestibular Schwannoma.,,...HRRT data was reconstructed using HRRT user community software generating images consisting of 256 × 256 × 207 voxels...,0.75,Accept,Experimental Usage,HRRT user community software
PMID:31033921,10.1097/MAO.0000000000002272,[18F]fluorothymidine and [18F]fluorodeoxyglucose PET Imaging Demonstrates Uptake and Differentiates Growth in Neurofibromatosis 2 Related Vestibular Schwannoma.,,...SPSS version 23 was used for all statistical analyses. The normality and homogeneity of variance for derived values was assessed...,0.8,Accept,Experimental Usage,SPSS version 23
PMID:33413690,10.1186/s40478-020-01103-4,Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing.,,qPCR was performed on a Bio-Rad FX96 apparatus using Bio-Rad iSCRIPT master mix,0.9,Accept,Experimental Usage,Bio-Rad FX96
PMID:33413690,10.1186/s40478-020-01103-4,Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing.,,"A freshly prepared single cell suspension of ~ 10,000 cells per sample was loaded into a 10X Genomics Chromium controller for transcript barcoding",0.9,Accept,Experimental Usage,10X Genomics Chromium controller
PMID:33413690,10.1186/s40478-020-01103-4,Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing.,,loaded into a 10X Genomics Chromium controller for transcript barcoding and sequenced on an Illumina HiSeq sequencer,0.9,Accept,Experimental Usage,Illumina HiSeq sequencer
PMID:33413690,10.1186/s40478-020-01103-4,Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing.,,Cell Ranger version 3.0.0 (10× Genomics) was used to process the raw sequencing data,0.95,Accept,Experimental Usage,Cell Ranger version 3.0.0
PMID:33413690,10.1186/s40478-020-01103-4,Human cutaneous neurofibroma matrisome revealed by single-cell RNA sequencing.,,The gene x cell expression matrices were loaded to the R package Seurat version 3.0.0 for downstream analyses,0.95,Accept,Experimental Usage,Seurat version 3.0.0
PMID:37440099,10.1007/s11060-023-04389-1,The impact of a virtual mind-body program on resilience factors among international English-speaking adults with neurofibromatoses: secondary analysis of a randomized clinical trial.,,"completed assessment measures at baseline, post-intervention, and at 6- and 12-month follow-up via REDCap, a secure online data collection and management system",0.85,Accept,Experimental Usage,REDCap
PMID:25433207,10.1016/j.ydbio.2014.11.017,Nf2-Yap signaling controls the expansion of DRG progenitors and glia during DRG development.,,Cell counting was performed using the ImageJ software,0.8,Accept,Experimental Usage,ImageJ software
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,selected by flow cytometry using a SH800 sorter (Sony),0.9,Accept,Experimental Usage,SH800 sorter (Sony)
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,"CellTiter 96 Non-Radioactive Cell Proliferation Assay (#G410, Promega) and a Glomax Discovery Multimode Microplate Reader (Promega)",0.9,Accept,Experimental Usage,Glomax Discovery Multimode Microplate Reader (Promega)
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,RNA quality was assessed by chip-based electrophoresis on a BioAnalyzer 2100 using the RNA 6000 Nano Kit,0.9,Accept,Experimental Usage,BioAnalyzer 2100
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,50 bp single end reads were sequenced on an Illumina HiSeq 2500 or NovaSeq,0.9,Accept,Experimental Usage,Illumina HiSeq 2500
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,50 bp single end reads were sequenced on an Illumina HiSeq 2500 or NovaSeq,0.9,Accept,Experimental Usage,NovaSeq
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,Quality control of FASTQ files was performed with FASTQC,0.85,Accept,Experimental Usage,FASTQC
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,Reads were mapped to the appropriate reference genome (hg19) using HISAT2 with default parameters,0.85,Accept,Experimental Usage,HISAT2
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,Transcript abundance estimation in transcripts per million (TPM) and differential expression analysis were performed using DESeq2,0.85,Accept,Experimental Usage,DESeq2
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,"PowerUp SYBR Green Master Mix (#A25918, Thermo Fisher Scientific) on a QuantStudio 6 Flex Real Time PCR system (Life Technologies)",0.9,Accept,Experimental Usage,QuantStudio 6 Flex Real Time PCR system (Life Technologies)
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,separated by reversed-phase chromatography using a Vanquish Neo high-performance liquid chromatography (HPLC) instrument (Thermo Fisher Scientific),0.9,Accept,Experimental Usage,Vanquish Neo high-performance liquid chromatography (HPLC) instrument (Thermo Fisher Scientific)
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,Eluting peptides were analyzed by an Orbitrap Exploris MS instrument (ThermoFisher Scientific),0.9,Accept,Experimental Usage,Orbitrap Exploris MS instrument (ThermoFisher Scientific)
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,Raw mass spectrometry data were searched using Fragpipe (v22),0.9,Accept,Experimental Usage,Fragpipe (v22)
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,using PhosphoLFQ ( 36 – 38 ) label-free quantification workflow,0.85,Accept,Experimental Usage,PhosphoLFQ
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,Statistical analysis was performed using MSstats (v4.8.7),0.9,Accept,Experimental Usage,MSstats (v4.8.7)
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,MSstats (v4.8.7) ( 39 ) from the artMS (v1.18.0) R package,0.9,Accept,Experimental Usage,artMS (v1.18.0)
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,Kinase enrichment analysis was performed using RoKAI Differential Expression analysis,0.85,Accept,Experimental Usage,RoKAI Differential Expression analysis
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,Eluting peptides were analyzed by an Orbitrap Lumos MS instrument (ThermoFisher Scientific),0.9,Accept,Experimental Usage,Orbitrap Lumos MS instrument (ThermoFisher Scientific)
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,APEX-labeled samples were acquired on a Bruker TimsTOFpro interfaced with an Ultimate3000 UHPLC,0.9,Accept,Experimental Usage,Bruker TimsTOFpro
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,acquired on a Bruker TimsTOFpro interfaced with an Ultimate3000 UHPLC,0.9,Accept,Experimental Usage,Ultimate3000 UHPLC
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,Raw mass spectrometry files were analyzed using Spectronaut (version 18.4.231017.55695),0.9,Accept,Experimental Usage,Spectronaut (version 18.4.231017.55695)
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,Visualization was performed in Cytoscape with additional connections included from the STRING database,0.85,Accept,Experimental Usage,Cytoscape
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,Visualization was performed in Cytoscape with additional connections included from the STRING database,0.85,Accept,Experimental Usage,STRING database
PMID:40587782,10.1073/pnas.2506823122,"A transcriptomic, proteomic, and functional genetic atlas dissects neurofibromin function in the peripheral nervous system.",,Quantification was performed in ImageJ (NIH) using the relative densitometry,0.85,Accept,Experimental Usage,ImageJ (NIH)
PMID:32443592,10.3390/ijms21103569,C-Fiber Loss as a Possible Cause of Neuropathic Pain in Schwannomatosis.,,"QST statistical analysis was performed using ""eQUISTA"" (Casquar GmbH, Bochum, Germany), which calculates a sensory profile by transformation",0.85,Accept,Experimental Usage,eQUISTA
PMID:32443592,10.3390/ijms21103569,C-Fiber Loss as a Possible Cause of Neuropathic Pain in Schwannomatosis.,,"EEG was recorded with nose-reference using 64 active channels (EASY CAP) and BrainVision Recorder-software (Brain Products GmbH, Gilching, Germany)",0.85,Accept,Experimental Usage,BrainVision Recorder-software
PMID:32443592,10.3390/ijms21103569,C-Fiber Loss as a Possible Cause of Neuropathic Pain in Schwannomatosis.,,"The data were analyzed offline using Fieldtrip software (Donders Centre for Cognitive Neuroimaging, AH Nijmegen, The Netherlands, www.ru.nl/fcdonders/fieldtrip)",0.85,Accept,Experimental Usage,Fieldtrip software
PMID:28065690,10.1016/j.biochi.2017.01.001,Medium throughput biochemical compound screening identifies novel agents for pharmacotherapy of neurofibromatosis type 1.,,"The values of IC50, the drug concentration required for 50% growth inhibition, were calculated using software package Calcusyn (Biosoft)",0.85,Accept,Experimental Usage,Calcusyn
PMID:30290804,10.1186/s12929-018-0474-9,Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.,,"The quality of the DNA was estimated using the Nano-Drop spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA).",0.8,Accept,Experimental Usage,Nano-Drop spectrophotometer
PMID:30290804,10.1186/s12929-018-0474-9,Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.,,"In this study, we took the advantage of this gene panel for the germline mutation analysis of NF1 using the Ion Personal Genome Machine® (PGM™) Sequencer (Life technology).",0.9,Accept,Experimental Usage,Ion Personal Genome Machine® (PGM™) Sequencer
PMID:30290804,10.1186/s12929-018-0474-9,Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.,,"the size distribution of the DNA fragments was analyzed on the Agilent Bioanalyzer using High-Sensitivity DNA chip (Agilent Technologies Inc., Santa Clara, CA)",0.85,Accept,Experimental Usage,Agilent Bioanalyzer
PMID:30290804,10.1186/s12929-018-0474-9,Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.,,the quality checking of ion sphere particles for the prepared library was performed using Qubit 2.0 Fluorometer (Life Technologies).,0.85,Accept,Experimental Usage,Qubit 2.0 Fluorometer
PMID:30290804,10.1186/s12929-018-0474-9,Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.,,"We used IT platform-specific pipeline software Torrent Suite, version 4.2, with the plug-in ""variant caller"" program (Life Technologies) to perform reference genome alignment",0.9,Accept,Experimental Usage,"Torrent Suite, version 4.2"
PMID:30290804,10.1186/s12929-018-0474-9,Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.,,The Integrative Genome Viewer (IGV) ( http://software.broadinstitute.org/software/igv/ ) was used for visualizing the status of each read alignment.,0.9,Accept,Experimental Usage,Integrative Genome Viewer (IGV)
PMID:30290804,10.1186/s12929-018-0474-9,Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.,,Variants with amino acid changes were further examined for whether the changes were potentially damaging alterations using Sorting Tolerant From Intolerant (SIFT),0.85,Accept,Experimental Usage,Sorting Tolerant From Intolerant (SIFT)
PMID:30290804,10.1186/s12929-018-0474-9,Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.,,"using Sorting Tolerant From Intolerant (SIFT) and Polymorphism Phenotyping v2 (PolyPhen2) softwares, which can predict the possible impact of an amino acid substitution",0.85,Accept,Experimental Usage,Polymorphism Phenotyping v2 (PolyPhen2)
PMID:30290804,10.1186/s12929-018-0474-9,Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.,,"We performed Sanger validation for all putatively pathogenic SNVs and indels variants on each detected patient (and their family members, if available) by PCR amplification and sequenced with Applied Biosystems 3730 Genetic Analyzer.",0.85,Accept,Experimental Usage,Applied Biosystems 3730 Genetic Analyzer
PMID:30290804,10.1186/s12929-018-0474-9,Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.,,analyzed on an Applied Biosystems 3730xl Automated Sequencer Genetic Analyzer (Life Technologies).,0.85,Accept,Experimental Usage,Applied Biosystems 3730xl Automated Sequencer Genetic Analyzer
PMID:30290804,10.1186/s12929-018-0474-9,Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.,,Sequence alignments and analysis were further performed using the Autoassembler computer program (Life Technologies).,0.8,Accept,Experimental Usage,Autoassembler computer program
PMID:30290804,10.1186/s12929-018-0474-9,Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.,,the PCR products were analyzed on a Genetic Analyzer 3730 capillary electrophoresis system and interpreted using Genotyper version 2.0,0.85,Accept,Experimental Usage,Genetic Analyzer 3730 capillary electrophoresis system
PMID:30290804,10.1186/s12929-018-0474-9,Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.,,"analyzed on a Genetic Analyzer 3730 capillary electrophoresis system and interpreted using Genotyper version 2.0 (Applied Biosystems, CA, USA).",0.85,Accept,Experimental Usage,Genotyper version 2.0
PMID:30290804,10.1186/s12929-018-0474-9,Genetic diagnosis of neurofibromatosis type 1: targeted next- generation sequencing with Multiple Ligation-Dependent Probe Amplification analysis.,,"In this study, we used the Coffalyser program (version 3.5) for peak area normalization and gene dosage calculation.",0.85,Accept,Experimental Usage,Coffalyser program (version 3.5)
PMID:24848258,10.1126/scitranslmed.3008639,Merlin deficiency predicts FAK inhibitor sensitivity: a synthetic lethal relationship.,,Statistical analysis was performed using Prism 6 software.,0.85,Accept,Experimental Usage,Prism 6 software
PMID:33279959,10.1093/brain/awaa404,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",,Guide RNAs (gRNAs) were designed using the CHOPCHOP website (http://chopchop.cbu.uib.no/),0.85,Accept,Experimental Usage,CHOPCHOP website
PMID:33279959,10.1093/brain/awaa404,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",,the staining was evaluated with Image-Pro Plus software (Media Cybernetics Inc.),0.8,Accept,Experimental Usage,Image-Pro Plus software
PMID:33279959,10.1093/brain/awaa404,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",,"The analysis was performed using GeneMaths software (Applied Maths, Inc., Austin, TX) with Pearson correlation as the similarity coefficient",0.8,Accept,Experimental Usage,GeneMaths software
PMID:33279959,10.1093/brain/awaa404,"Stepwise crosstalk between aberrant Nf1, Tp53 and Rb signalling pathways induces gliomagenesis in zebrafish.",,the travelling distance of each larva was analysed using DanioVision software (Noldus),0.8,Accept,Experimental Usage,DanioVision software
PMID:38900740,10.1371/journal.pone.0301040,Revisiting the NPcis mouse model: A new tool to model plexiform neurofibroma.,,Relative expression was calculated using qBase,0.85,Accept,Experimental Usage,qBase
PMID:29566645,10.1186/s11689-018-9230-4,"Oscillatory motor patterning is impaired in neurofibromatosis type 1: a behavioural, EEG and fMRI study.",,"The paradigm was designed and presented using the Psychophysics Toolbox 3 [32, 33], running on Matlab R2013b",0.8,Accept,Experimental Usage,Psychophysics Toolbox 3
PMID:29566645,10.1186/s11689-018-9230-4,"Oscillatory motor patterning is impaired in neurofibromatosis type 1: a behavioural, EEG and fMRI study.",,"The complete processing pipeline and analysis of the functional data was done using BrainVoyager QX 2.8.2 (Brain Innovation, Maastricht, The Netherlands)",0.9,Accept,Experimental Usage,BrainVoyager QX 2.8.2
PMID:29566645,10.1186/s11689-018-9230-4,"Oscillatory motor patterning is impaired in neurofibromatosis type 1: a behavioural, EEG and fMRI study.",,"Data were acquired using Scan 4.5 (NeuroScan, Compumedics, Charlotte, NC), and the acquisition reference was set to an electrode",0.8,Accept,Experimental Usage,Scan 4.5
PMID:29566645,10.1186/s11689-018-9230-4,"Oscillatory motor patterning is impaired in neurofibromatosis type 1: a behavioural, EEG and fMRI study.",,"The processing was performed using the EEGlab toolbox [34] for Matlab (MathWorks, Natick, MA)",0.85,Accept,Experimental Usage,EEGlab toolbox
PMID:32245042,10.3390/genes11030331,Kinome Profiling of NF1-Related MPNSTs in Response to Kinase Inhibition and Doxorubicin Reveals Therapeutic Vulnerabilities.,,"15,000 tumor cells was isolated from the surrounding microenvironment using a Pixcell II LCM system (Arcturus, Mountain View, CA, USA)",0.85,Accept,Experimental Usage,Pixcell II LCM system
PMID:32245042,10.3390/genes11030331,Kinome Profiling of NF1-Related MPNSTs in Response to Kinase Inhibition and Doxorubicin Reveals Therapeutic Vulnerabilities.,,"Using an Aushon 2470 arrayer (Aushon BioSystems, Billerica, MA, USA) equipped with 185 μm pins, samples and standard curves",0.85,Accept,Experimental Usage,Aushon 2470 arrayer
PMID:32245042,10.3390/genes11030331,Kinome Profiling of NF1-Related MPNSTs in Response to Kinase Inhibition and Doxorubicin Reveals Therapeutic Vulnerabilities.,,"Acquired images were analysed using the MicroVigene software version 5.1 (Vigene Tech, Carlisle, MA, USA)",0.9,Accept,Experimental Usage,MicroVigene software version 5.1
PMID:32245042,10.3390/genes11030331,Kinome Profiling of NF1-Related MPNSTs in Response to Kinase Inhibition and Doxorubicin Reveals Therapeutic Vulnerabilities.,,"All analyses were conducted using R v3.2.2 (https://cran.r-project.org/), with an assumed level of significance of α = 0.05",0.8,Accept,Experimental Usage,R v3.2.2
PMID:32245042,10.3390/genes11030331,Kinome Profiling of NF1-Related MPNSTs in Response to Kinase Inhibition and Doxorubicin Reveals Therapeutic Vulnerabilities.,,Plots were generated using R v3.6.1,0.8,Accept,Experimental Usage,R v3.6.1
PMID:32245042,10.3390/genes11030331,Kinome Profiling of NF1-Related MPNSTs in Response to Kinase Inhibition and Doxorubicin Reveals Therapeutic Vulnerabilities.,,data were fit by stat_smooth using loess with span = 1 using ggplot2 (v3.2.1),0.8,Accept,Experimental Usage,ggplot2 (v3.2.1)
PMID:32245042,10.3390/genes11030331,Kinome Profiling of NF1-Related MPNSTs in Response to Kinase Inhibition and Doxorubicin Reveals Therapeutic Vulnerabilities.,,All analyses were done using R (v3.6.2),0.8,Accept,Experimental Usage,R (v3.6.2)
PMID:29137242,10.18632/oncotarget.18301,Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy.,,"samples were washed twice with buffer, resuspended in 1% paraformaldehyde fixative, and analyzed on a BD FACS LSR II using BD FACSDiVa software version 4.0",0.85,Accept,Experimental Usage,BD FACS LSR II
PMID:29137242,10.18632/oncotarget.18301,Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy.,,analyzed on a BD FACS LSR II using BD FACSDiVa software version 4.0 (BD Biosciences),0.85,Accept,Experimental Usage,BD FACSDiVa software version 4.0
PMID:29137242,10.18632/oncotarget.18301,Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy.,,Flow cytometry data analysis was performed using FlowJo version 7.6.5 (Tree Star),0.85,Accept,Experimental Usage,FlowJo version 7.6.5
PMID:29137242,10.18632/oncotarget.18301,Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy.,,All stages of the immunohistochemistry procedure were automated on the Bond III Immunohistochemistry (IHC) system (Leica Microsystems),0.85,Accept,Experimental Usage,Bond III Immunohistochemistry (IHC) system
PMID:29137242,10.18632/oncotarget.18301,Immune profiling of NF1-associated tumors reveals histologic subtype distinctions and heterogeneity: implications for immunotherapy.,,Data were processed using GeneSpring GX v7.3.1 (Agilent Technologies) with background correction and Robust Multi-array Average (RMA) normalization,0.85,Accept,Experimental Usage,GeneSpring GX v7.3.1
PMID:29662612,10.18632/oncotarget.19335,Exploiting mitochondrial and metabolic homeostasis as a vulnerability in NF1 deficient cells.,,Analyses were performed using BRB-Array Tools Version 4.2.1. BRB-ArrayTools is an integrated software package for the analysis of DNA microarray data,0.85,Accept,Experimental Usage,BRB-Array Tools Version 4.2.1
PMID:29662612,10.18632/oncotarget.19335,Exploiting mitochondrial and metabolic homeostasis as a vulnerability in NF1 deficient cells.,,Hierarchical clustering was employed to generate heat maps for subsets of significant genes using the open source software Cluster/Treeview written by Michael Eisen,0.8,Accept,Experimental Usage,Cluster/Treeview
PMID:29662612,10.18632/oncotarget.19335,Exploiting mitochondrial and metabolic homeostasis as a vulnerability in NF1 deficient cells.,,"Bioenergetics analysis was performed with a Seahorse XF96 Bioanalyzer (Agilent Technologies, Santa Clara, CA)",0.85,Accept,Experimental Usage,Seahorse XF96 Bioanalyzer
PMID:29662612,10.18632/oncotarget.19335,Exploiting mitochondrial and metabolic homeostasis as a vulnerability in NF1 deficient cells.,,"Both experiments were repeated a minimum of three times, with a representative experiment shown. The analysis was performed with Seahorse Wave 2.2/2.3",0.85,Accept,Experimental Usage,Seahorse Wave 2.2/2.3
PMID:26066488,10.1371/journal.pone.0129099,A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene.,,"All sample libraries were equimolarly pooled and sequenced on the Illumina MiSeq Sequencer (Illumina, San Diego, CA, USA) with MiSeq Reagent Kit v2",0.85,Accept,Experimental Usage,Illumina MiSeq Sequencer
PMID:26066488,10.1371/journal.pone.0129099,A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene.,,Amplicon reads were aligned against the human reference genome hg19 with BWA MEM,0.8,Accept,Experimental Usage,BWA MEM
PMID:26066488,10.1371/journal.pone.0129099,A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene.,,GATK version 2.5.2 was used to recalibrate base qualities and realign aligned reads around indels,0.85,Accept,Experimental Usage,GATK version 2.5.2
PMID:26066488,10.1371/journal.pone.0129099,A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene.,,SNVs were identified using MuTect version 1.1.4 with standard parameters,0.85,Accept,Experimental Usage,MuTect version 1.1.4
PMID:26066488,10.1371/journal.pone.0129099,A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene.,,GATK IndelGenotyperV2 (with minFraction = 0.001 and minCnt = 3) was used to detect InDels,0.85,Accept,Experimental Usage,GATK IndelGenotyperV2
PMID:26066488,10.1371/journal.pone.0129099,A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene.,,Genomic and functional annotation of detected variants was made by Annovar,0.8,Accept,Experimental Usage,Annovar
PMID:26066488,10.1371/journal.pone.0129099,A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene.,,"HRM analysis was performed on the Rotor Gene 6000 Instrument (Corbett Research, Sydney, Australia)",0.85,Accept,Experimental Usage,Rotor Gene 6000 Instrument
PMID:26066488,10.1371/journal.pone.0129099,A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene.,,"BigDye Terminator v1.1 Cycle Sequencing Kit (Life Technologies Applied Biosystems, Austin, Texas, USA) and a model 310 automated sequencer",0.85,Accept,Experimental Usage,model 310 automated sequencer
PMID:26066488,10.1371/journal.pone.0129099,A Systematic Assessment of Accuracy in Detecting Somatic Mosaic Variants by Deep Amplicon Sequencing: Application to NF2 Gene.,,"Electrophoresis data were analyzed by GeneMapper software (Life Technologies, Carlsbad, CA, USA)",0.85,Accept,Experimental Usage,GeneMapper software
PMID:19306381,10.1002/glia.20866,Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells.,,"The number of cells in each photographed field were counted using Image Pro Plus (version 4.1) software (Media Cybernetics; Silver Springs, MD)",0.85,Accept,Experimental Usage,Image Pro Plus (version 4.1)
PMID:19306381,10.1002/glia.20866,Neuregulin-1 beta and neuregulin-1 alpha differentially affect the migration and invasion of malignant peripheral nerve sheath tumor cells.,,"controlled by a computer equipped with StereoInvestigator software (MBF Bioscience, Inc.; Williston, VT)",0.85,Accept,Experimental Usage,StereoInvestigator software
PMID:28644838,10.1371/journal.pone.0178639,"Characterization and utilization of an international neurofibromatosis web-based, patient-entered registry: An observational study.",,The spreadsheets were converted to text files (comma-separated) and imported into the R Statistical Environment V 3.2.4,0.85,Accept,Experimental Usage,R Statistical Environment V 3.2.4
PMID:28644838,10.1371/journal.pone.0178639,"Characterization and utilization of an international neurofibromatosis web-based, patient-entered registry: An observational study.",,Tabulations were performed using the stat.table function of the Epi package,0.8,Accept,Experimental Usage,Epi package
PMID:28644838,10.1371/journal.pone.0178639,"Characterization and utilization of an international neurofibromatosis web-based, patient-entered registry: An observational study.",,Invitae uses MySQL Server as the back-end relational database,0.75,Accept,Experimental Usage,MySQL Server
PMID:24686726,10.1038/oncsis.2014.10,Activation of Sonic hedgehog signaling in neural progenitor cells promotes glioma development in the zebrafish optic pathway.,,"Microarray was performed using Agilent-026437 (Agilent, Santa Clara, CA, USA), Zebrafish GX v3 4×44K",0.85,Accept,Experimental Usage,Agilent-026437 Zebrafish GX v3 4×44K
PMID:18931645,10.1097/MAO.0b013e31818b6cea,Bioluminescent imaging of intracranial vestibular schwannoma xenografts in NOD/SCID mice.,,"Ten minutes after luciferin injection, mice were imaged with an IVIS 2.50 cooled charged-coupled device camera (Xenogen 200 series)",0.9,Accept,Experimental Usage,IVIS 2.50 cooled charged-coupled device camera
PMID:18931645,10.1097/MAO.0b013e31818b6cea,Bioluminescent imaging of intracranial vestibular schwannoma xenografts in NOD/SCID mice.,,"For BLI analysis, an intracranial area of signal was defined using Living Image software, and the total number of photons per second per steradian centimeter was recorded",0.85,Accept,Experimental Usage,Living Image software
PMID:41616055,10.1126/sciadv.ady8382,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,,"Abnormal tissue and nuclear quantifications were performed using H&E-stained slides and a custom or pretrained HALO AI DenseNet module, respectively (Indica Labs, version 4.0, RRID:SCR_018350)",0.9,Accept,Experimental Usage,HALO AI DenseNet module
PMID:41616055,10.1126/sciadv.ady8382,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,,"Synergy graphs and Zero Interaction Potency score (ZIP), Loewe, and Bliss synergy scores were computed using the SynergyFinder package (version 3.2, RRID:SCR_019318) in R",0.9,Accept,Experimental Usage,SynergyFinder package
PMID:41616055,10.1126/sciadv.ady8382,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,,Log 2 [counts per million (CPM) + 4] normalization of raw counts was performed using iDEP.96,0.9,Accept,Experimental Usage,iDEP.96
PMID:41616055,10.1126/sciadv.ady8382,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,,Plots for gene set enrichment (Figs. 2 and 3) and cell type mapping (reference dataset: LM22) were generated in Omics Playground software v2.7.18,0.9,Accept,Experimental Usage,Omics Playground software
PMID:41616055,10.1126/sciadv.ady8382,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,,"The filtered_bc_matrix.h5 files were read into R using the Read10X_h5 function in Seurat (version 4.0.2, RRID:SCR_016341)",0.9,Accept,Experimental Usage,Seurat
PMID:41616055,10.1126/sciadv.ady8382,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,,"CellChat (version 2.1.2, RRID:SCR_021946) was used to assess cell-cell communication within human VS",0.9,Accept,Experimental Usage,CellChat
PMID:41616055,10.1126/sciadv.ady8382,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,,Raw files were processed for label-free quantification (LFQ) using MaxQuant LFQ and default parameters,0.9,Accept,Experimental Usage,MaxQuant
PMID:41616055,10.1126/sciadv.ady8382,Inhibition of focal adhesion kinase impairs tumor formation and preserves hearing in a murine model of NF2-related schwannomatosis.,,"Arbitrary densitometry units were calculated and quantified using the ImageJ software [National Institutes of Health (NIH), version 1.53]",0.9,Accept,Experimental Usage,ImageJ
PMID:29590612,10.1016/j.celrep.2018.03.014,A Conserved Circadian Function for the Neurofibromatosis 1 Gene.,,"Locomotor activity during days 1–7 in constant darkness was analyzed with Clocklab software (Actimetrics, Wilmette, IL)",0.85,Accept,Experimental Usage,Clocklab software
PMID:29590612,10.1016/j.celrep.2018.03.014,A Conserved Circadian Function for the Neurofibromatosis 1 Gene.,,calcium data were subjected to Jonckheere-Terpstra-Kendall (JTK)_CYCLE and Lomb-Scargle (LS) analysis using the Meta-cycle R program,0.85,Accept,Experimental Usage,Meta-cycle R program
PMID:29590612,10.1016/j.celrep.2018.03.014,A Conserved Circadian Function for the Neurofibromatosis 1 Gene.,,All images were analyzed with ImageJ software,0.8,Accept,Experimental Usage,ImageJ software
PMID:17216419,10.1007/s10048-006-0078-5,Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies.,,The GeneNetwork (http://www.genenetwork.org/search.html) was searched for Nf1 in mouse B×D datasets from the brain,0.8,Accept,Experimental Usage,GeneNetwork
PMID:17216419,10.1007/s10048-006-0078-5,Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies.,,WebQTL interval mapping was used to determine regions of the genome responsible for variation in Nf1 expression levels across different B×D strains,0.8,Accept,Experimental Usage,WebQTL
PMID:17216419,10.1007/s10048-006-0078-5,Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies.,,Probe sets were verified for their binding to the Nf1 mRNA using a blast-like alignment tool (BLAT) search in the UCSC Genome Browser,0.75,Accept,Experimental Usage,UCSC Genome Browser
PMID:17216419,10.1007/s10048-006-0078-5,Nf1 expression is dependent on strain background: implications for tumor suppressor haploinsufficiency studies.,,"PCR products were analyzed for the number of cycles required to reach the threshold using a quantitative real-time PCR machine, the MX4000 (Stratagene)",0.85,Accept,Experimental Usage,MX4000 (Stratagene)
PMID:27760236,10.1001/jamapsychiatry.2016.2600,Disease Burden and Symptom Structure of Autism in Neurofibromatosis Type 1: A Study of the International NF1-ASD Consortium Team (INFACT).,,"With the use of empirically derived SRS factors, a series of mixture models (MPlus, version 7.3) were used to investigate the presence of latent classes",0.85,Accept,Experimental Usage,"MPlus, version 7.3"
PMID:18927496,10.4161/cbt.7.12.6942,Suppression of proliferation of two independent NF1 malignant peripheral nerve sheath tumor cell lines by the pan-ErbB inhibitor CI-1033.,,"DNA analyses were made with a FACScalibur instrument (BD Biosciences, San Jose, CA)",0.85,Accept,Experimental Usage,FACScalibur
PMID:18927496,10.4161/cbt.7.12.6942,Suppression of proliferation of two independent NF1 malignant peripheral nerve sheath tumor cell lines by the pan-ErbB inhibitor CI-1033.,,"Percentages of cells in the G0/G1, S, and G2/M stages of the cell cycle were determined with a DNA histogram-fitting program (MODFIT; Verity Software, Topsham, ME)",0.85,Accept,Experimental Usage,MODFIT
PMID:18927496,10.4161/cbt.7.12.6942,Suppression of proliferation of two independent NF1 malignant peripheral nerve sheath tumor cell lines by the pan-ErbB inhibitor CI-1033.,,"ImageQuant software (GE Healthcare, Piscataway, NJ) was used for densitometry and quantification of immunoblot signals",0.85,Accept,Experimental Usage,ImageQuant software
PMID:18671844,10.1186/1741-7015-6-21,Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin.,,Methacrylate embedded tibiae were scanned in plastic blocks using a vivaCT40 scanner from ScancoMedical,0.9,Accept,Experimental Usage,vivaCT40 scanner
PMID:18984156,10.1016/j.cell.2008.08.041,Nf1-dependent tumors require a microenvironment containing Nf1+/-- and c-kit-dependent bone marrow.,,"examined with a FEI Tecnai G2 electron microscope (Philips, Eindhoven, Netherlands).",0.85,Accept,Experimental Usage,FEI Tecnai G2 electron microscope
